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Treatment ofAqueous n'aste Streams at Eli Lilly—Alternatives to Incineration

Abstract
The aim of this project ivas to investigate the potential to treat liquid waste (secondary) from
production processes at Eli Lilly with the emphasis on minimising the volume of waste sent for
thermal oxidation. In addition, the project aimed to investigate if the chosen technology was diverse
and potentially capable of handling waste streams from different processes. Membrane technology
was identified as one of the most suitable technologies and trials were carried out on secondary
waste from three production processes. The literature review and practical thals aswell as
assessment of trial results ran from October 2003 to June 2005.
All the production process waste streams were characterized using a “stream selection matrix’’
whereby streams were scored on such qualities as the annual volume of waste being produced
from each process forecast for the coming years, the pharmaceutical molecule size for the relevant
production process and the campaign duration of each process during the production period. From
this system, waste from three production processes was selected to bring forward to small scale
trials. Membrane plant manufacturers were also contacted and a screening process was
undertaken to find the most suitable companies to work with. From this process, two vendors were
chosen to carry out pilot thals on each of the three chosen production waste streams.
Pilot thals were carhed out on each waste stream and a successful volume reduction and API
rejection was achieved on the Tilmicosin process waste stream while limited success was achieved
on the remaining two process waste streams. In light of the successful first round thals on the
Tilmicosin waste stream, a second round of thals were planned and carhed out so as to further
assess the repeatability of results on a larger scale and also to obtain design information for a
potential full scale plant. The initial targeted goal of the thals was to achieve an overall volume
reduction of 75% and also to consistently achieve the desired API removal so as to remain
significantly and consistently below limits for API emissions to the environment. Results from these
trials indicated that for the Tilmicosin waste stream the process required two membrane passes and
when cleaning volumes were taken into account the achievable volume reduction was 60%. This
result was deemed to be satisfactory and as a result funding was given for a full scale plant to
process Tilmicosin waste. The plant became fully operational in March 2006.
This technology is seen as potentially playing a large role in the treatment of waste on Lilly sites
wohdwide and as a result it is likely that further research will be carhed out in this field in the near
future.
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Chapter 1 Project Overview

Summary
This chapter gives an overview of the current processes for disposing of production process waste
on site at Lilly. From this overview it is obvious how, economically and environmentally, there are
many dhvers to reduce the amount of liquid process waste being disposed of by thermal oxidization
on site. The process of reviewing alternative technologies aswell as the final selection on a
technology to bring forward to pilot trials is also discussed and summarised
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1.0 Overview of the company
Eli Lilly S.A. - Irish Branch is the Irish affiliate of Eli Lilly and company. It is a research orientated
company that sells human health products, cosmetics and agricultural products in more than 138
countries. The home office of the company is located in Indianapolis, Indiana, USA. The company
base in Ireland is at Dunderrow, Co, Cork, located approximately three miles from Kinsale town. It
currently employs 450 people, mostly from the surrounding locality. The plant is involved in scale-up
and validation of new products for clinical trials, registration and product launch. The facility makes
intermediate and final products for both the human and animal health divisions of the company,
primarily serving customers outside the USA, but product is also manufactured for the American
market.
Manufacturing varies from dedicated facilities, where only a single product is produced, to multi
product campaigned equipment. Production scale ranges from 8,000L reactors to small laboratory
scale production. Computer systems monitor each production step through detailed process
recipes. This technology enables the safe and controlled manufacture of products, assuring quality,
through automation.
The site is divided into four production areas namely IE 2, IE3, IE8 and IE16. IE2 is a small scale
production area capable of producing human health dmgs. Development work for several new
reactions that use less raw material and produce less waste is investigated here. Currently there is
no production in the IE2 building but the facility may come into use again in the near future,
depending on the level of demand for current products aswell as any development work that may
need to be done for new products. The three remaining production buildings are large scale
production buildings. IE3 is dedicated to the production of animal health products. The building has
a single production rig and products are manufactured here on a campaign basis. Two of the
products currently manufactured in the building are used as an antibiotic for respiratory disease in
livestock and a lean meat enhancer in livestock respectively. In IE8 there are three production rigs,
each separately contained, allowing three distinct processes to run simultaneously at any time. Two
rigs, the Intermediate and Technical rigs, produce intermediate step products that are transformed
into finished production on the Final Bulk rig. A total of seven finished products are produced in this
building with purposes ranging from treating Attention Deficit Disorder in children to a drug for the
treatment and prevention of postmenopausal osteoporosis. In IE16 there are two production rigs,
each separately contained, allowing two processes to run simultaneously. One of the rigs is of a
much smaller scale than the other and the rigs are therefore named Large Scale and Small Scale.
Market demands dictate how much of each product is produced and production is scheduled
around this demand. This means that the products are run on a campaign basis. A certain number
of batches are produced on a chosen equipment rig, the rig is then cleaned (to remove trace
product) for the next production campaign.
A fifth production building was constructed while this project was being worked on. Again this facility
concentrates on the production of human health products. This plant commenced production in
2006.
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Lilly recognize the importance of investing in research and development to maintain a healthy
product pipeline for the company. In 2003, Lilly invested 19% of its total sales in research and
development. Lilly contributes over 86 million euro annually to the local economy in salaries,
purchases of services, maintenance expenses, energy and food purchases, all in all a vital
contributor to prosperity in the region.

1.1 The drivers for this project
1.1.1

Current waste treatment poiicy on site

Like any industrial site, Lilly produces waste from a number of different sources on site. Sanitary
and kitchen waste is gravity fed to a central collection point. Rainwater which falls on site is
collected in a series of sumps and drains which feed into a centralized collection point. Solid waste
is produced from a number of sources on site such as PPE (Personal Protective Equipment),
materials packaging etc. Waste is also produced from the production processes themselves. Gases
are used in some cases as raw materials and gases are also produced as part of the reactions
carried out on site. Liquid waste is also produced from the manufacturing process.
Overview of site wide waste origin and disposal
Figure 1.0 shows an overview of the waste origins, technologies used for waste treatment and the
resulting emissions from the site as a whole. On the left of the diagram are all the sources of waste
on site.
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In-process flue gas waste is incinerated into simpler compounds in the Recco incinerator. The flue
gas passes through scrubbers that remove some of these simpler molecules ( such as SO2) to
acceptably low levels that are within the company’s IPPC (Integrated Pollution Prevention and
Control) licence for these molecules.

In process liquid waste (i.e. liquid waste from various process steps from the various processes
running on site ) is broken down into 3 categories:
Primary waste : Waste with greater than 50% organic solvent. The remainder of this waste is made
up of water and lower levels of dissolved and suspended solids
Secondary waste : Waste with 5 to 50% organic solvent. The remainder again is made up of mainly
water and lower levels of dissolved and suspended solids.
Aqueous waste : Waste consisting of less than 5% organic solvent. As the name suggests the
remainder is mainly made up of water and low levels of dissolved and suspended solids
In the John Zinc and Thermal incinerators, primary and secondary waste are fed in at different
points due to their different calorific values, which ensures that the incinerator operates at maximum
efficiency. Auxiliary fuel (Diesel) is also used in the incinerators to ensure that the temperature in
the chamber is kept at the optimal value to ensure the complete destruction of waste molecules.
The two liquid incinerators have different capabilities and capacities as follows ;
John Zinc Incinerator: processes liquid streams of varying solvent content. This incinerator can
operate with or without auxiliary fuel. Auxiliary fuel is required to keep the combustion temperature
at the desired level when the solvent level in the waste stream is low.
Thermal Incinerator: this incinerator is used to burn both solid and liquid waste - solid waste would
include any waste containers, packaging, PPE or any other general litter produced on site. Liquid
fuel is also processed here. This incinerator mainly runs on diesel fuel.
All three incinerators produce a number of waste streams that need to be further processed before
they are emitted from site. These waste streams include incinerator blowdown, cooling tower water
and spent scrubber water.
Aqueous waste is primarily production generated, in addition with contaminated surface waters
arising from rainfall within open bunded areas (eg. tank farm/waste tank farm). The WWTP system
also treats domestic sanitary waste from the site.
All aqueous waste streams received by Environmental Control are treated in an activated sludge
bio-treatment system where the organic carbonaceous material present is broken down by bacteria
to yield end products of CO2 and H2O plus new cellular material (sludge).
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Aqueous wastes are routed through what would be regarded as a relatively standard waste water
treatnnent plant for a pharmaceutical installation. After being treated, the aqueous stream enters T36. From T-36, the effluent is pumped to sea through a 5-mile pipeline that discharges in the outer
Kinsale Harbour at Sandycove. The pipeline extends out to sea for approximately 500 meters from
where the effluent is discharged through a diffuser arrangement ensuring maximum mixing.

1.1.2 Active pharmaceutical ingredients in Aqueous waste
There is some ambiguity about the definitions given previously for primary, secondary and aqueous
waste. They were originally defined to assess the calorific content (or to be more exact organic
solvent composition ) of each waste stream and therefore what streams may be disposed of
through incineration and what streams may be sent directly to the waste waster treatment plant for
treatment.
In reality, the designation of waste as primary, secondary or aqueous depends on more than the
calorific content. Many of the waste streams on site, irrespective of their calorific value, contain
components that need to be efficiently and safely disposed of such as active pharmaceutical
ingredients (API’s) and certain organic solvents. As it stands incineration is a reliable technology for
ensuring this disposal (the incinerator has at least a 99.99% efficiency in the destruction of organic
compounds in waste streams).
A large subsection of components that need to be efficiently disposed of are the API’s. Lilly has
developed what are called Lilly Aquatic Exposure Guidelines ( LAEG’s ). A formal explanation of
LAEG’s is as follows :
The discharge of materials that are unique to Lilly bulk manufacturing, fill/finish, development and
research operations (such as API’s) may not be specifically regulated as a part of a facility's
wastewater discharge permit (in this case the IPPC licence). However, the biological activity of
these discharged materials may have the potential to impact the operation of an onsite ora
municipal wastewater treatment plant, aquatic species in streams, rivers, ocean, or a drinking water
source.
These materials have the potential to enter the environment since wastewater treatment plants may
not completely degrade or remove a particular active ingredient. Lilly Aquatic Exposure Guidelines
(LAEG’s) are developed for pharmaceutical and animal health products that have the potential to
occur in wastewater or enter the environment through other pathways.
The LAEG value is the maximum allowable concentration of a material in a stream, river or ocean,
which has been determined to be safe for aquatic organisms and drinking water use”[1]
LAEG’s vary from product to product depending on the characteristics of the API molecule.
Given the nature of largescale production, all production streams no matter how aqueous will
always contain levels of API. When it comes to the environment, the site policy is to always err on
the side of safety and environmental protection. As a result, many highly aqueous streams are sent
for incineration to ensure that the LAEG limits are not breached.
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As the site has been expanding in recent years, so too has the volume of inprocess liquid waste
being produced. In addition, new legislation on incineration requires Lilly to increase its combustion
time for liquid streams. This means that the incinerator chamber volume must be increased to
increase the residence time of the vapourised liquid without compromising waste processing
capacity. Overall the capacity on the incinerators is being pushed ever closer to the limit. On
average the calorific value of the waste being incinerated has dropped which in summary means
higher incineration costs for the site. It is estimated that the current cost of incinerating 1 litre of
secondary waste is approximately 20 cents.
This simple economic fact was one of the main drivers for this project. In addition, Lilly’s global
headquarters had put forward four environmental goals that are to be met over the coming years.
Two of the goals are directly relevant to this project and are as follows :
1)
Each business unit within the company (e.g. Manufacturing, Sales and Marketing) will have
a minimum of one indexed waste reduction goal of 5% per year, for at least one waste stream, from
2005 through to 2008.
2)
Reduce energy intensity (energy usage per dollar of sales) and the corresponding
greenhouse gas emission intensity by 60% in the period of 2003 to 2012.

In addition, Lilly’s IPPC licence (licence no. 726, last granted in June 2005 ), which was granted as
part of the Waste Incineration Directive 2000/76/EC, required a future reduction in waste emissions
and energy consumption.
A successful treatment plant on site would go along way in meeting both of these goals.
The site at Kinsale was selected by global headquarters to investigate alternatives to incineration.
The ultimate goal was to roll out a successful alternative technology to Lilly manufacturing sites
worldwide. The aim of this MSc was to investigate the different technologies available and if
possible to demonstrate a success for a production stream (waste from one process ) at pilot scale.
Looking at the flexibility of the technology for the treatment of other wastes was also in the scope of
the project.
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1.2 Alternative technologies
Source treatment alternatives (source treatment is the treatment of waste streams at the source of
their production) have been outlined in the latest Best Available Technology Reference (BREF)
document. These documents are set out by the IPPC (Integrated pollution prevention and control 1996 E.U. directive ) bureau. They are basically reference documents for best available
technologies (BAT’s) for industrial waste treatment.
Possible alternatives to incineration are listed as ;
precipitation
crystallization
chemical oxidation
wet air oxidation
supercritical water oxidation
chemical reduction
chemical hydrolysis
adsorption
ion exchange
extraction
distillation/rectification
stripping
waste water incineration
evaporation
membrane filtration ( nanofiltration / reverse osmosis )

1.2.1 Selection criteria
After discussion with the Lilly Waste Water Engineer, the following characteristics were deemed
important for any potential source treatment technology.
(1) Flexible for different waste streams
The initial goal of the project was the demonstration of a source treatment technology on a single
waste stream. However, the overall goal of this project was to show that the technology was flexible
for many processes as ultimately it was envisaged that this technology may be rolled out to Lilly
manufacturing sites worldwide.
(2) A tried and tested technology (ideally on site )
When it comes to deciding on a full scale technology at any site, it is easier to decide on a full scale
treatment facility if the technology being proposed is already in use with a reliable operation record
on site. Also, the fact that source treatment of pharmaceutical ingredient had not been tried by any
other pharmaceutical company to date* made a tried and tested technology an easier proposal for

Glaxosmithkiine Ringaskiddy had started some similar trials to treat aqueous waste while this project was proceeding. From
discussion with GSK engineering personnel, the trials were a success in terms ofdesirable API rejection and volume reduction.
Unfortunately the product whose waste was used in these trials was a development product and the product failed clinical ttials. As a
restdt, the GSK trials were not taken anyfurther.
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the corporate department Lilly to accept. However, it must be stressed that all alternatives were still
looked at without bias on their own individual potential.

(3) Economics
As stated already, economics was a huge driver for this project. It is logical that the alternative
technology would need to have relatively low installation and mnning costs. Incineration in general
is an expensive technology to support. This gave a certain amount of freedom when choosing an
alternative in that ail alternatives should be economically preferable. But in addition, the payback
period of any project is also important and as always when it comes to two technologies that
function equally well, the cheaper alternative will be preferable.

(4) Reliable and user friendly
A reasonably simple automated process means a lower risk of breakdowns and minimal operator
supervision required. It is a general policy to keep the amount of additional operator time required
on site to a minimum where possible.
(5) Require high retention / destruction of the API
To make the project a success, the retention / destruction of API would need to be high. Again for a
successful proposal at corporate level, it would need to be shown that a treated stream being fed to
the WWTP contains API at levels that are significantly and consistently below the LAEG for the
relevant API. At this early stage, it is estimated that the retention / destruction of API would need to
be somewhere in the region of 90 to 99%^ for the majority of products produced on site.

1.2.2. The alternatives available
Initially these technologies were screened at a very basic level. Stripping and Distillation /
Rectification were eliminated as these technologies transfer volatile pollutants from the water phase
to the gas phase (in general API’s are less volatile than water). The merits of the remaining
alternatives are discussed in more detail as follows:
1.2.2.1 Ion exchange
Ion exchange is a unit process in which ions of a given species are displaced from an insoluble
exchange material by ions of a different species in solution

Estimations at this stage, were made on the les’els ofAPI in the waste streams. Using the average LAEG of the waste streams, and the
limited knowledge on API content in some waste streams, it was estimated that a membrane plant would need to reject between 80 and
99% of the API. The level ofAPI in the waste streams was based on information supplied by .some of the process chemists on the various
processes on site.
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For the removal of TDS both anionic and cationic exchange resins can be used. TDS removal can
take place in separate exchange columns arranged in series, or both resins can be mixed in a
single reactor. Wastewater application rates range from 0.2 to 0.4 .3/m^.min[2]. In some situations it
appears that ion exchange may be as competitive, if not more so, with reverse osmosis.
To make ion exchange economical for advanced wastewater treatment, it would be desirable to use
regenerants and restorants that would remove both the inorganic anions and the organic material
from the spent resins. Chemical and physical restorants found to be successful in the removal of
organic material from resins include hydrochloric acid and methanol. To date ion exchange has had
limited application because of the extensive pretreatment required, the relatively short life of the ion
exchange resins, and the complex regeneration system required.
Ion exchange can potentially be used on the following groups of compounds :
Soluble, ionic or ionisable organic compounds, e g. carboxylic acids, sulphonic acids, some
phenols, amines as acid salt, quaternary amines, alkyl sulphates and organic mercury can be
removed[3]. This technology may be useful in the treatment of API’s. It is noted that this criteria
would only cover a few of the API’s of interest to this project
1.2.2.2 Precipitation
Chemical precipitation involves the addition of a chemical to alter the physical state of dissolved
and suspended solids and facilitate their removal by sedimentation.
In current practice, chemical precipitation is used ;
(1)
as a means of improving the performance of primary settling facilities
(2)
as a basic step in the independent physical-chemical treatment of wastewater
(3)
for the removal of phosphorus
(4)
for the removal of heavy metals
Some sources suggested that precipitation was efficient at precipitating sulphates and fluorides in
addition to heavy metals and phosphorous. Many of the potential API’s to be removed did not
contain any of these functional groups[4].

At a basic level, the applicability of precipitation was unclear. In addition to the precipitation process
a secondary filtration system would also be required. Given the high rejections required, it is likely
that a fine membrane filtration would be required after the precipitation plant. Precipitation may
have more use as part of a multi-unit operation for an overall solution, but as a technology on its
own, there is a strong possibility that it would not achieve the desired rejections.
Another point is that a technology is required that is not over sensitive with respect to operating
parameters i.e. if the parameters are not well controlled the efficiency of the plant will not drop
drastically. This may be an issue with precipitation, the BREF document mentions that the pH and
flocculants addition levels need to be controlled tightly. It is obvious that if they are not, there is
nothing to stop the precipitation rate decreasing significantly.

10
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The ability to precipitate different materials is highly dependant on the solubility of the solute in the
solution at varying physical conditions. Precipitation in dilute streams can also be difficult. Many of
the possible streams to be treated could be highly dilute. In some cases the API levels in the feed
may need to be brought down to approximately 50ppm and the applicability of precipitation is
questionable.
1.2.2.3 Crystallisation
In most cases crystallization is applied to remove heavy metals from waste water streams and to
recover them subsequently for further usage, but fluoride, phosphate and sulphate can also be
treated. Examples of use in the chemical industry are :
•
Recovery of zinc, nickel in the production of rubber additives, with feed concentrations
between 50 and 250ppm
•
Recovery of nickel and aluminum in the production of elastiomers, the crystallization device
worthing prior to a central WWTP, with feed concentrations between 50 and 400 ppm of nickel.
In principle almost all heavy metals, metalloids and anions can be removed from all kinds of waste
water by crystallization. The formation of salt pellets is feasible when the solubility of the generated
salt is low and the metal or anion crystallizes quickly into a stable lattice. Whereas metals are
normally extracted as carbonates, hydrocarbonates, hydroxyl carbonates, hydroxides, sulphides,
phosphates, sulphates, fluorides etc anions are generally removed as calcium salts[5].
Crystallisation is very similar to precipitation and as a result a lot of the same points apply. It is likely
that a fine filtration would be required in addition to the crystallization step. Again not all chemicals
crystallise out well as some API’s would not contain the groups that are likely to crystallise.
Crystrallisation was seen as a technology with reasonable potential.

1.2.2.4 Chemical processes
This covers a number of different treatment options including :
Chemical oxidation
Wet air oxidation
Supercritical water oxidation
Chemical reduction
Chemical hydrolysis
All of these processes require very high temperature and pressure which can translate into high
operational costs. One of the main disadvantages of each of these processes is that molecules are
broken down into simpler molecules.
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It is unclear as to what simpler molecules the API’s would be broken into. The oxidation of specific
compounds may be characterisied by the extent of degradation of the final oxidation products as
follows :
•
•
•
•

Primary degradation : A structural change in the primary compound
Acceptable degradation : A structural change in the parent compound to the extent that
toxicity is reduced.
Ultimate degradation : Conversion of organic carbon to inorganic CO2
Unacceptable degrading : A structural change in the parent compound resulting in
increasing toxicity[6].

Assuming that a reaction takes, quantifying the level of toxicology of the resulting degraded
molecule may prove difficult. Lilly has their system of LAEG’s for each API which would need to be
reviewed for any semi degraded molecules. It is likely that for this method to be an efficient
success, API’s would need to undergo an ultimate degradation so as to be in accordance with the
current LAEG system for toxicology analysis.
In early 2004, a final year research project was carried out by a chemical engineering student
{Allen, K) which looked at some alternatives to incinerating Tilmicosin secondary waste by
eliminating API from the waste stream[7]. As part of the project, the possibility of acid hydrolyzing
Tilmicosin waste was investigated. A trial was carried out in an attempt to acid hydrolyse a sample
of waste. The colour of the feed ( strong tinge of yellowish brown ) was identical in colour before
and after the attempted hydrolysis. From experimentation and analysis as part of this thesis project
(Chapter 4), it was shown that the yellowish brown colour in tilmicosin waste can be solely attributed
to Tilmicosin API. It was concluded that the API was not significantly degraded in the attempted
reaction.
1.2.2.5 Extraction
Extraction is also a process which appears to have limited potential. In general, looking at the API
production processes at Lilly, many of the process waste streams are produced in an extraction
step where the API is extracted from the watery phase into an organic solvent phase, the layers are
allowed to settle out and the aqueous phase is discarded to waste (this is essentially a one stage
extraction). The levels of API in the aqueous layer as a result of this extraction (which are the waste
streams received into EC) are still much too high to send the watery waste straight to the WWTP. A
multistage extraction column would definitely improve the overall efficiency, in terms of removal, but
whether the removal would be high enough is questionable. A different solvent would be required
for each API and it is likely that the inprocess solvent for each API would already be one the most
suitable. Many of the solvents which would be mixing with the column influent would need to be
stripped before entering the WWTP. Again it is a disadvantage that there is no physical boundary to
ensure that rejection will not be compromised irrespective of the control of operating parameters.
As part of the previously mentioned student research project[8], an extraction trial was carried out
whereby the student attempted to extract Tilmicosin from the waste matrix into octanol which has a
high solubility coefficient relative to the waste matrix. The student did not get the opportunity to
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carry out API analysis on the waste stream. He did note that the colour (yellowish brown )and
composition of the initial feed phase was identical to the feed phase after the extraction was carried
out. It is therefore concluded that there were still relatively high levels of API in the treated waste
which is not encouraging from the point of view of looking at this technology further.
1.2.2.6 Adsorption
Adsorption is the process of accumulating substances that are in solution on a solid interface. This
is a technology that showed promise in terms of flexibility for use from product to product.
Adsorption is useful in the removal of a large amount of organic molecules. Powder and granulated
activated carbon are the most commonly used adsorbents. Some similar applications in industry
include the removal of TOC, colour and dyes in the textile industry and the removal of COD and
xylene in the detergent industry.
Both powder and granulated activated carbon have a low adsorption affinity for low molecular
weight organic compounds [9]. It is also suggested that obtainable rejections are sensitive to a
number of factors such as the stereochemistry of the molecule and the molecular weight. Also
regeneration and reactivation of the adsorbent material is a relative unknown. Typically some of the
adsorptive capacity of the material will be lost (4-10%) each time a regeneration is carried out. The
process is also relatively expensive [10]. A major drawback is that a mixture of organic compounds
in the waste stream may significantly reduce the adsorptive capacity. This may have particular
relevance to the process streams being looked at as waste streams in general would have much
higher levels of solvent than API and in ail likelihood the adsorption of the API would be much lower
than adsorption of the solvent. This makes the necessity of pretreatment in the form of stripping a
strong possibility which is not ideal. Also the adsorbent needs to be disposed or regenerated, either
way replacement may be frequent and expensive. On the upside, assuming that the desired
rejection could be achieved, the volume efficiency (i.e. volume percentage of feed that would be
treated and leave as effluent) would be high. This technology was definitely worth looking into in
more detail.
The student research project also looked at the possibility of using adsorption as a method of
reducing Tilmicosin API in Tilmicosin secondary waste. A trial was carried out that reacted
Tilmicosin secondary waste with activated carbon for a period of time and the resulting mixture was
filtered through a 100 micron filter. The resulting filtrate was clear. This is a promising result as a
clear filtrate indicated that much API has been removed.[11]
1.2.2.7 Evaporation
Evaporation was also a technology with potential. It had almost all the attributes of an ideal
technology. It is flexible and can be applied to any waste stream. It will provide close to 100%
removal of API in the effluent assuming that no API molecules evaporate off with the water which
seems to be a valid assumption given the difference in boiling point of the APIs and the liquid waste
stream. This was to some degree validated as the final year student project looked at distilling a
sample of Tilmicosin secondary waste. The feed to the distillation was as expected a strong
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yellowish green colour and the distillate was colourless which indicates that the levels of API in the
distillate are significantly less than the feed.
Evaporation is also a tried and tested technology on site (evaporators are located in the solvent
recovery area of one of the production buildings). However, the energy costs associated with this
technology are a major drawback. In reality the energy costs would be of the same order as
incineration. Installing a new technology, which would be expensive to install, and would be almost
as expensive to run as incineration cannot be justified . This was the main reason for ruling
evaporation out.
A simple energy balance was reviewed for the energy requirements for an evaporator compared to
the current incinerator. For simplification it was assumed that the secondary waste was pure water.
The evaporator was assumed to run at atmospheric pressure and 100°C and the incinerator was
assumed to operate at 1100°C. Looking at steam at 1 bar and lOO^C. The enthalpy is 2675.5 kJ/kG
[12]. For superheated steam at 500°C and 1 bar the enthalpy has increased to 3488 KJ/kg.
Assuming a relatively linear increase in enthalpy up to 1100°C which it is the operating temperature
of the current incinerator. The enthalpy is of the order of at most 2 to 3 times the enthalpy of steam
at lOOX.This symbolizes energy costs for a distillation plant being at most 2 to 3 times less than
that of the incinerator. One of the primary goals of this project is to reduce energy costs and
evaporation looks to be a limited alternative for meeting this goal.
1.2.2.8 Membrane Filtration
Membrane filtration was a technology that appeared to have a lot of potential. It is a relatively
inexpensive technology to install and running costs are also limited. It is a tried and tested
technology on site and is very straight forward to operate. It is used to purify water for inprocess
use. The membrane plant has a good operational record and requires a minimum amount of
operator interaction. It is also a fail safe process in that rejection will not be compromised by
operating parameters such as temperature and pH. The only possibility of rejection being
compromised is if the membrane is breached. A membrane breach would show up as a pressure
drop across the membranes which would be detected immediately or a dramatic change in
conductivity of the process waste stream from the membrane plant. The membrane breaching
would not be an LAEG breach issue if it was a multistage membrane process which is a realistic
possibility. Membranes have the potential to be very flexible for different API’s. One of the
drawbacks is that the volume efficiency would be limited. The BREF document suggests a volume
reduction of waste of 90% which means that 90% of influent to the plant leaving as effluent to the
WWTP and the remaining 10% to be disposed of by incineration. This volume reduction can be
further hampered by high levels of dissolved solids in the feed, which may be the case in some of
the waste streams. However if this is the case, there are pretreatment technologies that can be
used to reduce the TDS levels. Electrodeionisation is such a technology which uses electrodes to
precipitate out dissolved species.
The removal of API from this feed should be very high as a multistage process can be implemented
if required. For this technology to be a success, efficient cleaning of the membranes would be
essential. At this stage, there is no way of telling how wash cycles would perform. Industrial data
suggested that in most cases a simple low volume acidic or basic wash was enough to clean the
membranes. In addition cleaning chemicals could be used to remove fouling from the membranes.
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The main concern with membranes was the potential for fouling of the membranes. Fouling is the
deposition and accumulation of constituents in the feed stream on the membrane. Typically, three
approaches are used to control membrane fouling ; pretreatment of the feed water, membrane back
flushing and chemical cleaning[13]. When assessing the potential for fouling in any stream to be
treated, it is very important to assess the feed stream to the membrane in terms of chemical species
and concentrations present and the physical properties of the waste stream. Given the number of
steps that can be taken to reduce fouling, if necessary, there is a strong possibility that the effect of
fouling could be minimized.
1.3 Final decision on using a technology for bench scale trials
Two technologies were short listed namely Adsorption and Membrane Separation technology. It is
also worth noting that prior to the commencement of the project, Lilly personnel had already
identified the use of membrane separation as a potential alternative to incineration. For the
purposes of this project it was deemed necessary to go through all the available technologies to
ensure that nothing had been overlooked.
The merits of these two technologies were looked at under the following headings ;
Achievable volume reduction
Achievable rejection
Fail safe capability
Tried and tested technology
Reliability and user friendly
Technology flexibility
Each aspect is now discussed with respect to each alternative.
(1) Achievable volume reduction
The volume reduction achievable from any adsorption unit is close to 100%. This has an advantage
over a membrane unit as any membrane unit will have a volume reduction less than 100%.
Realistically 90% is optimistic and volume reduction for a membrane plant can be much lower
depending on the nature of the feed to the plant.
Conclusion - adsorption was preferred here
(2) Achievable rejection
The rejection achievable for an adsorption unit is questionable since ail organic substances will be
adsorbed onto the adsorbent surface. The majority of potential waste streams to an adsorption
plant would contain high levels of solvent relative to API. As a result, the adsorbtive capacity will be
taken up by solvent (the adsorbance of any organic substance is the same i.e. solvent will be
adsorbed as much as API).
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The rejection achievable for a membrane plant should be superior as the rejection is to a large
extent independent of all factors other than the molecule size and the molecular weight cutoff of the
membrane.
Conclusion - membrane separation was preferred here
It should be noted that achieving the desired rejection is the fundamental starting point for a
successful source treatment technology. Although volume reduction is also important for the project
to be a success, it will be irrelevant if the API is not rejected sufficiently. One could argue that both
are equally important, but in many cases, pre treatment can be added later on to increase the
volume reduction, whereas not much can be done if the API is not being rejected sufficiently.
(3) Fail safe capability
The fail safe capability of an adsorption plant was less straight forward than membrane separation
since the plant relies on the adsorbance of API onto the adsorbent to ensure that the API is
retained. This retention would depend to a certain extent on keeping operating parameters constant
aswell as the quantities of other organics present in the waste stream
A membrane plant has a naturally large fail safe capacity due to the physical boundary created by
the membrane
Conclusion - membranes separation was preferred here
(4) Tried and tested technology
A Micro filtration (MF) membrane plant is used for water purification in IE4. This plant has a good
operational record and has performed well over a number of years. There are no adsorption
processes running on site at Kinsale.
Conclusion - membrane separation was preferred here
(5) Reliability and user friendly
Both technologies have been installed on many sites in the cork region and both technologies are
reported to be relatively straight forward to run
Conclusion - both technologies were assumed to be equally reliable
(6) Technology flexibility
Both technologies appeared to be equally flexible.
From the above analysis, aswell as from preliminary research carried out by Lilly personnel prior to
the project commencing, it was decided to move forward with a membrane plant.
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Summary
The first section of this chapter reviews general membrane theory. Following on from this, the
relevant theory is elaborated on as applicable to this project. A thorough literature review ivas then
carried out. In reality, there w/as a limited amount of directly relevant information available on the
removal of pharmaceutical Ingredients from process waste streams using membrane technology. All
the relevant literature that was sourced is summarized towards the end of the chapter
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2.0 Membrane usage in industry
At present membranes are used for a multitude of separations and concentrations with many water
treatment applications. Some of these applications include:
Drinking water purification
Colour removal from surface water
Microbial removal; bacteria, pyrogens, giardia and Cryptosporidium cysts
Pesticide removal
Potable water production from seawater [14]

2.1 Membranes general theory
2.1.1 Subdivisions and applications
Membrane filtration is classified into four main sub divisions with the classification based on the
smallest molecules that will be filtered out by the membrane which is termed the “molecular weight
cutoff’ (MWCO). Figure 2.1 [15] is a diagram of what is generally termed “The Filtration Spectrum”.
The spectrum illustrates the subdivisions of membrane filtration and the industrial applications that
are relevant to each subdivision.
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The subdivisions for membrane filtration are :
Microfiltration ( 100.000 to 500,000 daltons )
This is the coarsest form of membrane filtration, filtering out molecules in the micron size range.
The main industrial applications would be filtration of gelatin, asbestos, tobacco smoke and paint
pigments. It is commonly used in waste water treatment plants to reduce levels of suspended solids
in waste streams. Micro particles are not visible to the naked eye: an optical microscope is needed.
[16]. Typically microfiltration membranes operate within a pressure range of 1 to 7 barg.

Ultrafiltration (1000 to 100.000 Daltons )
This is a finer filtration than microfiltration with the molecular weight cut-off in the range of 1,000 to
100,000 Daltons. From the filtration spectrum, it can be seen that there is a certain amount of
overlap between each of the subdivisions. For example, ultrafiltration slightly overlaps with
nanofiltration and microfiltration. Ultrafiltration membranes can separate medium to large sized
dissolved molecules from solution due to the simple sieving mechanism. Typically ultrafiltration
membranes operate within a pressure range of 0.5 to 10 barg

Nanofiltration ( 200 to 10.000 Daltons )
Nanofiltration is a term coined in the mid to late 1990’s to define membranes which can be referred
to as “loose RO” membranes. They have pores close to one nanometer diameter and have a partial
salt rejection. Typical nanofiltration membranes pass a higher percentage of monovalent salt ions
than divalent and trivalent salts. Most NF membrane polymers carry formal charges which exclude
multi valence ions more than monovalents from passing through the membrane with the solvent
water. NF membranes span the gap between RO and UF classes.
Sugar, synthetic dye and endotoxins are particles rejected within this range aswell as smaller
particles of gelatin, colloidal silica and larger charged ions such as hardness. Several different types
of nanofiltration membranes cover the entire spectrum of the area between RO and UF[16].
The main advantage of using nanofiltration in preference to RO is that nanofiltration systems
operate at lower pressures than RO which in general means lower capital and operating costs.
Typically NF membranes operate within a pressure range of 3 to 30 barg.

Reverse osmosis (500 Daltons and less)
Reverse osmosis is the finest membrane filtration available. It can be used to separate species at
an ionic level. Today it is a very common and useful technology especially for the filtering of salts
with ionic radii in the low molecular range. The major application of reverse osmosis in modem
industry is in the desalination of brackish water and seawater to produce potable water. Pores in
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RO membranes are so small that they have not yet been resolved even by the most advanced
microscopic techniques. Typically RO membranes operate within a pressure range of 5 to 80 barg.
The mechanism of rejection is more complex than the UF and MF. The exact mechanism is both
theoretical and disputed. There are at least two different schools of thought regarding this
phenomenon. The first is Dr. Sourirajan’s surface force pore repulsion approach. Simply put, the
preferential sorption of water molecules and subsequent desorption (repulsion by dielectric effects )
causes exclusion of charged solutes even smaller than the membrane pores from movement
through the membrane. The second the “solution diffusion theory” stated simply says that RO
membranes, although dense membranes, are to some degree like porus films in which both solute
and solvent dissolve at the membrane. The solute moves through the membrane mainly under
concentration gradient while the solvent transportation is dependant on the hydraulic pressure
gradient. Solution diffusion is widely accepted as the main transport mechanism, however some
researchers still look at the pore model also.

2.2 Module types
Membranes are generally modular in design in that membranes are generally designed and
incorporated into a membrane plant in such a way that they are easily removed and replaced.
There are a number of different types of membrane modules. In general, a stream which is to be
treated will be optimally treated (and may only be possibly treated) by one module type. In summary
the main module types are ;
•
•
•
•

Tubular
Plate and Frame
Hollow Fibre
Spiral Wound

As mentioned already, it became apparent that NF or RO ( and to a less likely degree UF )
membranes would be the likely solution for filtering the API’s. Spiral wound and hollow fibre
configurations are the most widely used configurations for these membranes. However, it also
became apparent that hollow fibre would not be suitable as they are not suitable for liquid streams
with relatively high levels of dissolved solids and solids present.

2.2.1 Spiral wound Modules
This module is characterized by a high packing density and a simple design. Essentially two or
more membrane pockets are wound around a permeate collecting tube with a special mesh being
used as spacers. The membrane ‘pocket’ consists of two membrane sheets, with a highly porous
support material in between, which are glued together along three edges. The fourth edge of the
pocket is attached to a collecting tube. Several such pockets are spirally wound around the
collecting tube with a feed-side spacer placed between the pockets forming a so called ‘element’.
Usually several elements are assembled in one pressure vessel. The feed side flow is strictly axial
in most designs or enters at the cylindrical surface of the element and exits axially. In any case the
permeate flows through the porous support inside the ‘pocket’ along the spiral to the collecting tube.
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Like the hollow fibre module, the spiral wound module cannot be cleaned mechanically. Cleaning is
usually accomplished by using a high velocity flush across the membrane which scours the surface
and generally removes the majority of attached material.

Figure 2.5 Illustration ofa spiral wound membrane module

Spiral wound design affords the best allround characteristics of high packing density, low area and
rugged and high pressure operation. With the recent advent of specialized feed channel spacer
materials, a wider range of applications now employs the spiral design.

2.2.2 Technology variations
Dialysis
Dialysis is a process where small molecules diffuse through a membrane because of a
concentration driving force. Large molecules are excluded. The process differs from UF since the
solute movement in dialysis is caused by diffusion while in UF, the major flux is that caused by
pressure gradients. In UF the small molecules are carried along with the solvent flux. In dialysis the
flux of small molecules is independent of the solvent flux[17].
Electrodiaivsis
Electrodialysis is dialysis in the presence of an electric field. The driving force for electrodialysis is
the electrical potential difference. The driving force pushed cations through cation exchange
membranes and anions through anion exchange membranes. Cation and anion exchange
membranes are alternated. In the presence of the electric field the anions will migrate towards the
cathode and the anions towards the anode. The cations can pass through the anion exchange
membrane but not through the cation exchange membrane. Because of the alternation of the cation
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and anion exchange membranes the result is to concentrate ions in the odd numbered
compartments and to dilute the ions in the even numbered compartments in Figure 2.6[18]. In this
way a desalted water and a concentrated brine are formed. As the project proceeded, a slight
possibility emerged that electrodialysis would be useful for the pre treatment of one of the waste
streams (Benzodiazepine HCI) due to high levels of TDS in the feed which was identified as a
possible reason for low flux levels for all of the tested membranes.

figure 2.6 : Graphic illustration ofElectrodialysis
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2.3 Designing, Commissioning and running a Membrane filtration plant
When designing a membrane plant, the first item that vendors request is a characterisation of the
feed stream to the membrane plant. This characterization would include :
Stream pH
TDS
TSS and particle size distribution
Solvent type and levels
Ionic breakdown
Volume flow of stream to be processed

From the detailed characterization of the waste stream to be treated, it should be relatively clear as
to which module design would be most successful in processing the stream. This decision would be
strongly influenced by such factors as the solids loading on the waste stream, the throughput
required and the general hydraulic properties of the waste to be treated (such as viscosity).
Once characterization of the waste stream has been carried out, small scale trials are generally
carried out to asses the treatability of the waste. There would normally be a number of options as to
which membrane to use and the merits of each membrane can be investigated during these small
scale trials.
Here manufacturers and project developers will look at
•
•
•
•
•
•
•

The ability to reject the desired molecules
The ability to permeate the stream and achieve the desired volume reduction
The longterm stability of the membrane in the process stream matrix
The optimal operating conditions namely, pressure, temperature, pH, feed and permeate
flow rates
The assessment of the ability to wash the membrane after use and obtaining information on
the optimum wash cycle
If necessary, the effect of plant permeate on the microbes in the WWTP
Obtaining sufficient information for potential scaleup for full scale plant

In all likelihood all of these questions would be answered with two or even three phases of trials.
The first phase of trials will obtain basic information on the above points on a dead end test cell
scale (< 100ml feed) and / or a bench scale (< 1000ml feed). The second phase of trials, which
would be carried out on a larger pilot scale (up to 2001 feed), would look at repeatability of results
and optimization of trials aswell as obtaining the majority of information for potential scale up.
Based on the findings of these trials, the cost of a full scale plant can be calculated which would
involve a process guarantee with respect to the plant being capable to process the stream to the
agreed level.
A basic membrane plant design includes a pump to provide the driving force and the crossflow
velocity required, connecting plumbing, control valves and instruments. Membranes are supplied as
elements and there may be a number of membrane elements within a housing. Pressure gauges
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and motor controls are required, but the degree of instrumentation and other controls does not vary
greatly. Roughing prefilter cartridges are included to reduce the membrane fouling. Everything from
simple on/off sensory lights to complex, sophisticated PLC computer controlled systems are
employed today for cross flow membrane machines.[19]

The ratio of permeate to feed volume also affects the fouling rate and is known as the “recovery”.
Volume reduction (VR) and Volume concentration factor (VCF) are other terms used to describe
this ratio. Recovery is measured on both an individual element basis and for the entire plant. Many
water treatment applications usually run at 75 to 80% plant recovery, with 90% the practical upper
limit. Some NF and RO applications have relatively high fouling rates, and these run at lower
recoveries. Seawater desalination via RO is typically run as low as 40% due to the high osmotic
pressure generated as the salt in the feed stream is concentrated.
Permeate flux is directly proportional to effective pressure, excluding the flux reducing fouling
phenomenon. Thus with a pure water feed system, increasing pressure proportionally increases
permeate output and the pressure limit would be based on the membrane element hardware
strength and the pump limitations.

2.3.1 Understanding the uniqueness of each membrane and solution
Membrane technology is evolving all the time so there are constantly new membranes coming to
market. In addition, the variation in streams to be treated is growing rapidly (which illustrates the
flexibility of the technology). Vendors can give general guidelines on whether a membrane will work
for a particular waste stream, research can point in the direction of whether streams will permeate
or not but ultimately the only way of knowing whether a membrane will work or not is to carry out an
experiment with the process stream, which is generally termed proof of concept testing or bench
scale testing. New products will have been tested on many standard organic solvents. They will also
have been tested on some standard solutions and the molecular weight cut off for the membrane
will be set from these trials.
However the stereochemistry and interaction behavior of molecules in the feed stream is an
unknown. Molecules may split into two or more smaller molecules under certain conditions which
may mean that the molecules will pass through the membrane. Molecules may also react under
certain conditions to form larger molecules that will not filter through the membrane.
There may also be ions in feed streams that have not been identified by analysis which are
detrimental to the integrity of the membranes. It is standard practice for the membrane vendor to
request that the process stream be tested for any potentially harmful ions before a membrane is
trialled at bench scale.
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2.3.2 Interactions of different membranes with different solvents
Early on in the project, it became clear that the majority of waste streams that were being
considered for membrane treatment were aqueous streams containing relatively high levels of
organic solvent. Membranes are classified as generally water stable or organic solvent stable
[20], The wide variation in solvent polarity requires a matching of the membrane characteristics with
the solvent class to achieve a practical flux. Hydrophilic solvent stable membranes are generally
used for aqueous solvent streams while hydrophobic solvent stable membranes are generally used
for other solvent mixtures.

Solvents are generally classified as polar or non polar. Also solvents go by what is known as the
“like with like rule” in that polar solvents dissolve polar solutes and non polar solvents dissolve non
polar solutes. In addition organic solvents are highly varied in polarity and structure. The stability of
any membrane with any solvent depends on a number of factors including the polarity of the
solvent, the groups attached to the solvent molecule and the potential reactivity between the solvent
and the membrane material. Therefore it is primarily not a case of stability (although this is also an
important factor) dictating what membrane is used where but more so a case of the aqueous or
otherwise nature of the solvent. So one of the first steps in deciding on a membrane is knowing if
the feed stream contains water as the solvent, organic solvent as the solvent or a mixture of both.
Once this is known, the identification of a suitable membrane can be narrowed down by looking at
the molecular weight cutoff required, the pH stability range of the membrane and the identification
of all molecular species present in the process stream that may be damaging to different
membranes (including the solvent itself).
With respect to this project, there are very few membranes on the market that are classified as both
organic solvent and water stable. At the time of this project there were only two manufacturers who
had such membranes in the nanofiltration range. However, Koch membranes was the only
manufacturer with a nanofiltration membrane with a molecular weight cutoff low enough to
potentially give the desired API rejections (the other manufacturer was MET Ltd). On the positive
side, this greatly reduced the uncertainty in deciding which membranes to trial at bench scale.

2.3.3 Effect of temperature on different membranes
In general increasing the feed temperature increases the temperature of the membrane which
causes pores to open up which in turn has the effect of increasing the average flux and which may
reduce the overall rejection. Temperature also affects the flux due to viscosity reduction ; the
warmer the feed stream the greater the throughput. Tsuru and Izumi [21] looked at the effect of
temperature on three nanofiltration membranes with MWCO’s of 200, 600 and 2000 respectively
using feeds over the temperature range of 20° to 60°C. As expected the rejection of solutes
decreased as the temperature was increased while the permeate volume flux increased.
It should be noted that in general, the higher the flux rate, the higher the potential fouling rate.
Arriving at the optimum balance of pressure, recovery, temperature and crossflow rate is an
engineering art and will vary for each feed source. However increasing the temperature up to the
limit of the membrane and system will tend to increase the efficiency. Cold feed sources require
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larger systems (increased membrane area). Decreasing solution viscosity has the same effect as
increasing temperature (Viscosity is the determinant for the temperature effect on flux)
Membranes in general will only operate efficiently within a specified operating temperature range
given for each membrane type by the manufacturer. For polymeric membranes, if the feed
temperature is too low the membrane pores may close up and fluxes may significantly fall off. If
feed temperatures are too high, the membranes may begin to loose their integrity and loosen up
with possibly a fall off in the rejection of the membranes aswell as long term damage to the
membrane structure.

2.3.4 Effect of suspended solids on membranes
High levels of suspended solids can cause deposition on the surface of the membranes or in
different parts of the piping of the membrane plant. In addition, larger suspended solids can cause
scouring on the surface of membranes which can damage the membranes. It is normal practice to
use a prefilter which would not allow molecules of larger than a few microns to pass into the
membrane plant. It is also common practice as part of the characterization of a process stream to
carry out a particle size distribution analysis which will give an idea of what quantity of particles will
be held back by any prefilter that is supplied, thus giving information on the size and type of prefilter
that is required.

2.3.5 The significance of TDS on efficient membrane operation
Total Dissolved Solids in a feed stream are made up of a number of constituents, the majority of
which are salts. These dissolved species are in equilibrium in that the concentration is uniform
throughout the waste matrix. What is essentially happening in a membrane operation is that this
equilibrium is being upset. Using pressure, some of the smaller water molecules are driven across
the membrane while in general the majority of the dissolved molecules are held back. From the
second law of thermodynamics, this equilibrium will attempt to re-establish itself. Water molecules
will naturally tend to pass back through the membrane. The pressure required to stop this
equilibrium re-establishing is the osmotic pressure. The TDS level of a waste stream is generally
correlated well with the osmotic pressure in the waste stream. Conductivity which is easily
measured using a conductivity probe is often used as an estimate of TDS levels in a solution.
One can analyse the factors that determine whether a given solute will dissolve in a solvent in terms
of the changes in intermolecular forces that accompany the conversion between the pure solute
and solvent and the solution. However, such an analysis does not generally enable us to predict the
condition of the solute once it has dissolved. Most ionic solids, for example, dissociate into ions
when they dissolve, but covalent bonds may or may not ionize. It would be useful to have some
general rules to help us predict whether a solute will dissociate or ionize to give ions, at least for the
common solvent water.
Depending on its class, a solid may or may not be soluble in water. If it is soluble, it may or may not
dissociate into ions, regardless of whether it is classified as an ionic solid. We can decide whether a
compound has dissociated into ions in solution by determining whether the solution conducts
electricity, a property associated with the presence of dissolved ions. A solute that dissociates into
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ions in aqueous solution is an electrolyte (e g. NaOH). A solute that retains its molecular identity in
solution and yields no ions is not an electrolyte (e.g. CH3CHO). General rules are available when it
comes to analyzing whether a solute is an electrolyte or not in solution [22], These are :
•

Most ionic salts are strong electrolytes in aqueous solution. Exceptions are some
compounds that might be predicted to be ionic salts but are physically soft, have low
melting points, and are molecular compounds. These include HgCb and lead(ll) acetate.
Such compounds retain their molecular identity when dissolved in water and are weak
electrolytes or nonelectrolytes

•

Most acids are weak electrolytes in aqueous solution. Exceptions are the strong acids,
which are also strong electrolytes

•

Most bases are weak electrolytes. However, most hydroxides if they are soluble are strong
electrolytes. Thus NaOH, RbOH, KOH, Ca(OH2) and the like are strong electrolytes.
Hydroxides of metal ions with a charge greater than 2+ are usually quite insoluble. NH3(aq)
is a weak electrolyte

•

A species not accounted for in the first three rules is not likely to be dissociated into ions in
solution

An attempt was made to apply these principles to the waste streams that were analysed as part of
this project (the three waste streams that were analysed during this project were Tilmicosin,
Benzodiazepine HCI and Atomoxetine HCI - see chapter 3 for more detail). For the Tilmicosin
process, the components in solution (of amyl acetate and water depending on the pH ) are
Desmycosin, Dimethylpiperidene, NaOH, sulphuric acid, phosphoric acid, formic acid, tylosin and
Tilmicosin. For the Benzodiazepine HCI process, the components in solution (of 3A alcohol and
water) are TCN intermediate, SnCb, HCI, and Benzodiazepine. For the Atomoxetine HCI process,
the components in solution of MTBE and water) are Atomoxetine free base, sodium mandelate and
hydrochloric acid.
Looking at all these compounds many of these compounds will be electrolytes in solution. The
correlation between TDS and conductivity for any solution is complex. As mentioned already, it
depends on whether species are strong or weak electrolytes and also the influence on the solvent
on measuring conductivity. It can be generalized that, in relation to a membrane plant, assuming
conditions such as pH are kept constant, a decrease in conductivity implies that TDS levels have
decreased. It should be noted that quantifying the exact decrease is not possible as some species
may or may not have been removed from the solution which do not contribute to conductivity at all.
All that a decrease in conductivity can indicate is that electrolytes have been removed. Conductivity
removal is therefore only an indicator of removal of TDS from process waste streams.
In general terms, many sources suggest “rules of thumb” that correlate TDS with conductivity. One
such correlation [23] suggests the following correlation ;
The calculation should only be used as a rough field check of a sample, though. TDS derived from
conductivity is not recommended for critical quantitive reporting purposes. The reason for this is that
the relationship between conductivity and TDS that is not very repeatable across different locations
and different dissolved material. The calculation used is :
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TDS = SC* 0.65
Where ;
TDS = total dissolved solids in ppm
SC = Specific conductance (temperature corrected) in uS/cm
The constant of 0.65 is only a very crude average for natural samples. The actual constant for any
particular sample with a specific mix of dissolved species present is dependant on the average
activity of all species in a sample. The activities are influenced by sample temperature, the relative
amounts of each species (they can influence each other) and the total concentration of dissolved
solids in the sample ( can be a non-linear relationship). Also some sources [24, 25] suggest that
osmotic pressure can be calculated from TDS levels using the relationship that obeys the ideal gas
law;
Posmotic = nRTA/
Where n is the number of moles of TDS per unit volume of solution.

2.3.6 The effects of high pressure on membranes
For any standard membrane separation, increasing the pressure on the feed side of a membrane
plant increases the driving force for permeation which in general increases the rate of permeation.
As pressure is applied to the membrane, it causes the membrane to compress and subsequently
causes the membrane pores to close. When the pressure is removed, the membrane will go back to
its original uncompressed structure.

In some cases, if the membrane is operated above its specified operating pressure range, the
compression can be irreversible and the membrane may be damaged. When the membrane is used
again, fluxes can be considerably less than what they were before. Irreversible membrane
compression is illustrated in the Figure 2.7.

Figure 2.7 .■ Illustration of irreversible membrane compression due to exertion ofhigh pressure on membrane surface
over extended periods.
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2.3.7 The effect of pH on membrane permeability
The majority of membranes on the market have a pH stability range which is the pH range that the
particular membrane can be safely exposed to. Operation outside of this range may damage the
membrane. Operating outside the range damages the membrane by altering the structure of the
membranes causing the pores to shrink or swell or generally causing a compromise in the structural
integrity of the membrane. In addition, varying the pH of the feed to a membrane plant can increase
or decrease the rate of permeation. In general, altering the pH can cause some species which may
be deposited on the membrane surface to dissolve into the feed stream thus reducing the
resistance to permeation. Conversely, altering the pH causing species to come out of solution and
deposit on the membrane can increase the resistance to permeation.
The dissolution of species by varying the pH can also cause the rejection of that species to drop
due to more of the species being present in dissolved molecular form as opposed to larger
particular form. Some studies have been carried out on the effect of feed pH on rejection for
nanofiltration membranes.

2.3.8 Cleaning of membranes, acid, base wash and cieaning chemicals
Membranes are generally cleaned at as high a temperature as possible. The limitation on the
temperature is usually due to the temperature specification on the membrane. The membranes
being considered for this project are polymeric and cannot tolerate very high temperatures. In
general they can tolerate temperatures of 50 to 70°C. The reason for cleaning at higher
temperature is mainly that warmer water contains more energy which is more efficient at removing
any molecules which may be fouled onto the membrane surface.
There are a large number of cleaning chemicals on the market for spiral wound membranes (which
were used at pilot scale for this project). Many of these cleaning chemicals are corrosive and / or
toxic. It is therefore preferable not to use cleaning chemicals if possible. Acid or base washes are
usually tried first. Polymeric membranes are generally only pH stable over a range of approximately
2 to 10. Acid and base cleans are generally carried out at pH’s close to these limits. The pH of the
feed stream to the membrane usually gives a good guideline to the pH that will give the best results
on the cleaning run. If a feed stream is acidic then a basic clean should be tried first. The logic
behind this is that whatever deposited on the membrane surface in acidic conditions may be very
soluble in basic conditions and vica versa

2.3.9 Recirculation flowrate
Although generally not as influential as the other parameters, operating at a higher recirculation
flowrate increases the crossflow velocity across the surface of the membrane which reduces the
extent of fouling on the membrane surface. This can have the effect of increasing the average rate
of permeation across the membrane.
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2.4 Membrane fouling
The ability to minimize the effect of membrane fouling is critical in assessing whether a membrane
plant will be successful or not. Given the indiscriminate nature of fine filtration, whatever molecules
that are present in feed streams which do not pass through the membrane may eventually lodge on
the surface of the membrane when the concentrations get high enough. Membrane fouling may be
irreversible where the foulant chemically binds to the surface of the membrane. In such cases the
particular membrane can no longer be used and will have to be replaced.
Fouling on RO and nanofiltration systems is inevitable. It is known that many parameters such as
design, operation and maintenance play a role. It is also worth noting that some degree of fouling
will have been designed for in any full scale membrane system. At the trials stage of any project, a
fouling run is carried out whereby a feed batch is run in a pilot plant on total recycle ( no permeate
is bled off) for a period of time and all parameters such as temperature and pressure are kept
constant at optimum operating values. The plant is allowed to pass permeate at the beginning and
end of the trial (but not during the trial) and the initial and final fluxes are measured. The falloff in
flux which will be primarily due to fouling is measured. This information is then taken into account
when designing the fullscale plant.
Concentration polarization
To understand fouling at a molecular level one needs to understand the effect of concentration
polarization. This is the process of accumulation of retained solutes in the membrane boundary
layer. Concentration polarization creates a high solute concentration at the membrane surface
compared to the bulk solution. The retained solutes are brought into the boundary layer by
convection and removal by a generally slower back diffusion. Concentration polarization is
illustrated in Figure 2.8

convective flow
back diffusion

solute

boundary layer

Figure 2.8 : Illustration of concentration polarisation

It can be seen that the concentration of solute increases near the membrane surface. The point at
where the concentration begins to increase is known as the boundary layer. The concentrations of
solute at various points are given as Cb; bulk feed concentration, Cw solute concentration at
membrane wall and Cp solute concentration in permeate. Js and Jy represent the fluxes of the solute
and solvent respectively.
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Gel layer formation
Gel layer formation is considered as the precipitation of organic solutes on the membrane surface.
This process usually occurs when the wall concentration due to concentration polarization exceeds
the solubility of the organic compound. Gel formation does not necessarily mean irreversible flux
decline. Gel formation is illustrated in Figure 2.9

gel layer
membrane

Figure 2.9 : Illustration ofgel layer formation (a) on membrane surface and within membrane pores and (b) on the
surface of the membrane

Categorisation of types of fouling
Some sources have categorized cake formation and pore blocking by precipitated material on
membranes . One author Schaefer et al [26] proposed that there are four subdivisions of membrane
fouling which are illustrated in Figure 2.10. These subdivisions are :
• Complete pore blocking
• Incomplete pore blocking
• Standard pore blocking
• External surface fouling

Figure 2.10 Diagram showing the various types ofmembrane fouling that can occur
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Membrane autopsy
Membrane autopsy is a useful technique which was used during this project to quantify the
performance of membranes after a sustained period of use or exposure to potential feed materials.
Membrane autopsy is the destructive method to characterize the nature and location of foulants
using predominantly surface characterization techniques. To perform membrane autopsy, the
membranes need to be sealed by covering the end caps after the elements are removed from the
installation, stored and transported in a cool environment and preferably all analysis performed
within a 24 hour period. Foulant deposits can be removed from the surface if the fouling layer is
sufficiently thick. Such deposits can then be analysed and their composition determined as mass
fractions using various analytical techniques. Surface characterization techniques used in
membrane autopsy are energy dispersion or x-ray spectroscopy. These techniques can identify the
main foulants present [27]. Membrane surfaces are also put under microscopes to see if there is
any damage or scratching evident on the membrane surface
Fouling prevention and cleaning
A number of steps can be taken to reduce the effect of membrane fouling ;
•

The feed stream may be prefiltered with a standard filter or with a looser membrane
filtration. This can significantly reduce the foulant levels being fed to the main membrane
bank. For nanofiltration and RO filtration, pretreatment methods include aggregation and
settling of particulate matter until an almost particle free feed is achieved. MF and UF may
be more effective in removing such particulates than conventional treatment but small
colloidal matter may still permeate.

•

Washing of the membranes when foulant levels build to significantly high levels is the best
available countermeasure. Coarse membranes (ultra and micro) can be backwashed. This
involves passing a wash back through the membranes from the permeate side to the feed
side to dislodge the foulant from the surface. This is a highly successful method as the
direction of flow across the membrane is fully reversed providing a direct force to remove
the foulant. This procedure may be carried out using a soluble cleaning agent but in many
cases a cleaning agent is not necessary.

•

Backwashing is generally not possible in nanofiltration and reverse osmosis membranes as
reversing the flow would damage the membrane. In these cases a high velocity cross flow
wash is used. Foulant removal is generally more efficient when a cleaning agent such as a
chemical or acid is used. Carrying out the clean at high temperature also aids the foulant
removal. Again a cleaning agent may be used
Mechanical cleaning, generally using sponges, may also be used in some membrane
configurations, for example in tubular modules where access to the surface of the
membrane is relatively easy to carry out (by opening the module casing, removing the
membrane and rubbing down with a spunge). However, mechanical cleaning is generally
not used in spiral wound modules which were used during this project due to the inability to
access the membrane surface with a spunge or other device.
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The most common chemical cleaning methods used in nanofiltration are summarised as follows ;
Alkali cleaning : The alkaline cleaning is often the most important as many foulants , especially in
natural wastewaters are of organic nature or inorganic colloids may be coated by organics. The
alkaline cleaning is aiming to remove organic foulants from the surface and from the pores of the
membrane. The high pH is usually a result of using sodium hydroxide and sodium carbonate
containing cleaning solutions
Acid cleaning ; The acid cleaning aims to remove precipitating salts (scaling) from the surface of the
membrane and from the pores. The acid procedure can be the most important cleaning step in RO
as the scaling problem occurs in connection with salt retention. In addition, acid can be used to
increase the solubility of many species in solution such as API. Increasing the solubility can have
the effect of redissolving many species that may have dissolved on the membrane surface at a
higher pH. Often the acid used is nitric acid at pH 1 or 2 depending on the pH stability range of the
membrane.
Enzymatic cleaning : Enzymes are used on a larger scale today than earlier. There are enzymes
that can take very high temperatures (70-90’C) even though in most cases their optimal
temperature is much lower. Enzymes can often be used where a more neutral pH for cleaning is
considered, when biofouling is expected or when polysaccharides are the typical foulants.

2.5 Further relevant design considerations
2.5.1 Pre and post treatment options for membrane plants
Pre and post treatment of feed streams to membrane plants can be benifical to improving the
optimization of the membrane process and may also be necessary to remove some species from
the waste stream. In some cases it may be necessary to pretreat the stream to the membrane plant.
This will involve the removal of one or more species. When pretreatment is employed, it is most
often to remove a component of the feed that is inhibiting permeation through the membrane or else
a component that may damage the membrane plant.
Components that can inhibit permeate flux rate include high TDS levels that create an osmotic
pressure which makes permeation more difficult as higher pressures are required to force the feed
across the membrane. Organic solvent can also create an osmotic pressure. In addition,
membranes are generally designed as either water stable or organic solvent stable (commonly
known as solvent stable membranes).
Water stable membranes do not work efficiently even with low levels of organic solvent present.
Conversely, organic solvent membranes do not work efficiently even with low levels of water
present.

Post treatment of feed streams is generally employed when components are present that may be
detrimental to the ongoing processing of the permeate down stream. Concentrating on this project,
this refers to components that would be damaging to the waste water plant. For example, some of
the organic solvents used on site at Kinsale are toxic to the WWTP and as a result they would have
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to be removed prior to sending the feed to the WWTP. Also dissolved species such as chloride are
also toxic to the WWTP.
The main technologies used to pre and post treat membrane plants are .
(1) Air stripping
(2) Electrodeionisation (which uses an electric fields to remove positively and negatively charged
species from solution)
(3) Coarse filtration
(4) Hydrogen peroxide addition, UV radiation and Ozonation
Hydrogen peroxide is highly reactive and reacts with unwanted species in waste streams. UV
radiation and Ozonation are radiation treatments which used highly concentrated electromagnetic
radiation to break down unwanted species in process streams

2.5.2 Mathematical modeling and mechanisms
Some mathematical modeling software has been developed for membrane processes in industry
mainly based on the solution diffusion theory (and some on the surface pore repulsion theory also).
Many of these models are relatively useful in predicting fluxes and obtainable volume reductions for
process streams with many membranes. However, looking at the situation from a second point of
view, membranes and membrane feed streams are highly varied and as discussed in previous in
section 2.3.1, each new membrane application can be quite unique. This is indeed the case for this
project where a relatively new membrane was used to treat a waste matrix with many constituents.
In addition, the timeline on this project was relatively short. Once the waste streams had been
characterised, the data was analysed by potential vendors and bench scale trials commenced
relatively quickly. In hindsight, some models could be now reviewed to see if they correlate well with
the installed full scale membrane process.

2.5.3 Diafiltration
As mentioned already, TDS levels in waste streams can be high enough to produce an osmotic
pressure which makes permeation through a membrane difficult. If the osmotic pressure exerted by
the feed stream is higher than the maximum allowable operating pressure for the membrane,
permeation is not possible. A technique which is sometimes used to allow permeation in such a
situation is diafiltration. The basic principle is as follows :
A feed stream as described above is diluted generally with the solvent in the feed stream. This has
the effect of increasing the volume of feed and reducing the osmotic pressure. This can result in
permeation across the membrane which can allow some of the dissolved solids to pass across the
membrane also. When the volume of feed has again reduced to its original volume before dilution,
the levels of TDS will have reduced, hopefully to a level which will allow the permeation of this
original volume. The dilution can be repeated thereby reducing the TDS levels further. The overall
effect of the diafiltration is that the molecule which needs to be rejected by the membrane is
concentrated into a small volume. The disadvantage is that the volume of permeate is large.
This would be useful for the API application as the main goal is to reduce the volume of feed waste
that needs to be incinerated by concentrating the API molecule on the feed side of the membrane.
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The volume sent through the membrane is not very important as it is planned that the permeate
would be sent to the WWTP anyway which has a large capacity. Here the overall increased volume
of feed to the WWTP would be relatively small anyway (as the WWTP received waste from a
number of different processes other than the process which the membrane plant would be applied
to). The possibility of diluting Benzodiazepine waste to see if it would permeate through a
membrane was investigated in Chapter 4.

2.5.4 Adsorption onto membrane surface
Adsorption of molecules onto the surface of molecules is a phenomenon that can improve the
obtainable rejection from a membrane. If the charge between the membrane and the rejecting
molecule is correct, the molecule will bond onto the surface of the membrane. In addition if other
constituents foul onto the membrane surface, the molecule being rejected may adsorb onto the
foulant or absorb into the foulant.
EPT, who are one of the membrane vendors that were consulted during the project, suggested that
they would be capable of treating one of the waste stream using a ceramic membrane. Ceramic
membranes are generally regarded as not having small enough pore sizes to filter nanofiltration
particles. However, EPT suggested that the membranes used frequently adsorb material onto their
surface which should have the overall effect of increasing the API rejection. In general ceramic
membranes are much more expensive than all other membrane types. The correspondence with
EPT on this topic is discussed in Chapter 3.

2.5.5 Recovery of retentate molecule
Where the molecule retained from a membrane plant has a high economic value, it may be worth
recovering the molecule. This is definitely relevant in the pharmaceutical industry. The main
concern in recovering API molecules is the purity of the recovered molecule. The pharmaceutical
industry is highly regulated and product needs to be manufactured to exact specifications. A lot of
validation work would need to be carried out before API could be recovered. Even if this validation
work was successful, the industry in general is very slow to carry out any work which alters the
production recipe considerably, even of the potential increase in profits are large. A lot of future
research work is likely to be in this field.

2.6 Biological waste treatment
Any successful membrane plant would have the effect of introducing new waste streams to the
waste water treatment plant. The performance of the waste water treatment plant is dependant on
the activity of the microorganisms and their metabolism which can be dramatically affected by the
presence of toxic material in the raw waste water. The extent to which inhibition may cause a
problem in waste water treatment plants depends, to a large extent, on the constituents of the
waste water undergoing treatment. Many materials such as organic and inorganic solvents, heavy
metals and biocides can inhibit the biological activity in the treatment plant. Table 2.1 lists the
inhibitory levels reported for some metals, inorganic and organic substances. The discharge of
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these materials from industrial activities should be controlled under the licencing provisions acts,
1977 and 1990
There are two forms of toxicity namely Acute and Chronic
Acute toxicity occurs when the level of toxic material in the waste water is high enough to inactivate
the biological activity. This happens rapidly. Chronic toxicity occurs slowly and results in process
failure due to gradual accumulation of toxic material in the biomass.
Toxic materials in the waste water can selectively inhibit single species of microorganisms. For
example, inhibition of one species of bacteria in the two species chain responsible for nitrification
can lead to nitrite rather than nitrate present in the outflow. Damage to protozoa in the activated
sludge process can lead to turbid outflow which may persist for days while damage to greasing
micro -organisms in a percolating filter will take time to exhibit itself but may eventually result in
clogging of the filter media.
The net effect of inhibition is an increase in the plant loading. A toxin with an EC50( Effective
concentration which causes 50% toxicity ) of 6.7 % means that 6.7 % solution of the toxin in the
waste water would cause 50% inhibition of the micro organisms. A (6.7/50%) 0.134% solution
would cause 1% inhibition, thereby adding 1% to the effective BOD load to the plant
The toxicity of industrial discharges to microorganisms is measured by respiration inhibition (a
reduction in the O2 consumption rate) and its measurement should be considered where the
treatment plant may be subject to shock loads of toxic material.
Any additional waste stream that would be fed to the waste water treatment plant would consist of
mainly membrane plant permeate with the possibility of smaller volumes of washwater also. It was
recommended by membrane vendors that respirometry trials should also be carried out as part of
any membrane trials.
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Table 2.1 Inhibatory levels for various species in waste water streams [281

Metals, nonReported range for
metals, inorganics activated sludge
and organics
units (ppm)
Cadmium
38991
1-100
Total chromium
Chromium III
18537
Chromium VI
1
Copper
1
Lead
0.1-100
Nickel
1.0-2.5
Zinc
0.3-5.0
Arsenic
0.1
Mercury
0.1-2.5
Silver
0.25-5
Cyanide
0.1-5.0
Ammonia
480
Iodine
10
Sulphide
10
Anthracene
500
100-500
Benzene
2 Chloropropenol
5
200
Ethylbenzene
Pentachlorophenol
0.95-50
50-200
Phenol
Toluene
200
Surfactants
100-500
Tin
0.4
Chlorides
10

2.7 T-methvl-butvl-ether (MTBE) removal from aqueous streams r291
One of the issues with one of the potential waste streams to be treated during this project was that
MTBE was the organic solvent used in the production process which meant that relatively high
levels of MTBE were present in the waste stream. The allowable emission levels of MTBE to the
environment are low and MTBE is detrimental to the biological population in the waste water
system. As a result it would be necessary to remove MTBE before any waste could be sent to the
WWTP. Air stripping and granular activated carbon (GAC) adsorption have been identified as the
most efficient methods of removing MTBE from aqueous streams. They have proven to productively
remove MTBE from municipal and private household drinking water.
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An air stripper consists of contaminated water flowing down a column filled with packed material
while a stream of air flowing upwards strips the MTBE from the water. Some air stripping specific
technologies consist of spray towers, bubble diffusion strippers, aspirated air strippers, low profile
air strippers and packed towers. Low profile air strippers have shown to be the most cost effective
at low flow rates cleaning at a rate of 97.5% removal of MTBE. Low profile air is easy to maintain,
install, modify low flowrates, and modify water quality conditions. This technology will usually cost
more than GAC units due to its need for operation and maintenance.
Granular activated carbon (GAC) adsorption is a technology most widely being used to remove
different types of organic compounds such as MTBE from private household water systems. This
method involves pumping water through a bed or canister of activated carbon, which causes the
MTBE to be adsorbed. Many of the canisters that house the GAC filtering system can be purchased
in an array of different shapes and sizes. The two types of carbon being used are coconut shell
carbon and coal shell carbon. In some cases coconut shell carbon has proven to be the most
effective carbon, however, both are capable of removing MTBE to non detect levels. In certain tests,
the coconut-shell activated carbon is able to last longer and absorbs a greater capacity of MTBE
than coal based carbon. In some cases coconut shell carbon has proven o be the most effective
carbon, however, both are capable of removing MTBE to non detect levels. In certain tests, the
coconut shell activated carbon is able to last longer and absorbs a greater capacity of MTBE than
coal based carbon. Both have better efficiency and effectiveness when the levels of MTBE are
below 300ug/L.Some home units have up to 6 year warranties that require little or no care.
It should be noted that the information above is specifically for small scale domestic units for
removal of MTBE. Given that air stripping is a technology that is already used on site at Lilly, it was
seen to be the best potential alternative for the stripping of MTBE from waste streams if needs be.
An air stripping trial was carried out on site during this project (see chapter 4).
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2.8 Vendor case studies
During the review of literature, it was difficult to find any applications that were entirely relevant to
this project. Any relevant journal articles found are summarised in section 2.9. The vendor that was
brought forward to full scale for this project was happy to supply some case studies of projects that
have recently been carried out in industry that are very relevant. These case studies are
summarised in the following sections.

2.8.1 Recovery of 6-APA from mother Liquor (Koch)
6 APA (Mr. = 216) is an intermediate in the manufacture of synthetic penicillin. It is manufactured in
a fermentation process or synthesised chemically. A schematic of the membrane process is shown
below in Figure 2.11
The typical mother liquor from the chemical reaction contains 0.37% of dissolved 6 APA, 16%
methanol and 2% methylene chloride. The solvent stable nanofiltration membrane having a low
molecular weight cut off, concentrates the 6 APA to 4 % at commercial scale. The 6 APA is then
returned upstream. The lifetime of the membranes is more than one year.
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2.8.2 Recovery of Solvents and Concentration of Main Fraction from Preparative HPLC
In many processes, preparative HPLC is used in reverse phase (water / solvent) or normal phase
{solvent/solvent) to separate the main fraction from contaminating molecules. In this situation,
HPLC produces two waste streams, the first stream contains the product that is to be concentrated
while the second stream is spent solvent that must be discarded.
A hydrophilic MPS-44 nanofiltration membrane is used to concentrate the product and a
hydrophobic MPS-60 membrane is used to purify the organic solvent. The general process
schematic is shown in figure 2.16.
The product stream from the HPLC contains low molecular weight pharmaceutical compound
dissolved in methanol: water solution (90:10).The compound concentration is 1% when leaving the
HPLC. The second eluting HPLC stream contains solutes at a lower concentration (0.025%) in the
same solvent composition.
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2.8.3 Recovery of Spent Caustic and Acids from CiP Systems
Cleaning of production equipment such as pipelines and evaporators in the food industry or
fermentation equipment in the pharmaceutical industry, is routinely performed to maintain high
hygienic standards and to ensure proper functioning of equipment.
The cleaning and sterilization of equipment is done typically with a hot solution of 2 % caustic
(NaOH). The hot caustic disinfects the equipment and removes caramelised organics, precipitated
proteins and fats from the surfaces of tanks, pipes, heat exchangers and evaporators. In some
cases, additional compounds, such as antifoams and chelating agents, are also added to the
caustic. The spent caustic solution is heavily contaminated with dispersed and soluble organics. It
can either be disposed of, or partially reused. Following the caustic step, acids are sometimes used
to remove water hardeners from the equipment. The AlkaSave membrane process is designed to
recycle spent caustic or acids from the cleaning process, and supply to the user ready to use, clean
and high quality caustic (or acids).By recycling spent caustic or acid with the Alkasave nanofiltration
process, the consumer achieves cost savings, reduction in effluent volumes and fees, as well as
smooth, trouble free production. A schematic drawing of the AlkaSave membrane unit, combined in
the CIP system, is shown in the diagram below.

Figure 2.13 Overview of caustic regeneration process

2.8.4 Recovery of Dissolved Catalysts from Organic Liquids
Homogenous catalysts are a group of soluble organic metal complexes of low to medium molecular
weight sizes (m.w.~ 110-1000). In a chemical process, catalysts dissolve in a liquid organic reaction
mixture and help expedite the reaction process. Catalysts, which are not consumed in the process,
are very expensive chemicals. They have to be separated from the organic liquid and reused.
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Today, several large scale industrial products are produced by homogenous catalysis. Some of the
most important catalytic processes are.
•
•
•
•
•

production of adiponitrile from HCN
conversion of propylene into butylaldehyde using cobalt carbonyl and/or rhondium
phosphine soluble catalysts
production of linear alpha olefins with aluminum alkyls
production of aldehydes with rhondium or cobalt based complexes
production of L-Dopa

One company (MPW Ltd.) has developed two solvent stable nanofiltration membranes for
applications in strong organic solvents. These membranes, which are available in a spiral wound
configuration in test scale elements and as flat sheets, demonstrate excellent immersion stability in
almost any organic solvent or liquid. The membranes have good rejections to dissolved
organometallic catalysts and thus can be used to recover catalysts from organic liquids. The
membranes pass the organic solvent or liquid product and retain the dissolved catalyst.

2.9 Literature review

2.9.1 Removal of APi’s
A large number of scientific journals and textbooks were searched for relevant information in the
field of membrane technology and many of these journals are discussed and referenced in the
preceeding sections. However, little research work has been done in the area of removal of API
from aqueous streams using membrane separations. Relevant sourced articles in this area were ;
1. Investigation into the potential of removing Pharmaceutical Active Compounds (PhAC’s) from
water and waste water using membranes [30]
This article looks at the removal of PhAC’s including xenobiotics which are persistent to the
conventional biological sewage treatment process. Several studies have shown that some PhAC’s
are not eliminated completely in conventional sewage treatment plants. Removals of common
PhAC’s from waste water plants are summarised in Table 2.2.
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Table 2.2 : Summary of results obtainedfrom studies on removal of various low molecular weight compounds at lab scale
andfrom waste water treatment plants

Molecular
weights

Compound

Raw sewage (ng/l)

Treatment
Removal process

Effluent

Remark

Diclofenac
Clofibric acid
Bezafibrate

318
215
362

not available
not available
not available

not available
not available
not available

4
13
none

Ciprofloxacin
Ciprofloxacin
Norfloxacin
Norfloxacin

331
331
319
319

313
447
255
435

68
62
51
55

79
86
80
87

WNTP

Switzerland

lopamidol
Diatrizoateb
loxithalamic acid

822
672
614

4300
3300
170

4700
4100
160

none
none
none

WWTP

Germany

Ibuprofen
Carbamazepine
Diclofenac
Sulfamethoxazole
Naproxen

494
236
318
253
231

1000
2000
400
1000
8000

600
1000
300
900
4000

52
39
30
27
58

WWTP

Austrailia

Flocculation Lab scale

The research groups then went on to focus on the biodegradation mechanisms of trace
contaminants and the optimization of conventional treatment processes for the removal of such
contaminants. It is also suggested that it is unlikely that a high removal of all compounds can be
achieved. Several studies have now shown the retention of PhAC’s by nanofiltration and RO. Table
2.3 shows the main results from such studies
Table 2.3 Summary of residts ofstudies on retention ofPhAC's by nanofiltration and RO

---------------------

Membranes

Compound

ESNA

Phenacetine
Primidone
Diclofenac

iMolecular
Iweights

Feed
concentration
microgram per
Retention (%) Scale
litre

1

179
218
318

100
100
100

19
87
93

Lab
Lab
Lab

NF-270

Sulfamethoxazole '
Carbamazepine

253
236

700
700

96
84

Lab
Lab

RO membrane

Carbamazepine
Clofibric acid
Diclofenac
Naproxen

236
215
318
231

0.43
0.33
0.329
0.038

>99.8
>99.7
99.7
95

Pilot
Pilot
Pilot
Pilot

RO membrane

Clofibric acid

215

7.4

89

Pilot

:
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Here it can be seen that the rejections achieved vary considerably. The reasons for this were
explored. It was suggested that physiochemical properties play a large role in the separation of
API’s. Physiochemical explicitly implies that separation can be due to physical selectivity (Charge
repulsion, size exclusion and steric hinderance) or chemical selectivity (hydrophobic interactions or
hydrogen bonding).

2. Rejection of neutral endocrine disrupting compounds (EDO’s) and pharmaceutical active
compounds by RO membranes [31]
The driver for this research was the concern that where waste water effluent is used as part of a
downstream drinking water source, PhAC’s and EDO’s that may be present in some waste water
effluent are a cause of large concern for drinking water supplies. The study looked at two
membranes namely the XLE, Dow Filmtec membrane and the SC-3100, Toray membrane. The
study only looked at compounds with a molecular weight of less than 300 as it was suggested from
many sources in this study that molecules with a molecular weight of greater than 300 should be
easily removed by RO or NF membranes. The study looked at 11 compounds.
A summary of the rejections achieved are shown in Table 2.4 below. Rejections were calculated on
the basis of;
Rejection = 1 - (Final bulk permeate/final concentrate) * 100

Table 2.4 Summary’ ofrejections achieved for each compound using both membranes during research trials

API/EDC
2-Naphthol
4-Phenylphenol
Phenacetine
Caffeine
NAC standard
Primidone
Bisphenol A
Isopropylantipyrine
Carbamazepine
Sulfamethoxazole
17b-Estradiol

Molecular Rejection Rejection
weight
XLE
SC-3100
144
170
179
194
201
218
228
231
236
253
272

57
61
74
70
79
87
83
78
91
70
83

0
11
10
44
0
85
18
69
85
82
29

The convention of MWCO is the molecular weight of a compound that can be rejected by 90% or
more. The XLE generally showed better rejections that the SC-3100.
The study then looked at the relationship of rejection with physical / chemical properties of the
molecules. The relationship between molecular weight and rejection was then plotted for each
membrane as shown in Figure 2.14
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Figure 2.14 Illustration ofrelationship between molecular weight and rejection with both membranes for the 11
compounds

Looking at these results it was concluded that the pore size i,e, sieving was the dominant factor for
the XLE membrane while other factors need to be considered to explain the results for the SC-3100
membrane. The study then looked at the relationship between rejection and the solubility product of
the feed for each of the membranes. The results are shown in Figure 2.15 below

Figure 2.15 : Illustration of the relationship between rejection and solubility product with both membranes for the 11
compounds investigated

For the XLE membrane no significant correlation was shown and for the SC-3100 membrane no
correlation is present either. The study then suggests that the polarity of the molecules needs to be
considered to explain the rejection behavior. The polarity of the compounds (represented by their
dipole moment) was then plotted against rejection for each of the membranes and the results are
shown in Figure 2.16
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Figure 2.16 : Illustration of the relationship between rejection and dipole moment with both membranes for the 11
compounds investigated

For the SC-3100 membrane, in general the higher the dipole moment the higher the rejection.
The study then goes on to suggest that the nature of the membrane material also plays a role in
that interaction with the membrane material with the dipole moment affects the rejection obtained.

2.9.2 Additional literature review articles.
A large amount of studies have been carried out on the removal of pesticides aswell as dyestuffs
from aqueous streams. Pesticides and dyestuffs are generally organic molecules which have similar
molecular weights to active pharmaceutical ingredients. As a result, this research information was
seen as potentially useful information in terms of understanding the overall topic.

Rejections of molecules
Many studies look at the achievable rejections of pesticides and dyestuffs using nanofiltration
membranes. Shang and Van der Bruggen [32] looked at the removal of two pesticides (Atrazine
mr=216 and Simazine mr=201.7) using four types of membranes. Rejections were always above
80%. Ku and Lee [33] looked at the separation of three different dyestuffs (acid red mr=382, acid
orange mr^452 and acid red 27 mr=604) from aqueous solution by nanofiltration. For most
experiments, dyestuff rejections of greater than 98% were achieved. Chen and Taylor [34] looked at
the removal of 11 different pesticides ranging in molecular weight from 198 to 286 Da. The
rejections achieved ranged from 46% to 100%. Kiso and Kitao [35] looked at the rejection of 11
kinds of aromatic pesticides (molecular weight range of 190 to 350) by four different NF
membranes. For the tightest membrane, 10 of the 11 pesticides had rejections of more than 92.4%,
except for one tricyclazole which as would be expected had the lowest molecular weight (mr=190).
Although the other membranes showed lower rejections, some pesticides were rejected at very high
rates (>95%) by ail membranes.
These studies have shown promising results in the context of this project. The molecular weights of
potential API’s that were to be treated at Lilly ranged from approximately 200 to 870 which are all in
the approximate range of these studies.
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Adsorption onto membranes and charge effects
Shang and Van der Bruggens [32] study which looked at the removal of two pesticides from
different water matrices (distilled water, tap water and river water) found that the rejection of
pesticides was higher in river water. This was mainly explained by ion adsorption inside the
membrane pores due to the adsorption of natural organic matter onto the membrane surface. This
appears to be a logical plausible assumption. This highlights the potential influence of the feed
matrix on rejection.
Kiso and Sugiura [35] who looked at the rejection of 11 different pesticides found that all the
pesticides were adsorbed on the membranes and the experiment indicates that adsorption
properties were controlled by both hydrophobicity and molecular shape of the solute.
The results obtained by Pontalier and Ismail [36] who studied two nanofiltration membranes showed
the selective properties of nanofiltration membranes come from a combination of several
physiochemical mechanisms. They showed that molecules are retained at the membrane surface
by electrostatic and steric interactions and small, weakly charged ions can enter the pores.
Adsorption of species on to membranes is helpful as in general, it can improve the achievable
rejections of molecules. During this project, the electrostatic and steric interactions were not
identified as primary importance in accounting for the variations in API rejection for the chosen
scaled up waste streams for this project. As a result, adsorption and charge effects on the
membrane were not studied in detail. It is noted that these interactions can play significant roles in
the rate of permeation achieved for membrane feed systems.
Crossflow velocity of the feed
Ku and Lee [33] who looked at the removal of three acidic dyestuffs in aqueous solution by
nanofiltration found that the permeability across the membrane was increased and the rejection of
the dyestuffs was increases with increased cross flow velocity in the solution. This is generally
taken as common knowledge in membrane processes whereby the efficiency of the process is
improved by operating at higher crossflow velocities. Obviously for any full scale plant, this needs to
be balanced against increased pumping costs at higher recirculation flowrate. This was seen as
potentially useful information and would be investigated further during the membrane trials
Stereochemistry
Surprisingly, from many studies the shape of molecules seems to have a larger than expected
effect on the achievable rejection from membrane processes. Kiso and Kitao [35] who looked at the
effects of hydrophobicity and molecular size on rejection of aromatic pesticides with nanofiltration
membranes found that adsorption properties of molecules onto membranes were controlled by both
hydrophobicity and the molecular shape of the solute. This has been highlighted by various
research groups. Pontalier and Ghoul [36] also found that large molecules are retained at the
membrane surface by steric interactions.
Again, it should be noted that as this research project progressed, stereochemistry did not appear
to be one of the dominant factors influencing how the three chosen streams permeated. As a result,
no attempt was made to quantify the influence of these affects during the project. But it is noted that
the affect of stereochemistry can be significant.
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Hvdrophobicitv / hvdrophilicitv
Kiso and Kitap [35] also found that adsorption properties were partly controlled by the
hydrophobicity of the solute. This has been highlighted by various research groups.
Again as this research project progressed, hydrophobicity / hydrophilicity aswell as stereochemistry
did not appear to be the dominant factors influencing how the three chosen streams permeated and
as a result, no attempt was made to quantify the influence of these affects. But it is noted that the
affect of stereochemistry and hydrophobicity can be significant.

Modeling membrane filtration
The developments in modeling membrane filtration systems in ongoing. Researchers are striving to
develop general models that will allow process developers and companies to obtain accurate
information on the applicability of membrane technology to various feed streams that may need
treatment. An interesting study on modeling NF and RO was carried out by Bellona, Jorg, Drewes
and Amy[g]. They looked at the factors affecting the rejection of organic solutes during NF/RO
treatment. In this study, the findings of a comprehensive literature review were reported, targeting
membrane rejection mechanisms and factors affecting rejection of certain pesticides, disinfection
by-products and endocrine disrupting compounds. The following key solute parameters were
identified to primarily affect solute rejection, molecular weight (MW), molecular size (length and
width), acid disassociation constant (pKa), hydrophobicity / hydrophilicity (measured as contact
angle) and surface morphology (measured as roughness). In addition, feed water composition, such
as pH, ionic strength, hardness, and the presence of organic matter, was also identified as having
an influence on solute rejection. From this knowledge gained, a rejection diagram was proposed,
which qualitatively allows prediction of solute rejection if certain solute and membrane properties
are known.
This is a useful concept for understanding membrane / solution system interactions. This diagram
was not applied to this project however given the potential usefulness of this concept it is likely that
further modeling and experimental development work will be carried out in the future. It should be
noted that even though modeling is useful as a preliminary evaluation step at pre trials stage and
will become increasingly more useful in the future, in field testing of individual membranes and
waste streams is the most comprehensive way to gain information on the potential of treating any
waste stream.
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Summary
The first section of this chapter looks at how process waste streams were chosen to bring forward
to pilot trials. A systematic approach w/as required to asses what streams had the most potential to
be treated with membrane separation technology. A “stream selection matrix’’ system was
developed which looked at different characteristics (e.g. LAEG) of all process waste streams on
site that would make them attractive candidates to treat as part of this project.
Using the stream selection matrix, every production process waste stream on site was weighted
and scored for each of these characteristics and the top three scoring streams were then identified
and were brought forward to pilot trials
When it comes to looking at the potential of treating any stream with membrane separation
technology, the initial step is to quantify the constituents in the stream. As part of the second
section of this chapter, it was decided to use three methods to characterize the three chosen waste
streams.
The methods used to characterize the waste streams were;
1.

A theoretical mass balance using the Process Flow Document (PFD) for the relevant
process

2.

Carry out a sampling campaign on each of the three chosen process waste streams

3.

Use waste Bill of Materials (BOM’s) for processes on site

After calculations and gathering of information using the three methods chosen, a summary of the
three characterized waste streams was sent to vendors.
The second section of this chapter looks at the evolution of discussions with the contacted vendors
and the process of coming to a decision to bring two vendors forward to bench scale trials.

49

Chapters Characterisim Waste on Site & yendor Selection

3.1 Characterising waste on site
3.1.1 Waste stream selection matrix
A basis was required for deciding on what streams would be potential candidates for membrane
treatment. A brainstorming session was carried out with the membrane project group and the
following five factors were shortlisted as important;
LAEG
Volume of waste produced on site
Molecule size
Availability of segregated process waste
Campaign Duration

(DLAEG
Product waste streams with relatively high LAEG’s were preferable. Low LAEG’s meant that it was
likely that less API would have to be held back by the membrane with more of the API not being
contained which is undesirable. Various vendors quoted API rejections of around 95% for
molecules in the molecular weight range of the API’s of interest. Although these rejections were
high, they might not be nearly high enough for some of the products produced on site. For example
the LAEG for the raloxifene process is extremely low and it was estimated that the process waste
could contain a relatively high amount of API. This would require almost perfect rejection which is
unlikely for any membrane [38]. In addition, the limit of detection on the API analysis technique
would not be able to detect API at such low levels (10ppm was the lower limit of detection for most
API analysis methods).
(2) Volume of waste produced on site
Products that produce large volumes of waste were preferable as they produced larger volumes of
waste that currently need to be incinerated. It was simple economics to go with large volume
streams. Larger volumes diverted from incineration would potentially justify a membrane plant and
accelerate the payback rate for a full scale plant.
(3) Molecule size
Larger molecules are easier to filter out of a waste stream. The problem with smaller molecules (in
the reverse osmosis range - less than 200 Daltons ) is that even though these molecules can be
filtered out with the correct membrane, the membrane will also filter out any other dissolved solids in
the stream which causes the osmotic pressure to build quickly and therefore limits the volume
reduction that can be achieved (operating in the RO range also means operating at higher pressure
which means a higher capital cost for any potential plant). In addition, preliminary research
indicated that solvent stable RO membranes are not commonly used in industry due to the current
inability to develop such a membrane.
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(4) Availability of segregated process waste
As covered already, membranes are sensitive to physical conditions such as pressure, temperature,
the chemical composition of the waste stream and the physical properties of the waste stream
(particularly TDS, TSS) that is fed to them. A membrane was to be chosen on the basis of the
composition of the feed stream. As a result, the feed to any plant needs to be well characterized
and segregated. Segregated here refers to the number of processes feeding into a central
collection tank (known as a secondary waste day tank) for any process building

(5) Campaign Duration
As mentioned in chapter 1, most products manufactured on site are run on a campaign basis
(campaigns typically run for 3 to 9 months). Given the duration of this project ( October ’03 to
March ’05 ), it was important that any potential waste streams for pilot trials were up and running for
a reasonable time during this period.

3.1.1.1 The Scoring system for the Stream selection matrix
Each of the six parameters were given a “base score” of either high, medium or low. To work out a
numerical score, high was given a value of 9, medium a value of 4 and low a value of 1. In addition,
each of the parameters was also given a weighting depending on the relative importance of the
parameter as some parameters were seen as more important than others. Weightings of either 4, 3,
2 or 1 were applied to each of the 6 parameters. Multiplying the base score by the weighting gave
the “parameter stream score” for the given stream for a particular parameter. Summing all the
parameter stream scores for any given stream gave the ‘final score” for any given stream.

3.1.1.2 Weighting the five parameters for the stream selection matrix
The five parameters listed above were of varying importance and as a result had different
weightings attached to them. For example, the LAEG was a very important parameter. If the LAEG
is extremely low, treatment of the waste stream would not be attempted as with a low LAEG almost
no API can be emitted through the waste water plant and it would therefore be required for the
membrane to provide a “perfect” rejection of API which is not possible. A less important parameter
would be the analytical method for the API. The five parameters were weighted as follows :
Parameter
LAEG
Volume of waste produced on
site
Molecule size
Waste segregation
Campaign duration

Comment
Very
important

Weighting
4

Important
Less
important
Less
important
Less
important

3
2
2
2
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As mentioned already, LAEG is a very important parameter in deciding on the potential of treating
the waste stream. LAEG was therefore weighted as 4.
Volume of waste produced is also an important parameter. Ideally product waste streams chosen
should be large volume waste streams. In short, there is no point in treating a waste stream with a
membrane separation if it only accounts for a very small percentage of total secondary waste. An
waste stream with an average volume may still have potential for processing. As a result, this
parameter was given a weighting of 3.
The size of the molecule (API) to be removed is also a relatively important parameter. It is much
easier to separate out a large molecule with a membrane. Large molecules allow operation with a
“looser membrane” which in general would mean that flux rates are maintained at relatively high
values while rejections are not compromised. Also many of the other impurities in the waste stream
have a greater potential of passing through a loose membrane thus keeping the osmotic pressure in
the feed stream relatively low. However, given the relatively close range of API molecular weights (
the relevant API’s range in size from 292 to 868 ), molecule size was not seen as critical for the
operation of a membrane plant, nor is it seen as dominantly important from an economic point of
view. As a result, molecular size was given a weighting of 2.
A waste that is not well separated would mean that for any full scale plant, additional segregation at
source would need to be carried out by additional tanks and piping to bring the waste to a single
location. However, waste segregation will not ultimately determine if a particular waste stream can
be chosen or not but it is relatively important in terms of obtaining sample waste for the pilot trials
and capital costs for any full scale plant. As a result waste segregation was given a weighting of 2.
For the purposes of this MSc project, the campaign duration was a very important parameter but for
the purposes of the company and moving forward with the concept of source treatment as a whole
(which has been identified as being of high priority to Lilly at a global level), it was not. As a result,
campaign duration was assigned an intermediate scoring of 2. It was likely that anything up to 6
months would be required to carry out pilot trials
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3.1.1.3 Scoring the parameters for the stream selection matrix
(1) LAEG
LAEG’s varied from 61,831g/day (for Ractopamine) to 33 g/day (for Raloxifene technical). A
summary of all LAEG’s are given in Table 3.0 below

Table 3.0 : LAEG’s for production processes running on Kinsale site 2003 - 2005

Product

LAEG limit
(g/day)

Product

LAEG limit
(g/day)

Ractopamine

61831

Raloxifene final

33

Tilmicosin

10202

Atomoxetine final

3546

Benzodiazepine
HCi

2400

Atomoxetine
mandelate

3546

Olanzapine Tech

2400

MTA steps 4&5

4151

Olanzapine final

2400

MTA steps 6&7

4151

Raloxifene Tech

33

Given the distribution of LAEG’s for different products within this range, it was decided to score the
LAEG’s as follows :
High (score of 9) = greater than 5000 g/day
Medium (score of 4) = between 500 and 5000 g/day
Low (score of 1) = less than 500 g/day

(2) Mass of waste produced on site
The figures for the volume of waste produced per year were based on work carried out by a
summer student at Lilly in 2003. These figures were an estimate of the average waste that would be
produced for each product from 2004 to 2007.

It was found that the largest waste producer was the Atomoxetine final process (595,000
litres/year) and the smallest producers were Olanzapine final. Raloxifene final and Ractopamine. A
summary of all waste volumes for 2003 to 2007 are given in Table 3.1
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Table 3.1 : Quantities of secondary waste producedfor production processes running on Kinsale site 2003 - 2005

Product

Waste mass
kg/year

Product

Waste mass
kg/year

Ractopamine

0

Raloxifene final

0

Tilmicosin

2,810,443

Atomoxetine
final

595,907

Benzodiazepine
HCI

699,593

Atomoxetine
mandelate

1,465,863

Olanzapine Tech

51,627

MTA steps 6/7

32,500

Olanzapine final

0

MTA steps 7/8

13,000

Raloxifene tech

854,400

Again given the distribution of the waste volunnes produced for each product, the volumes were
scored as follows :
High (score of 9) = greater than 500,000 litres/year
Medium (score of 4) = between 100,000 and 500,000 litres/year
Low (score of 1) = less than 100,000 litres/year
(3) Molecule size
In general the molecular weights of the API’s on site are within a relatively close range. The
smallest API is Atomoxetine final with a molecular weight of 292. Some of the intermediate products
which are also classified as API are slightly smaller than the final molecule. For example
Desmycosin which is an intermediate of Tilmicosin, is smaller than Tilmicosin which is the largest
API (molecular weights of Tilmicosin and Desmycosin are 868 and 756 respectively).
The smallest API intermediate associated with the relevant API’s is Atomoxetine free base ( Mr =
255 ) which is an intermediate in the production of Atomoxetine mandelate and Atomoxetine HCI.
The molecular weights of ail relevant API’s are shown in Table 3.2 below
Table 3.2 : Molecular weights ofAPI’s for production processes running on Kinsale site 2003 - 2005

Product

API
molecular
weight

Product

API
molecular
weight

Ractopamine

338

Raloxifene final

509.6

Tilmicosin

868

Atomoxetine final

291.82

Benzodiazepine HCI

265.8

Atomoxetine
mandelate

407.51

Olanzapine Tech

312.4

MTA steps 4&5

655.7

Olanzapine final

312.4

MTA steps 6&7

471.38

Raloxifene Tech

559.54

The molecular weight range is on the border between Reverse Osmosis membranes and
Nanofiltration membranes. To be more precise, it is at the lower molecular weight cut-off limit of
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nanofiltration membranes. From speaking with membrane vendors, it was suggested that there was
a significant advantage to dealing with a larger molecule even within this range. The MWCO of
many of the NF membranes on the market is in the range of 200 to 800 (MWCO of the Dow NF200
and Koch MPS-44 membranes are both 200) and vendors suggested that the achievable rejections
of the larger API’s could be much higher than for the smaller API’s. The API was therefore scored
on the following basis ;
High (score of 9) = molecular weight greater than 600
Medium (score of 4) = molecular weight between 400 and 600
Low (score of 1) = molecular weight less than 400
It should be noted that for simplification, only true API’s were used for scoring API’s ( and not API
intermediates)
(4) Waste separability
Each of the production buildings on site at Lilly have a secondary waste day tank which collects all
the secondary waste produced in that building. An exception is the IE16 production building which
has two day tanks - one for the small scale production rig and one for the large scale production
rig. A single product waste feed stream filling into any of the day tanks in the various buildings was
the ideal scenario.
More than 2 products feeding into any of the various day tanks was seen as the least desirable
scenario since waste from multiple processes will be mixed in together. Table 3.3 shows the
segregation for all relevant processes on site.
Table 3.3 : Segregation ofproduction processes running on Kinsale site 2003

Product

Segregation

Product

Segregation

Ractopamine

1

Raloxifene final

2

Tilmicosin

1

Atomoxetine
final

2

Benzodiazepine
HCI

2

Atomoxetine
mandelate

more than 2

Olanzapine Tech

2

MTA steps 6/7

more than 2

Olanzapine final

2

MTA steps 718

more than 2

Raloxifene tech

2

As a result waste separability was scored as follows
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High ( score of 9 ) = Only a single product feeding into the building day tank at any one time.
Medium ( score of 4 ) =Two product waste feed streams feeding into the secondary waste day tank
at any one time
Low ( score of 1 ) = More than two product waste streams feeding into the building secondary waste
day tank at any one time
(5) Campaign Duration
From speaking with membrane vendors and from inhouse discussions with relevant Lilly personnel,
it was agreed that at up to 6 months would be required to carry out membrane trials. The campaign
durations for all the processes within the time constraints of the project are summarised in Table 3.4
below
Table 3.4 : Campaign durations for production processes running on Kinsale site 2003 - 2005

Product

Campaign
duration
(weeks)

Product

Campaign
duration
(weeks)

Ractopamine

11

Raloxifene final

0

Tilmicosin

16

Atomoxetine final

19

Benzcxliazepine
HCI

10

Atomoxetine
mandelate

32

Olanzapine Tech

10

MTA steps 6/7

10

Olanzapine final

11

MTA steps 7/8

Raloxifene tech

14

As a result campaign durations were scored as follows
High (score of 9) = greater than 6 months
Medium (score of 4) = between 2 and 6 months
Low (score of 1) = less than 2 months
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3.1.1.4 Results from the waste stream selection matrix
The stream selection matrix was not a perfect system. It was simply a guideline method to
systematically select suitable waste streams for membrane treatment. It is open to future
adjustment of weighting factors scores and parameter changes if needs be. A copy of the stream
selection matrix is given in Appendix A. The matrix produced the five highest scoring streams as
follows :
Table 3.5 Highest scoring waste streams from waste stream selection matrix

Tiimicosin

108

Atomoxetine mandelate

78

Atomoxetine final

72

Ractopamine

58
54

Benzodiazepine HCI

However two of the streams were ruled out for the following reasons :
Forecasts for Ractopamine production on site were extremely limited for the next 3 years and this
was unlikely to change. For this reason, Ractopamine was ruled out. Atomoxetine mandelate was
also ruled out as the solvent used on this process is toxic to the waste water treatment plant. An
additional step of most likely air stripping would therefore be required for any membrane filtration
plant assuming that some of the solvent would pass through the membranes. It should be noted
that these facts became apparent after the stream selection matrix process had been carried out.
As a result it was decided to move forward with the remaining three streams. The next step was to
characterize each waste stream and the methods used to do so are described in the next section.

3.1.2 Methods used to characterise waste streams on site - Tiimicosin, Benzodiazepine HCI
and Atomoxetine HCI
Characterisation of waste streams is a term used to describe the process of collecting stream data
in terms of volumes and components of the waste streams and the presentation of this data to get a
full overview of the waste stream to be treated. This information would then be forwarded to
membrane vendors for assessment of treatability. The three selected streams were characterized
using the following methods .
(1) Theoretical mass balance
A theoretical mass balance was carried out for each of the processes using information from
the “Process Flow Document”. This document contains descriptions and data on each process
recipe and it is the best source of information on site for stream compositions. As with the
majority of production processes, raw material and product streams were well characterized
while waste streams were not. The theoretical mass balance would use the raw material and
product stream data using some basic assumptions to predict what the waste stream
compositions would be.
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(2) Sampling
Where possible, if relevant processes were running on site, samples were taken and analysed
for API, organic solvent levels, TDS, TSS, conductivity and pH. From various research sources
and from discussion with vendors, these parameters are seen as standard for the
characterization of waste streams to be potentially treated with a membrane plant.
(3) Use waste BOM’s.
BOM which is an abbreviation for Bill Of Material is a spreadsheet which characterises the
waste volumes and composition of the waste streams produced from the various production
processes on site. An example of a BOM is shown in Table 3.6 below.
Table 3.6 Benzodiazepine HCl waste BOM 2003

Waste Stream

Quantity (kg)

Prim. Waste

3,624.00

Sec. Waste

20,779.36

Watery Waste

8,800.08

Tin Waste

2,000.00

Subtotal

35203.4

This BOM shows the volumes of primary, secondary and watery waste produced per batch of
Benzodiazepine HCl.
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3.1.3 Detailed characterization of the chosen 3 waste streams
3.1.3.1 Characterisation of the Tilmicosin stream
Step 1 : Tilmicosin PFD and theoretical mass balance

Mass Balance Tilmicosin process
Hydrolysis reaction

Figure 3.0 Overview diagram of the Tilmicosin process

Figure 3.0 above is an overview diagram of the Tilmcosin production process in IE3. A description
of the process is as follows. Raw materials are fed to T-12 and a reaction is carried out whereby an
intermediate product is synthesized (Desmycosin). A watery waste stream is produced at this stage
of the process (WS1T). The intermediate product is then forward processed to T-18 where a
reaction takes place that produces Tilmicosin. A vacuum distillation occurs in T-18 that removes the
water layer which is sent to secondary waste . The remaining contents of T-18 are forward
processed to T-24. Here the contents are ‘^Arashed” with a large volume of water by stirring the
water and amyl acetate layers together and allowing them to settle out before decanting off the
water layer as a watery waste stream (WS2T). Three water washes are then carried out in
sequence and as a result, three more watery waste streams are produced (WS3T, WS4T, WS5T).
A large volume of water is again added to T-24 and the pH is altered to facilitate the transfer of the
product from the amyl acetate phase to the water phase. The amyl acetate layer is then sent to
primary waste or organic solvent recovery depending on the quality. The water layer is forward
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processed to T-6 where a vacuum distillation is carried out to increase the concentration of the final
product in water. This produces the final watery waste stream from T6a (WS6T).
Decants from the amyl acetate process are manually controlled by the operators. The operators use
a sight glass on the exit pipes at the base of T-12 and T-24 to decide on the end point of each
decant. When the decant is near completion, the liquid in the sight glass begins to cloud up due to
the emulsion which is present at the interface between the waste layer and the layer which needs to
be retained for further processing. This manual control is subject to variability and as a result it may
influence the overall composition of secondary waste produced.
Note ; The LAEG for each process is based on the levels of the sum of intermediate and final
products for each process. For the Tilmicosin process, Tylosin is classified as an intermediate
product as it was manufactured in a previous process with the ultimate goal of manufacturing
finished Tilmicosin. As a result the LAEG for Tilmicosin is based on the sum of Tilmicosin,
Desmycosin and Tylosin. However from the PFD for the process, the conversion of raw Tylosin to
Desmycosin is 99.5% by mass and it was therefore assumed that the levels of Tylosin in the
secondary waste from the process was negligible. As a result during these trials only the levels of
Desmycosin and Tilmicosin were summed to give the levels of API in any waste stream.
The waste balance carried out on Tilmicosin based on the PFD is shown in Tables 3.7, 3.8 and 3.9
below
I'able 3.7 Reagent additions (kg) to the Tilmicosin process

Waste stream ID

Description

DIW

WS1T
WS2T
WS3T
WS4T
WS5T
WS6T

T12 decant
T24 decant
T24 first rinse
T24 second rinse
T24 third rinse
T6 distillate

3057
1300
750
750
750
6607

TOTALS

NaOH H2SO4 HCOOH H3PO4 Water
530
120
3468
70
55
1410
750
750
750
1300
600

120

55

0

7128

Table 3.8 : Waste Composition (kg) of the Tilmicosin process

Waste stream
ID
Description

Amyl
acetate API DMP Na CHO2 HCO3 PO4

WS1T

T12 decant

WS2T

T24 decant

WS3T
WS4T
WS5T

22.59 11.45 3.79
T24 first rinse
T24 second rinse 22.59 11.45 3.79
T24 third rinse
22.59 11.45 3.79

WS6T

T6 distillate

TOTALS

Combined
SO4 API (ppm)

25.06 52.96
76.16
103.67 58.77 13993.5
23.18 21.53 7.13 10.06 4.63 59.87
14013.3

116.01 108.9 18.5 86.2
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14533.6
14533.6
14533.6

4.6

59.9 103.7 58.8

14171.2
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Note ; seal water is used for a vacuum pump in the Tilmicosin process. Data from Tilmicosin
production personnel indicated that the seal water was changed approximately every 24 hours
which would roughly correspond to a change of seal water per batch of Tilmicosin produced.
Therefore approximately 1700 kg of water is recirculated to the vacuum pump.

Table 3.9 Process yield data from the Tilmicosin process

Tylosin percentage in raw ingredient
Desmycosin percentage in raw ingredient
Tylosin percentage conversion
Desmycosin in T12
Percentage theoretical yield of Tilmicosin
Tilmicosin in T24
Percentage API losses as Desmycosin
Tilmicosin losses to waste
Desmycosin losses to waste
Tylosin losses

92.3 %
1.8 %
99^5 %
778.5 kg
81.8 %
775 kg
65%
41.6 kg
67.3 kg
18.5 kg

The following information was obtained from the PFD:
Tylosin percentage in raw ingredient
Desmycosin percentage in raw ingredient
Tylosin percentage conversion
Percentage theoretical yield of Tilmicosin
Using this information it was possible to calculate the quantity of Desmycosin in the T12 decant and
the quantity of Tilmicosin in the T24 decant. The percentage loss of Desmycosin was therefore
deduced. This then allowed the calculation of Tilmicosin and Desmycosin. When calculating the
organic solvent losses in each of the decants/washes, the solubility of amyl acetate in water [39]
was summed with the remaining known losses of amyl acetate (from the PFD/BOM) which were
divided equally between each of the waste streams.
In addition, 3,5 Dimethylpiperidine losses were calculated from the process yield. The distribution of
3,5 Dimethylpiperidine losses in each waste stream segment was assumed to be proportional to the
volume of water in each waste stream segment. For simplification, it was assumed that no
impurities were present in the T6 distillate stream (this is seen as a reasonable assumption since it
is a vacuum distillation ).
Step 2 : Tilmicosin sampling
A sampling campaign was carried out on the Tilmicosin waste in January 2004. The purpose of this
sampling campaign was to get an idea of the composition of different segments of the waste from
the Tilmicosin process. As with any sampling campaign, the more samples taken (from various
sampling points and for different batches of production ), the better the quality of averaged data
from process to process. This had to be weighed against the work load for taking each sample. Two
T-6A distillate and two T-40 seal water samples were taken. T-12 decant and T24 decant and
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washes are carried out by the operators by manually decanting the production tanks, so it was
important that samples were taken at the time of the decants. It was decided to allow samples be
taken by operators. It was decided to limit the number of samples to be taken to 2 batches. In
addition it was decided only to take T-12 decant, T-24 decant and T-24 third wash samples and not
any T-24 second and third wash as the results would be expected to lie somewhere between the T24 decant and T-24 third wash samples. 2 litre samples were taken in all cases. The samples were
analysed and results are shown in Table 3.10
Looking first at the solvent results, there are two layers present in each sample. Both layers were
analysed for solvent and from the results it can be seen that the majority of the bottom layer is water
while the majority of the top layer is solvent. Only the bottom layers were analysed for API due to
limited lab resources and the fact that the water layer was much larger in volume than the amyl
acetate layer.
Surprisingly in some cases, the conductivity of the T24 3^'^ wash was higher than the conductivity of
the T24 decant. It would be expected that the conductivity and TDS levels on the T24 decant
sample would be higher than the T24 third wash given that the third wash is a final wash of the amyl
acetate layer and at this stage, the majority of the TDS should have been removed by previous
washes. However time and resources did not allow this to be investigated further.
It should be noted that solvent results were suspect throughout the project. The probable reason for
this is as follows - Gas chromatography (G.C.) was used to analyse solvent levels in the waste
samples. The expected elution times for different solvents were established under controlled
conditions using solvent standards prepared in matrices of very consistent quality. Occasionally,
unusual sample matrices that differ greatly from the standard matrix can interfere with the elution
process causing a delay in the time it takes for various solvents to elute from the G.C. column. As a
result, depending on the type and number of solvents present in the sample, the delay in the elution
time may be such that the solvents are incorrectly identified or are not detected at all although
present in the sample. Such matrix effects would typically be noticed by the analyst during the
review of the test chromatograms. It is not possible to review all chromatograms at times where
there is a large number of samples. The impact of this on the project was not easy to quantify. The
solvent levels in the waste streams did not differ largely from the values predicted in the mass
balance. In general the solvent levels were higher in the samples than what was predicted by the
mass balance, but not hugely so. This was as expected given that decants are carried out manually
which means that some solvent will pass through into the waste stream from the layer that is being
held back in the process vessel. It was noted that some Tilmicosin samples that were sent to the lab
solvent analysis emitted a strong odour of solvent yet the results from these samples were no
detect for solvent.
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It should also be noted that the solubility of Tilmicosin in water or amyl acetate varies dramatically
depending on pH. At high pH (10 - 10.5), Tilmicosin is highly soluble in amyl acetate and highly
insoluble in water. The solubility of Tilmicosin in water at pH 9 is 7.7 ppm [39]. As pH is
decreased the solubility of this API in water increases (Tilmicosin solubility in water is 566 ppm at
pH7). Somewhere between pH 5.8 and 6, Tilmicosin becomes almost infinitely soluble in water
whereby a brown paste will be observed when a quantity of Tilmicosin is dissolved in a small
quantity of water. At lower pH, Tilmicosin becomes highly insoluble in amyl acetate.

Step 3 : Tilmicosin waste BOM
The waste BOM for Tilmicosin is shown in Table 3.11,
Table 3.11 Tilmicosin waste BOM

Quantity per
batch (mass
units)
176
9035
1385

Waste stream
Primary
Secondary
Aqueous

The BOM had some discrepancies. From speaking with the Tilmicosin process chemist, no waste
is designated as aqueous waste with all the dilute waste streams being sent to secondary waste
If it is assumed that the 1385 kg of water was sent to secondary waste, this gives a total of 10420
kg of water being sent to secondary waste. Comparing the BOM to the mass balance in section
3.1.3.1.2, the mass balance suggests that there should be 7128 kg of secondary waste produced
from the process. This does not include the 1700 kg of seal water used in the production process.
Including this 1700 kg, the mass balance suggests that there would be 8828 kg of secondary
waste produced per batch. In general waste BOM’ss are conservative figures for waste
production (they usually multiply what the process mass balance would predict by a factor
usually 1.2 to 1.5 to account for other sources of waste such as drain washings and rainwater).
Summary of Tilmicosin waste stream
The main objective of waste characterization was to get an idea of the composition of the waste
that would be fed to any full scale membrane plant. As a result, a copy of the Tilmicosin waste
balance was forwarded onto selected vendors along with the sampling results. Vendors were
advised that the actual volume of waste produced may be larger than found in the mass balance.
If this were the case it would be a welcome advantage as it would dilute the waste stream which
would make the Tilmicosin waste easier to permeate through a membrane plant.
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3.1.3.2 Characterisation of the Benzodiazepine HCI waste stream
Step 1 : Benzodiazepine HCI PFD and theoretical mass balance
Mass Balance Benzodiazapine HCI Process

Figure 3.1 : ()\’er\’iew diagram of the Benzodiazepine HCI process

Figure 3.1 is an overview diagram of the Benzodiazepine HCI process. A brief description of the
process is as follows. Raw materials are added to T-1 and a reaction is carried out that produces
an intermediate product. The contents of T-1 are then transferred to T-8 where the intermediate
product is reacted with raw materials to give Benzodiazepine HCI. The contents of T8 are then
transferred to T19 where water is added from T7. The contents of T19 are first vacuum distilled to
remove the majority of alcohol which is sent for solvent recovery (note : this stream is outside the
scope of the membranes project). Water is again added to wash the contents of T19 whereby the
majority of the tin rich supernatant is removed aswell as some solvent. This wash stream is sent
to watery waste (WS1B). A second wash is carried out to further remove the tin rich supernatant
and again some solvent will be removed (WS2B). The contents of T19 are then centrifuged
whereby the crystallized product is filtered and the mother liquor is sent to watery waste for
treatment (WS3B). Water is also used in the centrifuge to wash the product crystals and this
stream is also sent to watery waste (WS4B).
Relevant information and assumptions in calculating Benzodiazepine HCI mass balance
The levels of API in each of the waste streams were assumed as follows ;
Second decant sample reduces the Benzodiazepine HCI yield by 1.5%
Third decant sample reduces the Benzodiazepine HCI yield by 1.0 %
Centrifuge mother liquor reduces the Benzodiazepine HCI yield by 0.25%
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Simple assumptions were also made for the levels of tin in each of the waste streams. These
were as follows :
Second decant sample reduces the tin levels by SOOppm
Third decant sample reduces the tin levels by 30ppm
Centrifuge mother liquor reduces the tin levels by 15ppm
Centrifuge wash reduces the tin levels by 5 ppm
The levels of chloride in each waste stream were assumed as follows :
The HCI molarity of second and third decant samples was given in the Benzodiazepine HCI PFD.
The centrifuge mother liquor was assumed to be 0.2 M HCI and the centrifuge wash was
assumed to be 0.02 M

The mass balance carried out on the Benzodiazepine HCI process is summarised in Tables 3.12,
3.13 and 3.14. It should be noted that only the shaded streams are waste streams of interest i.e.
secondary waste streams

Table 3.12 : Reagent Additions to the Benzodiazepine HCI process (kg)

Waste stream ID Description
Primary waste
WS1B
WS2B
WS3B
WS4B

Raw materials charged
T19 first decant
T19 second decant
T19 third decant
Centrifuge mother liquor
Centrifuge wash

Tank
19
19
19
n/a
n/a

PWEC

574

SnCl2 Benzo HCI
1300
4259

574

1300

HCI
6459

5826
5826
5826
1148
18626

TOTALS

TON

4259

6459

Sn

Cl

Total

Table 3.13 : Waste Composition of the Benzodiazepine HCI process (kg)

Waste stream ID Description

WS1B
WS2B
WS3B
WS4B
TOTALS

Water 3A aicohoi

Raw materials charged
T19 first decant
5558.00
T19 second decant
5826
5826
T19 third decant
Centrifuge mother liquor 5826
Centrifuge wash
1148
18626.0
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Benzodiazepine
HCI
i

4140.18
96.56
18.28
3.32
0.65

25.96
8.83
5.88
1.47
0.29

813.62
0.16
0.02
0.01
0.00

910.93
120.01
22.72
4.13
0.81

6052
5873
5835
1150

18.8

16.5

0.19

147.7

18809
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Table 3.14 : Process yield data from the Benzodiazepine HCl process

574.0
259.3
189.6
265.8
527.0
588.4
89.6

TCN charge (kg)
TCN molecular weight
SnCI2 molecular weight
Benzo HCl molecular weight
Benzo Cl mass yield (kg)
Benzo Cl theoretical yield (kg)
Product percentage yield

Note: a blended Benzodiazepine HCl sample was analysed for various constituents as part of the
vendor bench scale trials later on (Chapter 5). The blended sample was created by mixing
samples of first decant, second decant, centrifuge mother liquor and centrifuge wash in volumes
proportional to their volumes in a typical batch of Benzodiazepine production . The main results of
this analysis are summarised in Table 3.15
Table 3.15 : Analytical results of blended Benzodiazepine HCl waste sample

TDS
(ppm))
Before
precipitation

29,000

BOD
COD
Total N
ClNa
(mg02/litre) (mg02/litre) (ppm) (ppm) Sn (pg/l) (ppm) pH
115,400

74,800

110

14,280 2,640,000 2,100

1

From this it can be seen that the actual levels of tin in the Benzodiazepine HCl waste are much
higher than that predicted by the mass balance{ mass balance predicts 0.19 kg tin per batch ).
However this information was not available at this stage of the project (this information was
obtained two months after the mass balance was carried out)

Step 2 : Benzodiazepine HCl sampling
The Benzodiazepine HCl process did not get up and running until February 2004. As a result, a
sampling campaign was not possible on the Benzodiazepine HCl. All of the information that was
sent to the vendors was based on the mass balance carried out on the process as the project
schedule demanded that information be sent to the vendors before January 2004. Some samples
were taken when the production campaign commenced in February and these results are
summarised in Table 3.16.
Table 3.16 : Sample results from the Benzodiazepine HCl sampling campaign

Benzodiazepine HCl samples sent to
vendor
3rd wash sample
mother liquor sample
2nd decant sample

Ethanol,
API, ppm w/w%
12.6
3.86
1.16
52.2
40.9
15.21
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Methanol,
w/w%
0.19
Non detect
0.74
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Step 3 : Benzodiazepine HCI Waste BOM
The waste BOM for Benzodiazepine HCI is shown in Table 3.17
Table 3.17 Benzodiazepine HCI waste BOM

Waste Stream

Quantity (kg)

Prim. Waste

3,624.00

Sec. Waste

20,779.36

Watery Waste

8,800.08

Tin Waste

2,000.00

Subtotal

35203.4

The watery waste was rerouted to secondary waste just prior to this project due to concern over
the levels of tin in the waste. The waste BOM indicated that 29,000kg of waste was sent to
secondary waste per batch. This was much higher than the volumes calculated in the mass
balance. It is likely that the mass balance volumes are closer to the volumes of waste produced
than the waste BOM figures which as mentioned already can be generally higher than reality.
Summary of Benzodiazepine HCI waste
A copy of the Benzodiazepine HCI mass balance was the only information that was forwarded to
the selected vendors as it was seen as an accurate representation of the Benzodiazepine HCI
waste matrix and it did not conflict significantly with the waste BOM. The sampling information
showed that the actual levels of solvent were higher than that predicted by the waste BOM but as
mentioned already this information did not come available until the February 2004 after the
information had been sent out to membrane vendors. A copy of the section sent to vendors is
shown in Table 3.18 (shaded streams are secondary waste streams for potential membrane
processing)
Table 3.18 Benzodiazepine HCI waste information sent to membrane vendors (kg)

Waste stream ID Description

WS1B
WS2B
WS3B
WS4B
TOTALS

Water 3A alcohol

Raw materials charged
5558.00
T19 first decant
5826
T19 second decant
5826
T19 third decant
Centrifuge mother liquor 5826
1148
Centrifuge wash
18626.0
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4140.18
96.56
18.28
3.32
0.65
18.8

Benzo
HCI

Sn

25.96 813.62
0.16
8.83
5.88
0.02
1.47
0.01
0.29
0.00
16.5

0.2

Cl

Sum

910.93
120.01
22.72
4.13
0.81

6052
5873
5835
1150

147.7

18809
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3.1.3.3 Characterisation of the Atomoxetine final waste stream
Step 1 : Atomoxetine final PFD and Theoretical Mass balance

Figure 3.2: Overview diagram of the Atomoxetine final process

Figure 3.2 above is an overview diagram of the Atomoxetine final process. A brief description of
the process is as follows. Raw materials are added to T22 and a reaction is carried out that
synthesise Atomoxetine free base. Water is added to remove the large amount of salts that are
produced and this water phase is sent to secondary waste (WS1 A). The contents of T22 are then
transferred to T24 where Atomoxetine free base is reacted with further raw materials to produce
the final product. Water is again added to T24 to further remove salts that are present in the
reaction vessel. This watery stream is sent to secondary waste (WS2A). A vacuum distillation is
then carried out to remove the majority of the remaining water present with the solvent phase.
The contents of the vessel are then transferred to T-11 where the API is prepared for
centrifugation and drying. After transferring the contents from T24, the tank is rinsed with 400L of
water and this stream is also sent to secondary waste (WS3A).
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Relevant information and assumptions in calculating Atomoxetine final mass balance
An environmental report carried out by Lilly in the U.S. by S Leeper [40] gave the range of solvent
levels in both first and second extraction streams. The average of each range was assumed for
each extraction i.e. 3.5% in extraction 1 and 2.5% in extraction 2. The API in each extraction was
assumed to be proportional to the amount of organic solvent present in each waste stream. The
quantities of salt ion and cation in each extraction were calculated by assuming that all the
Atomoxetine mandelate was converted to Atomoxetine free base and that 95% of the salt that
was released would be sent to waste with the first extraction with the remaining 5% being sent
with the second extraction.
The waste balance carried out on Atomoxetine final is summarised in Tables 3.19, 3.20 and 3.21.
Table 3.19 : Reagent Additions to the Atomoxetine final process (kg)

Waste stream ID Description
WS1A
WS2A
WS3A
TOTALS

PWEC NaOH

Extraction from T22
Extraction from T24
Rinse

2160
2160
400
4720

163

163

Table 3.20 : fVaste Composition of the Atomoxetine final process (kg)

Waste stream ID Description
WS1A
Extraction from T22
WS2A
Extraction from T24
WS3A
Rinse
TOTALS

Water

MTBE

API

2285
2160
400
4845

94.86
55.83
2.01
152.7

25.18
14.82
0.53
40.5

Sodium Mandelate
38.04
2.00
40.0

Table 3.21 Process yield data from the Atomoxetine final process

Atomoxetine mandelate charge (kg)
Atomoxetine mandelate molecular weight
Atomoxetine free base molecular weight
Salt molecular weight
Atomoxetine final molecular weight
Percentage yield (%)
Maximum possible Atomoxetine final losses (kg)
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720
407.5
255.4
174.13
291.82
88.5
51.9

292.28
15.38
0.00
307.7

Sum
2735
2248
403
5386
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Step 2 : Atomoxetine HCI sampling
The Atomoxetine HCI process was up and running in early 2004 and samples of first and second
decant samples were taken. Again it was possible to take only two samples as samples were
taken by operators who were reluctant to carry out more work than the minimum on this project
given their other commitments. Only first and second samples were taken and no rinse sample
was taken, (the rinse waste stream is a small portion i.e. 10% of the total waste volume from the
process). The results are shown in Table 3.22
Table 3.22: Results ofAtomoxetine final sampling campaign

Sample
Description

1st decant

1 St decant

2nd decant

Visuals /
Special Conductivity
Sampie
(mS/cm)
Location/Point Conditions
TSS ppm TDS ppm

Date

13-Jan-04

17-Jan-04

13-Jan-04

MTBE
(%)

pH

Exit of T-24

sample is
clear with
single phase

38.20

86.5

122935

2.63

9.3

Exit of T-24

sample is
clear with
single phase

41.60

80.5

126827

2.64

9.7

Exit of T-24

sample is
clear with
single phase

1.98

5.5

3952

3.96

12.4

1.50

102.0

1284

4.43

11.2

0.90

25.0

1190

3.55

7.6

0.70

17.0

869

2.99

8.2

2nd decant

17-Jan-04

Exit of T-24

Rinse

13-Jan-04

Exit of T-24

Rinse

18-Jan-04

Exit of T-24

sample is
clear with
single phase
sample is
clear with
single phase
sample is
clear with
single phase

Also API analysis of samples was not possible until march 2004 as the samples had to be sent
offsite to a contract lab (which had to be funded and organized ). It should be noted that these
samples were analysed two months after the main stream characterization was carried out. In
addition, only three samples were sent, as at the time of sending the projection was moving in the
direction of looking at Tilmicosin waste for further trials while minimizing the research work on
Atomoxetine and Benzodiazepine. Three samples were sent to the contract lab and the API
results are shown in Table 3.23 ;
Table 3.23 . API results from Atomoxetine final sampling campaign

Waste stream
First decant
Second decant
Rinse

APi, Atomoxetine finai (g/kg)
0.94
1.47
0.33
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These samples were also analysed for total solids, total suspended solids and total dissolved
solids and results are shown in Table 3.24
Table 3.24: Dissolved solids results from Atomoxetine final sampling campaign

TS (ppm)
118993
6120
346.6
54833

first decant
second decant
rinse
blend

TSS (ppm)
1028
190
32
316

TDS (ppm)
117965
5930
314.6
54517

At the time of this waste stream characterization, the Atomoxetine HCI process was not running
at Lilly. As a result no sampling of waste streams from this process was carried out.

Step 3 : Atomoxetine final waste BOM
The waste BOM for the Atomoxetine final process is shown in Table 3.25
Waste Stream
Primary
Secondary
Aqueous

Quantity (kg)
6,650
5,120
1,700

Volume (litres)
8,494
5,120
1,000

Aqueous waste is only produced when this product is manufactured in IE8 due to the use of
vacuum pumps in this process which use vacuum pump seal water. The majority of Atomoxetine
HCI to be manufactured in the future will be manufactured in IE16. The secondary waste stream
includes WS1A, WS2A and WS3A.

Summary of Atomoxetine final waste
The waste balance carried out on Atomoxetine final was sent to each of the selected vendors.
The waste BOM was also used. In addition, the mass balance was a reminder that the actual
volume of waste produced in each process may be larger than that predicted in the BOM due to
excess rinses being used in the production processes. Solvent sample results aswell as TDS and
TSS results were also sent to the vendors.
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Looking at the mass balance, the solvent levels predicted in the first decant sample were
approximately right (4.1% predicted). The solvent levels in the second decant sample were
actually higher than predicted ( 0.7% in predicted ). Table 3.26 gives a summary of the
information sent to vendors.
Table 3.26: Atomoxetine final information sent to vendors

Categorised Atomoxetine
Finai waste
First decant
Second decant
Rinse

Water (kg) MTBE
soivent(%)
<5%
2400
<5%
2200
<5%
500

TSS (ppm) TDS (ppm)
<1200
<200
<50

<130000
<6000
<350

APi
(ppm)
<11
<7
<2

The mass of water was slightly increased beyond what was predicted in the waste balance as a
conservative safety factor. The levels of solvent were assumed to be less than 5% in all of the
waste stream. Although the levels of solvent in the Atomoxetine final rinse were not measured,
they should be less than 5%. TDS and TSS levels were based on the worst case sample
analysed in each case. API levels were determined from the mass balance as at this stage, API
analysis was not possible (the laboratories on site were tied up with analysing production
samples and contract negotiations with an offsite contract lab were still ongoing). It should also be
noted that a formal copy of the waste balance carried out was also forwarded to the vendors.
Note : At Kinsale, Lilly personnel would be concerned with MTBE not being disposed of directly
by incineration due to its potential toxicity to the environment. This solvent is also not very
biodegradable and is highly mobile in the aqueous phase and as a result, if the solvent were sent
to the waste water treatment plant, the majority of the solvent would pass out into the
environment. An alternative was to look at air stripping of the organic solvent which was
investigated as part of this project and the results of this are presented in the later sections of this
report.
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3.2 Vendor selection
3.2.1 Sourcing accredited vendors
The procedure of sourcing accredited vendors was mainly dictated by Lilly’s previous experience
with various vendors. A Lilly technical expert on separations who is based in Indiana, provided
the names of a number of vendors that he had dealings with in the past. These vendors were :
Koch Membranes, Pall and PCI.
Also, Lilly personnel on site at Kinsale (mainly the Lilly Waste Water Engineer) had some contact
with two waste water technology vendors (Veolia, EPT) in the months prior to the commencement
of this project. It was decided to contact all five vendors to assess their potential suitability for
handling the project.
In addition, a Lilly employee who had technical experience with membranes mentioned a vendor
(Millipore) with whom he had some previous experience working with.
Criteria for selecting vendors
When sourcing an accredited vendor, the following characteristics were deemed to be important:
(1) a vendor that had installed some similar applications to this project i.e. removing
molecules of similar size from industrial waste streams
(2) a vendor that was prompt with their response to any questions or requests put forward by
Lilly
(3) a vendor with a technical base in Ireland. It was felt that this would be essential to ensure
that the installation and maintenance of any full scale plant would be maximized.
(4) a vendor who would directly manufacture the membrane plant. Some vendors work
through another company who would manufacture the membrane plant
(5) a vendor that would offer a competitive price for pilot and full scale trials
(6) a vendor who would be confident that they could obtain results at pilot scale

3.2.2 Vendor Discussions
3.2.2.1 Original email that was sent to vendors and the level of response
Initial contact with all the vendors was made with a generic email summarizing the overall project.
The email included the current policy for treatment of watery waste on site, the driver for this
project and what was seen as the best solution to the project i.e. the installation of a membrane
treatment plant. It was also stressed that Lilly were open to other alternative applications that may
be superior.
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3.2.2.2 Questionnaire that was sent to vendors
Initially a lot of varying information was coming back from each of the vendors. This information
needed to be standardised. As a result, a generic questionnaire was sent to each of the vendors.
The questions were as follows ;
•

What level of technical support and servicing would be offered by the company once the
membrane unit was up and running?

•

Had the company carried out similar applications within the pharmaceutical industry,
specifically, the removal of pharmaceutical ingredients from waste streams. If not, how
similar were the applications that had been carried out by the company?

•

Had the vendor any case study data available on similar installations in industry? This
was of interest as part of this report.

•

•

Would the pilot plant unit be rented from the vendor or were pilot units tailor made for the
particular process and sold to the customer. Also could the pilot plant be easily changed
over to treat another waste from a different process assuming the pilot plant tests on the
first process were successful
Lilly hoped to have the pilot plant up and running on site on June 26*^2004. From past
experience the general time required from purchasing a unit at Lilly to having it up and
running on site was 3 rnonths. From the vendors point of view when would the decision
need to be made by Lilly to purchase/rent a unit from the vendor to meet the June 26*^
deadline? (As part of the initial project schedule decided for the project, this was seen as
the final date that pilot trials needed to commence - this date was later brought forward
as the trials progressed)

A ballpark estimate of the size and cost of a pilot plant unit.
What were the material compatibility issues associated with the vendors membranes in
relation to fouling and solvent compatibility etc?
What ballpark working pressure would the pilot plant operate at?
What cleaning regime and method would be required for the membrane unit?
What would be the expected life expectancy of the membranes?
What ballpark volume reduction would be expected from this process and what
percentage of pharmaceutical ingredient would be expected to pass through the unit?
Was it possible to graph the amount of API passing through the membrane as a function
of volume reduction or how would this information best presented?
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•

Also what sort of flux rates would be anticipated from the pilot plant unit?

•

What other generic problems could be encountered when installing and running
membrane units?
Outline of the bench scale testing capabilities of the company?

3.2.2.3 Progression of discussions with each of the vendors - the advantages and
disadvantages of each
The progression of the discussions with each of the six vendors is summarised in this section.
The main advantages and disadvantages to the selection of each of the vendors are also
discussed.
PCi
PCI have built a large number of pilot plants. PCI have bench scale plants that are located in
their laboratories in England. They have also built a lot of larger pilot scale plants and a pilot scale
plant for use at Lilly Kinsale was quoted as costing in the region of £60,000 to £80,000.
In general, the level of response from PCI was rapid and of a good standard. PCI also completed
the questionnaire that was sent out to them and the answers were positive and promising.
A meeting was held with a PCI representative in December 2004 and the goals of the project
were outlined. Waste stream information aswell as pilot and full scale information was also
exchanged. It was also decided that a feasibility study aswell as a bench scale protocol trial
would be drawn up by PCI. These protocols were forwarded to Lilly within a few days of the trials
but the content of the protocols was very generic.
In January, the level of response began to drop from PCI. Some of the assumptions made by PCI
in their feasibility study did not appear to make much sense. For example, they were suggesting a
95% rejection of Atomoxetine HCI and Benzodiazepine HCI API from the membrane even though
the molecular weight cutoff (MWCO) of the proposed membrane was right in this area i.e. 200
daltons.
The initial bench and pilot scale protocols from PCI also included long term chemical
compatibility tests that would be used to assess the impact of the waste matrix on the
membranes.
At this stage a detailed trials protocol was required including information on the number of trials
that would be carried out, the range of process conditions that would be carried out i.e. pressures,
temperatures etc. In particular, it was important to find out how many samples needed to be
analysed as this was becoming an important issue due to the fact that samples would need to be
sent to an off site contract lab for API analysis. Also the fact that PCI didn’t rent out pilot scale trial
units to site was a negative.
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Pall
All pilot plants that were being rented out by Pall were not Ex rated {explosion proof). A non Ex
rated unit was not viewed favorably due to the uncertainty over the amount of solvent present and
therefore the explosion risk.
In light of all the stream characterisation information that was sent onto Pali, they expressed
some concerns about their capability of handling some of the waste. The Benzodiazepine HCl
stream was characterized as having an 80/20 spilt of water and organic solvent. Pall were not
confident of handling these percentage volumes of solvent. They suggested using a settling tank
or decanter followed by a coalescer (which coalesces solvent phases in water). This technology
would not have been suitable for the Benzodiazepine HCl stream as the organic solvent is
extremely soluble in water and the waste is essentially a single phase.
The response level from Pall in general was poor. They did not answer the questionnaire and
they were not willing to meet with Lilly until January 2004 at the earliest. A meeting was held with
Pali’s Irish representatives, Gilroys, in December 2004. However, Gilroys technical knowledge on
the project was poor indicating their communications with Pail were limited. Their knowledge on
membrane technology was also limited. In addition, Pall did not have any membrane that was
particularly designated as solvent and water stable.
Veolia
Veolia were initially slow to respond on their capability to work on the project. A meeting was held
with a representative from the Irish branch based in Kilkenny in December 2004. The overall
project goal was discussed and this information was relayed to Veolia technical staff in Paris. The
correspondence between Lilly and Veolia improved rapidly, once the technical division realized
the nature and scale of the project.
Veolia also had the capability of carrying out such assays as BOD, COD, solvent concentration
and TDS. They were also capable of carrying out respirometry analysis if required. This analysis
measures the rate of oxygen uptake from a biosludge sample which quantifies the degradability
and toxicity of the sample being introduced to the biosludge. This would be very useful when
assessing the effect of any membrane plant permeate on the biosludge in the waste water plant
on site. The possibility of having such a range of analysis carried out was very advantageous
given the limited analysis resources available to this project on site.
In addition to membranes, Veolia also work with other technologies in the waste treatment area
such as air stripping and electrodeionisation technology. This gave Veolia a clear advantage in
the areas of pre and post treatment to membranes that may be required for some waste streams.
It should be noted that Veolia did not market their own membranes and all the membranes they
would use would be purchased from some other membrane manufacturer and used in their pilot
and full scale plants.
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Millipore
Millipore concentrate on product recovery aswell as API removal from waste. They generally tend
to be more expensive than vendors that just concentrate on API removal. They also do not rent
units out be it for bench or pilot scale. Plants are generally tailor made for each application. A
preliminary quote from Millipore suggested a figure of €350,000 for a plant to segregate the
Tilmicosin waste which was not very attractive.

Koch
Koch provided prompt and encouraging answers to our initial questionnaire. They were also
willing to bring their full scale pilot plant to site at Kinsale for first round trials on the chosen waste
streams. The overall plan for any chosen vendor was to carry out small scale bench trials and
based on these trial results, a decision would then be made on whether to go to pilot scale or not.
A full scale pilot plant coming to site for the first round trials was a clear advantage as a success
on these first round trials would almost guarantee a success on the second round trials as the
same plant would be used for both trials.
Of the six vendors chosen. Koch were the only company with a membrane that was officially
classified as an organic solvent and water stable membrane. Preliminary data suggested that the
membrane would be stable in Amyl acetate, MTBE and 3A alcohol. Another vendor (MET Ltd)
also manufactured an organic solvent and water stable membrane but this membrane has a
molecular weight cutoff of 500 that would probably not be adequate.

Koch also provided a good draft of a first round trials protocol (which was later tailored to suit our
specific needs). There was good communication between Koch and Lilly in refining this protocol
and a final draft was reached quickly.

EPT
EPT use ceramic membranes in their advanced fluidized composting technology. Ceramic
membranes in general are highly resistant to the majority of chemicals and as a result they do not
need to be replaced too often.
However, ceramic membranes are generally loose membranes in the kilodalton and micron
range. The capability of the EPT membranes for treating the waste streams was questionable.
EPT claimed that biofouling on the membranes would help to absorb the API and as a result, they
could achieve the desired rejections for each API. However EPT could not provide us with any
information on similar sized molecules that they had removed using their ceramic membranes.
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Z.2.2.4 Choosing final 2 vendors

It was decided to bring two of the six vendors forward to bench scale trials. The reasoning for
doing this was as follows ; Membrane technology had not been tried for a similar application
previously. All the vendors admitted that they were not sure as to how successful the trials would
be. At a basic level, bringing two vendors forward to bench scale doubled the probability of
successful trials at bench scale. In addition, the budget on the project was such that it allowed
bench scale trials with more than one vendor to be carried out. A maximum of two vendors were
chosen as more than two vendors would have generated too much work given the limited labour
resources on site at Kinsale for this project. Also, the chosen two vendors had access to all of the
candidate membranes on the market which would make trials with a third vendor unnecessary. In
February 2004, a final decision was made on the two vendors to bring forward namely Koch and
Veolia.

I.Koch
Koch had always been the front runner. The level of communication with Koch was always
positive from the start and they had visited Lilly twice by Feb 2004. They provided a well defined
bench scale protocol as requested. This protocol allowed a sampling plan for API analysis on site
to be set out where the number of samples to be analysed was determined. Koch was also willing
to bring a pilot scale unit to site in March for the purposes of “proof of concept” / bench scale
tests. Koch was also the only company that manufactured a highly solvent stable membrane that
could hold back molecules smaller than 500 daltons ( many API’s are in the range of 200 to 500
daltons).
2.Veolia
Initially Veolia were slow to respond but by Feb 2004 they level of communication and the quality
of information coming back from Veolia was very encouraging. A bench scale protocol was
refined and improved which looked very promising. The majority of technical expertise was
located in Paris, however, the technical staff at the Irish office in Kilkenny also had good technical
knowledge which was advantageous. For bench scale testing, the majority of analysis of the
permeate for the purpose of assessing its biodegradability could be done in France ( e.g. BOD,
COD, respirometry, cation analysis ). This was a strong reason for opting for Veolia as none of
the other vendors could provide this level of analysis. A disadvantage was that the Dow
membranes that Veolia were proposing were not classified as solvent stable. However, given the
relatively low levels of solvent in the waste steams, Veolia was reasonably confident that
deterioration of the membrane over time would be minimal.
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Summary
The primary goals of these trials was to asses the potential of membrane separations to volume
reduce the three selected waste streams and also to assess the rejection of API from the
membranes to determine if permeate levels would be below the relevant LAEG’s. These objectives
would be carried out on one pilot and two bench scale units using the Koch MPS44 membrane but
other membranes were also considered depending on the level of success from the MPS-44.A 75%
volume reduction had been targeted as a practical economic target in relation to the potential of
bringing the trials forward to full scale.
Koch brought their large pilot plant to site for first round trials on Atomoxetine HCI, Tilmicosin and
Benzodiazepine HCI waste. These trials started on March
2004 and ran for one month. The
ability to permeate the three waste streams was investigated and details of the trials carried out
along with results obtained are presented in the frst section of this chapter.
It should be noted that starting with a larger scale pilot scale plant and subsequently scaling down
to bench scale trials is not standard protocol when investigating the potential to treat any feed
stream by membrane separation. In general, one begins working at smaller bench scale and then,
based on the results, will proceed to a larger pilot scale before an investment in a full scale plant.
The reasoning forgoing with the larger scale pilot trials first was as follows:
A first set of trials needed to commence roughly between February and April 2004 for the trials to
stay within the schedule of the Masters project. At this stage, Koch had yet to validate their new
bench scale flat sheet recycle membrane unit (known as CF-1) which had a feed tank volume of
500 cm^. Koch also had a smaller scale dead end filtration flat sheet membrane unit (known as FC3). The FC-3 unit only had a feed capacity of 30cm^ and the dead end flow hydraulics would give
limited scale up information fora larger scale pilot plant. However, Koch were willing to bhng their
larger scale pilot plant (known as PP02) to site for a first round of trials. As a result it seemed logical
to run trials on the larger scale unit. The only difficulty with bhnging the larger scale pilot scale plant
to site so early was that more preparation work was required in terms of finding a suitable location
to run the trials and to supply hot water (for washing the plant) and electricity to run the plant. In
addition, a number of larger waste samples had to be collected and the collection, transport and
storage of these samples had to be co-ordinated.
The PP02 trials on Tilmicosin were a success. A volume reduction of 75% was achieved and API
levels in the permeate were below the LAEG for Tilmicosin fora number of runs. Limited success
was achieved on the Atomoxetine HCI process waste stream with some permeation achieved on
some segments of the waste and not on others. No permeation was achieved on the
Benzodiazepine HCI process waste stream.
In light of the Benzodiazepine and Atomoxetine results, it was decided to run two small scale trials
campaigns on the FC-3 and CF-1 units in an attempt to resolve the inability to volume reduce these
streams satisfactorily. The main findings from these trials were that for Benzodiazepine HCI, the
level of TDS in the waste stream made it difficult to permeate using the MPS-44 membrane. A
second membrane (Koch SR3) was tested on Benzodiazepine HCI waste and a good volume
reduction aswell as API rejection was achieved but it should be noted that this membrane was not
classified as solvent stable and as a result the applicability of this membrane to the process is
questionable.
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For Atomoxetine HCI waste, the FC3 trials showed that the organic solvent in the waste stream
(MTBE) was not a major flux inhibitor on the MPS44 membrane. The CF1 trials showed that the
main contributor to flux inhibition on the MPS44 membrane was the YDS levels in the waste. In
addition, the TDS levels can vary for both first and second decant samples (which are the two large
waste producing waste segments for the Atomoxetine HCI process). In some cases, the TDS levels
are much higher for second decant samples than first decant samples.
In light of all the Koch first round results, it was decided to move ahead with a second round of
detailed trials on Tilmicosin waste by modifying the PP02 unit to increase the pilot plant capacity.
These trials are summarized in chapter 6
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4.1 Koch first round trials
A schematic diagram of the PP02 plant is shown in Figure 4.0.

4.1.1. Protocol for first round Koch trials

The main goal of these trials was to assess the potential of treating each of the three waste streams
with the Koch MPS-44 membrane. To an extent a detailed formal protocol was not possible. At any
stage of the trials, future trials would be dictated by the results from previous trials. This was made
possible by the fact that trials were staggered by carrying out approximately 3 trials per week and
results were coming back at various stages of the trials. A general idea of what the trials would
contain is as follows ;

Each of the three process wastes would be investigated for suitability starting with Tilmicosin as this
was the stream that scored highest in the stream selection matrix. For this set of trials, the potential
for treating each of the streams associated with each process needed to be assessed. The
Tilmicosin process produces seven waste streams. From the characterization work done on the
Tilmicosin waste stream it was likely that the T12 decant and T24 decant streams appeared to be
the worst case feeds to a membrane plant and that the T24 third decant was an average
representation of the remaining 5 waste streams. It was decided to initially look at the T24 decant
and T12 decants. The reasoning here was that a good volume reduction on these streams would
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mean that the overall volume reduction of a representative blended sample for a batch of waste
would be at least as good or probably better. As mentioned already the goal of the trials was to
achieve a 75% volume reduction of selected waste streams.

Another important aspect of these trials was the LAEG and the rejection achieved for each of the
API’s. The final bulk permeate concentration for any volume reduced run is most important as
knowing this concentration will allow the calculation of the “relative LAEG” i.e. the amount of API
that would be present in the bulk permeate coming from a full scale membrane plant relative to the
LAEG for that API (see Appendix B for Tilmicosin LAEG calculation)

To optimize the operation of any plant, it is necessary to look at the effect of operating the plant at
different operating conditions, in this case, vary the driving force pressure on the membrane plant
and vary the feed pH and temperature. These parameters would be important in assessing how the
plant could be operated optimally in terms of maximising the volume reduction while not
compromising the API rejection beyond its limits.
It was also important to carry out a flux decline trial on the different waste streams. This trial would
involve feeding a sample to the pilot plant and placing the pilot plant on full recycle for a sustained
period. The drop off in permeate flux with time would be recorded which would give an idea of the
effect of fouling with time on the membrane plant (in this case, concentration effects are eliminated
as the concentration is unchanging).
Finally it was important to look at the effectiveness of cleaning the membranes after each run had
taken place. This effectiveness would be measured in terms of the Clean water flux (CWF) obtained
after each clean had been carried out. The CWF is the flux of water through the membranes
typically at 20^.

In terms of the logistics of operating the pilot plant, a general protocol was drawn up and this can be
seen in Appendix D
4.1.2 Hazop and prequaiification checklist
A hazop was carried out along with the waste water engineer and the project engineer for the
Waste Water Treatment Plant upgrade. A checklist was made up and completed at the installation
and commissioning period for the pilot plant. A copy of the checklist can be seen in Appendix E

4.1.3 Description of trials
For the majority of the trials carried out, SOL of waste was fed to the pilot plant at the start of the trial
and a sample was taken. Further segments of waste were added as required so that in total, more
than SOL of waste was processed for the majority of trials. No mechanical mixing was deemed
necessary as the recirculation flow rate was high enough (12 l/min) to adequately mix the feed tank.
A summary of the results of the Koch first round PP02 trials are shown in Table 4.0
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4.1.4 Results interpretation - the main talking points
4.1.4.1 Tilmicosin

Figure 4.1 illustrates the pressure excursion that was carried out in run 1. Looking at the graph,
the permeate flux increases from 6 Imh at 24 bar to 11 Imh at 32 bar. Spot permeate samples
were taken at each of the three pressures and each of these samples were sent for API analysis.
No conclusive information on the effect of pressure on rejection was obtained as all the API
results were less than 10 ppm which is the lower detection limit for the Tilmicosin API method.
However assuming that the API concentration in the permeate is 10 ppm, this gives a rejection of
>0.99 on the membrane.

Run 7 - Temperature excursion trial

Figure 4.2 : Graph illustrating temperature excursion for run 7 on Tilmicosin

Figure 4.2 illustrates the temperature excursion carried out in run 7. Looking at the graph, the flux
appears to increase relatively linearly as the temperature is increased. API samples were taken
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again but were not sent for API analysis as at the time there was a limit on the number of
samples that could be sent for analysis. Results were as expected, in that in general, increasing
the feed temperature increases the temperature of the membrane which causes the pores to
open up which in turn has the effect of increasing the average flux but which may reduce the
overall rejection.
Temperature also affects the flux due to viscosity reduction. The warmer the feed stream the
greater the throughput. It should be noted that no permeate samples were taken for the
temperature excursion trial

Figure 4.3 illustrates the flux versus volume reduction for a standard T24 decant trial. Looking at
the result, the flux falls off steadily and appears to almost stabilize at a flux of 2 Imh. A flux decline
versus volume reduction curve is important for the design of any full scale plant as it is used to
determine an average flux for the run. This is the basis for deciding on the area of membrane
required for the full scale plant. It also shows the achievable limit on volume reduction for each
run given the fall off in flux that is experienced. From practical experience Koch suggest that it is
not practical to operate a full scale membrane plant at a permeate flux of much less than 2 Imh.
This curve combined with the API results in the final bulk permeate would determine how far the
volume reduction could be pushed. This information is better illustrated in run 10 which is
described later in this section.
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Run 9 - T12 decant. Flux versus VCF

VCF

Figure 4.4 : Flux decline curve for first round koch trials on a Tilmicostn T12 decant sample

Figure 4.4 shows the flux decline versus volume concentration factor for a T12 decant. This
segment of Tilmicosin waste was the most difficult to treat due to the very high levels of salts
present. Looking at the graph, all the fluxes are relatively low and the correlation between flux
decline and VCF appears to be relatively loose. However, looking in more detail, the range of
fluxes are from approximately 1.6 to 0.6 Imh. Within such a tight range effluxes, the associated
measuring error would have been large and the low correlation coefficient for the graph can
largely be explained by this. The main finding from this trial was that a poor VCF was achieved
i.e. 2.11. After this trial it was decided to simulate a bulked blended Tilmicosin waste as there was
concern over the low VCF achieved here.

Run 5 - Tilmicosin T24. Flux decay at fixed concentration

-♦— Run 4 at 10.51/min recirc flow
-■—Run 5 at 16.51/min recirc flow

Figure 4.5 Graph illustrating flux decline at fixed volume reduction for runs 4&5

Figure 4.5 compares the flux decay for two runs carried out at different recirculation flowrates.
The flux decline should be less for the run carried out at high recirculation rate due to the
improved turbulence on the feed side of the membrane which would limit the amount of fouling on
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the membrane surface. Looking at the graph, the average flux for the run at the lower
recirculation flowrate is much higher. However as expected, the fail off in flux over the entire run
is less for the run carried out at higher recirculation rate. The fall off in flux for the high
recirculation run is approximately 2 Imh while the fall off in flux for the low recirculation flowrate is
approximately 3 Imh.
At the high recirculation flowrate, the flux appears to stabilise after 30 minutes whereas the flux
continues to drift downwards in the other case. Therefore to optimize efficiency, a full scale plant
should operate at the higher recirculation flowrate.
API spot permeate samples for the flux decline trial on run 4 varied from 20 to 30 ppm i.e no
noticeable change in API rejection as the flux decline trial proceeded.
Run 5 - Effect of pH on API concentration in bulk permeate

-♦— Tilmicosin
-■— Desmycosin

1‘igure 4.6 : Graph illustrating the effect ofpH on API rejection using data from run 5

Figure 4.6 shows the effect of pH on API concentration in the bulk permeate. It can be seen that
the API concentration is relatively stable when the pH is decreased from the natural pH of the
waste stream (roughly pH 9 to 10 ) to pH 6. Below pH6, the amount of API passing through the
membrane increases rapidly. This increase is related to the increase in the solubility of the API at
lower pH . Above pH6, a lot of the API is present as precipitate either deposited on the
membranes or recirculating around the feed loop in the membrane plant. When the pH is
decreased beyond 6, the majority of this API dissolves. It is suggested that the rejection of the
membrane remains constant but the amount of API present in the feed as solute increases and
as a result the API concentration in the bulk permeate will increase proportionately. Additional
evidence for the rejection of the membrane remaining constant is seen in the Koch second round
trials where the rejection of second pass samples i.e. permeate samples that are permeated
through the membrane plant again are indistinguishable from the rejections achieved from
Tilmicosin first pass runs ( see results from CH6 ).
As mentioned already, at high pH, the API is highly soluble in the organic solvent layer and not
very soluble in the water layer, however when the pH is decreased below pH 5.8, API becomes
highly soluble in the water later and highly insoluble in the amyl acetate layer. The trials have also
shown that organic solvent rejected by the membranes ( samples of final concentrate and final
bulk permeate were sent to for solvent analysis and the results were 3.5% and 0.1% respectively.
Therefore, above pH 5.8, the majority of API which passes across the membrane only does so

88

Chapter 4 Koch First Rimrul Trials

while in the organic solvent layer which does not permeate very well across the membrane.
Below pH 5.8, the API is present in the water layer with the water layer (including dissolved API),
passing more easily across the membrane.

Figure 4.7 . Graph illustrating the flux decline versus volume concentration factor for a blended Tilmicosin feed using
data from run 10

Figure 4.7 shows the flux decline versus VCF curve for the blended Tilmicosin sample. The VCF
on this run needed to be pushed as far as possible as this waste stream was similar to the typical
feed to any full scale plant. Looking at the graph, a VCF of 5.8 was achieved and the final
permeate flux was 1.75lmh. As mentioned previously, this is around the guidance value
recommended by Koch as the practical lower limit for the final flux. Anything lower and the
membrane area required for the membrane plant increased rapidly. In turn, this would increase
the holdup volume and the cleaning waste that would have to be reprocessed. Also the API
concentration in the final bulk permeate will dictate how far the volume reduction can be pushed.
If the API concentration in the final bulk permeate was to approach the LAEG, the volume
reduction may need to be “stepped back”, in other words, not pushed so far in an attempt to
reduce the API concentration in the final bulk permeate (increasing the volume reduction
generally increases the API levels in the bulk permeate ).
Note : feed and permeate samples were sent for solvent analysis. As already mentioned in
chapter 3, the accuracy of the solvent analysis is questionable due to possible waste matrix
interference. In relation to amyl acetate which is the solvent in the Tilmicosin process, feed and
concentrate samples were sent for solvent analysis. The feed sample showed trace levels of
solvent and the concentrate showed a 0.7% concentration of amyl acetate.
It should be noted that a sticky residue was found in the feed tank towards the end of some of the
Tilmicosin concentration runs. It can only be assumed that this residue also deposited within the
spiral wound membrane spacer layers. A sample of this residue (1.2g) was dissolved in a nitric
acid (pH2) and water solution (at pH2) and a sample was then analysed for API. The result was
as follows :
Tilmicosin ; 1156 ppm, Desmycosin : 182 ppm
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This residue sample was collected from run 3, a T24 decant sample. At this stage of the process,
the reductive amylation reaction which converts Desmycosin to Tilmicosin has been carried out
and as expected, the levels of Tilmicosin are much higher than the levels of Desmycosin. From
the PFD for Tilmcosin [45], the conversion from Desmycosin to Tilmicosin should be greater than
95%. From this it can be seen that the ratio of Tilmicosin to Desmycosin is roughly what would be
expected at this stage of the process (the levels of Desmycosin are slightly higher than what
would be expected - at this stage of the process would expect approximately 58 ppm of
Tilmicosin given a 95% conversion).
In summary, the residue is essentially API. The result above suggests that both Tilmicosin and
Desmycosin molecules are equally coming out of solution.

Cleaning the plant after Tilmicosin trials
Initially for the first number of trials, it was decided to clean the plant using potable water at 50°C.
It was felt that operating at higher temperature would help to remove any foulants from the plant.
The plant did not clean well under these conditions and it was decided to vary the pH of the water
for the clean in an attempt to improve the results. It was found that cleaning the plant using water
at 50°C and pH 2 was optimal for cleaning the pilot plant. A summary of the cleaning regimes
used are summarised in Table 4.1 below
Table 4.1 : Summary of cleaning regimes carried out on Koch PP02 first round trials

Initial clean
water flux
(Um^hr)

Trial
1
2
3
4
5
6
7
8
9
10

^
;

1
I
1
1
1

33
19.5
17.5
18.5
25
24.7
23.5
26.1
27.5
25.5

Cleaning regime used

Final clean
water flux
(L/mlhr)

Water at pH 7 and 50°C
Water at pH 7 and 50“C
Water at pH 10 and 50° C
Water at pH 2 and 50°C
Water at pH 2 and 50‘’C
Water at pH 2 and 50°C
Water at pH 2 and 50°C
Water at pH 2 and 50°C
Water at pH 2 and 50°C
Water at pH 2 and 50°C

19.5
17.5
18.5
25.0
24.7
23.5
26.1
27.5
25.8
26.2
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Main conclusions of trials and the way forward with Tilmicosin
•
Overall the tilmicosin trials were a success. The desired volume reduction and API
rejection were achieved. For a representative blended Tilmicosin sample a VCF of 5.8
and an overall API rejection of 98.5% was achieved
•

It was shown that the plant appears to foul towards the end of each concentration run but
that the foulant can be efficiently removed at the end of each run using a pH2 50°C water
wash

•

The optimum pressure, temperature and pH to concentrate Tilmicosin waste was
identified

•

The effect of fouling on permeate flux was quantified

Planning ahead for second round Tilmicosin trials
The results on Tilmicosin paved the way for a second round of trials that would examine the
repeatability of the concentration trials and the effect of the variability of the bulk waste feed on
the achievable volume reduction and the relative LAEG. These trials would also include design
trials as specified by Koch that would aid the accurate design of a potential full scale plant. These
trials needed to start in October 2004. In the interm, a trials protocol needed to be refined so that
all the required information would be obtained from this set of trials.

4.1.4.2 Atomoxetine HCI
Three runs were carried out on Atomoxetine HCI waste. Permeation was obtained for some of the
waste segments and no permeation was obtained for other segments of waste
Run 11 looked at an Atomoxetine HCI first decant sample ;
Run 11 - Flux decline versus volume reduction Tor Atomoxetine HCI first
decant sample

Figure 4.8 : Flux decline versus volume concentration factor for run 11 using Atomoxetine HCIfirst decant waste
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Figure 4.8 shows the flux decline versus volume concentration factor for the first decant sample.
This run was carried out with a feedside pressure of 34 bar. It can be seen that the rate of
permeation decreases gradually from 13 Imh to 3 Imh as the feed is concentrated. A VCF of 8
(which corresponds to a volume reduction of 87.5%) was easily achieved. The flux dropped off
dramatically at the end of the run on the addition of 2 I of fresh feed from a new Atomoxetine HCI
first decant feed drum (from a different batch of Atomoxetine production).
It was also noted that there appeared to be a buffering effect associated with the Atomoxetine
HCI waste. The pH of the raw Atomoxetine first decant waste was approximately 12. On addition
of acid to drop the pH, the pH fell slowly until it reached pH 10 where it suddenly dropped to a pH
of 6.
Run 12 was used to examine this dramatic fall off in pH in more detail. A fresh sample of
Atomoxetine HCI first decant from a new drum was fed to the membrane plant. No permeation
was achieved. This suggests that there was some property of this fresh drum of first decant that
made it non permeable across the MPS-44 membrane.
At this stage, it was thought that it was either the TDS levels or the solvent levels in the
Atomoxetine HCI waste which was inhibiting permeation. Run 13 aimed to further examine the
inability to permeate. Also investigated was some of the first decant sample with specific
emphasis on the TDS levels in the waste streams. The permeability of Atomoxetine HCI second
decant and the possibility of permeating a blended stream of first and second decant through the
membrane.
The first decant sample which would not permeate in previous trials was taken on the 18/03/04.
The conductivity of this feed was 27.7 mS/cm (it is worth noting that this conductivity was not
high relative to the Tilmicosin waste which permeated easily with no problem through the
membrane). Some second decant feed taken on 18/03/04 was also tested and the conductivity
of this feed was measured as 3.4 mS/cm. This sample permeated easily through the membrane
with an initial flux of 8.5 Imh. By the end of the run the flux had dropped to 6 Imh. 2L of the first
decant raw feed was then added in again in an attempt to blend the feeds. The flux immediately
dropped off to 1.75 Imh.
In light of the results of the Atomoxetine HCI trials, the following suggestions were made to move
forward with the Atomoxetine HCI trials :
(1) A titration was to be carried out to determine the amount of nitric acid required to bring
the pH of a 1®* decant sample down to various pH’s and from this a full pH cun/e could be
generated. This would quantify the buffering effect which occurs on Atomoxetine HCI
waste. This would also have use when the contribution of acid to TDS and hence osmotic
pressure was being quantified. ( see Appendix F for this titration result)
(2) Consider air stripping MTBE

(3) It was agreed with Koch that they would supply their FC-3 deadend flow pressure test cell
unit and a CF1 bench scale crossflow recycle unit to allow further investigative trials to
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be carried out. This bench scale unit would be an improved on the dead end test cell. It
was on the same scale as the dead end cell but incorporated a cross flow recycle and a
feed tank ( approx. 500 ml). This cell would be an improved simulation of any full scale
plant. Delivery of the test cell was arranged for arrival on site in mid-August 2004.
(4) A sample of feed will be air stripped before feeding it to the test cell. A pH stable ( non
solvent stable ) membrane will be used. The purpose of this trial is to eliminate the nitric
acid and solvent influence on the osmotic pressure. No permeation in this case would
suggest that the mandelate in the feed was the main contributor to osmotic pressure.
Note: for the “recycle pressure test” trials, Koch and Lilly needed to decide on what membranes
need to be ordered for the trials. Some of the membranes that were mentioned included the MPS
34- pH 0-14 and the SR3 - pH 0-14. The specifications for these membranes are given in
Appendix H

4.1.4.3 Benzodiazepine HCI
No permeation was achieved for Benzodiazepine HCI with the exception of the Benzodiazepine
HCI diluted by a factor of 60.
After the trials, the possibilities with Benzodiazepine HCI waste were discussed with Koch and the
following was recommended.
•

Identification of the precipitate that comes out of solution when NaOH is added to the
Benzodiazepine HCI waste was essential. A general cation sweep was required and
Veolia had the capabilities to do this. This cation sweep would look at the concentration
of the cations in a raw blended Benzodiazepine HCI sample and also the concentration of
the cations in the supernatant after precipitation with NaOH. (This sweep was carried out
immediately and the results indicated that huge quantities of tin were coming out of
solution. Before the addition of NaOH, the tin level in the feed was 2640 ppm. After the
addition of NaOH, the level of tin in the supernatant had dropped to 0.6 ppm )

•

The supernatant produced on the addition of NaOH to increase the pH of raw
Benzodiazepine HCI waste reduces the levels of TDS in the supernatant. However, at
some point the levels of TDS may begin to increase again due to all the potential
precipitate species coming out of solution and excessive Na+ ions going into solution. For
the purposes of further trials, it would be useful to know the pH at which the TDS of the
supernatant is minimized. As part of Veolia’s trials (Chapter 5) which were running in
parallel with these trials, Veolia were instructed to carry out a trial that would
incrementally increase the pH of a blended Benzodiazepine HCI sample and thereby
determine the TDS of the resulting supernatent at each of the increments of pH. From
this trial, the optimal pH was found to be pH 3 (the results of this trial are detailed in
Appendix G).
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An improved waste stream characterisation for the Benzodiazepine HCI was required at
this stage (assuming that the alcohol was not the main flux inhibitor). Using the same
blended Benzodiazepine HCI waste sample described in point (1) above, the original
sample, the supernatant sample and the precipitate sample were sent for cation and
anion analysis with VeoliaV The results are shown in Table 4.2 below.
Table 4.2 Main results oj catiowanion analysis on Benzodiazepine HCI sample

TDS
(ppm))
Before
precipitation

29,000

BOD
COD
(mg02/litre) (mg02/litre)i
115,400

74,800

Total N
(ppm)
110

Cl- (ppm) Sn (pg/l)
14,280

Na (ppm)

2,640,000

2,100

To rule out the presence of alcohol as a flux inhibitor Koch suggested that alcohols
should not have any effect on efficient operation of the MRS 44 membrane. The levels of
3A alcohol in the waste stream were relatively high (approximately 12w/w%). It was
logical to start by ruling out the alcohol as the flux inhibitor. As part of the proposed CPI
trials, a run would be carried out on the recycle test cell with a 3A alcohol / water mix with
alcohol levels similar to the waste feed stream.
Koch’s MPS-34 membrane is a non solvent stable membrane with a MWCO of 200. In
general alcohols have a minimal effect if any on the stability of non solvent stable
membranes. This membrane would also be trialled on the CF-1 unit using raw
Benzodiazepine HCI waste.

if changed molecules such as tin and/or chbride Ions were responsible for the TDS (and, thus, the high osmotb
pressure), there may be a case for using Electrodeionisation technology to reduce the dissolved solids.
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4.2 Trials on Koch FC3 Dead End unit
Based on the first round trials carried out on PP02, it was decided to carry out a second set of
trials on Koch’s small pressure test cell unit to further examine the difficulties in permeating some
of the Atomoxetine HCI waste and all of the Benzodiazepine HCI waste. This test cell unit was the
smallest and simplest test unit offered by Koch. The FC3 is a dead end test unit in that there is no
recirculation of flow into the cell. These types of cells are not ideal for generating information on
full scale plants, however, they do give an idea as to whether a stream will permeate or not and
also the amount of API that will pass through the membrane. The protocol for this set of trials was
generated from the decisions made in sections 4.1.4.2 and 4.1.4.3.
An overview diagram of the Koch Pressure test cell unit - FC3 is shown in Figure 4.8 below. A
nitrogen cylinder was used to provide the required pressure of 40 bar for the trials (as this was
the maximum pressure limit for any of the membranes that would be used in the trials). The
pressure test cell is shown on the right of the diagram. A rotating magnet was used to simulate
turbulent flow which to some extent increases crossflow velocity.
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Figure 4.9 Diagram of Koch FC3 pressure test cell unit
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4.2.1 Atomoxetine HCi trials on FC3 unit
It was suspected that the lack of permeation of some of the Atomoxetine HCI waste was due to
either high TDS levels or the effect of the MTBE solvent in the waste on the membrane. For this
set of trials, it was decided to look at the effect of the solvent on the waste. The impact of TDS
was investigated later in the CF1 trials.
A sample of 5% MTBE and 95 % DIW was made up and 30 cm^ of sample was placed in the
pressure test cell. A flux rate of 12lmh was achieved at 30 bar

4.2.2 Benzodiazepine HCI trials on FC-3 unit
As mentioned already, no permeation for the Benzodiazepine HCI waste was obtained during the
PP02 trials. It was suspected that the high levels of TDS in the waste produced a iarge osmotic
pressure which was inhibiting permeation. It was decided to look at different combinations of
diluting, precipitating and blending of the waste with the aim of reducing the TDS of the feed to
the pilot plant. The level of TDS was deduced by measuring the conductivity of each of the waste
samples. A summary of the FC3 trials is given in Table 4.3. Each of the trials are summarized as
follows;
Trial 1 (pH adjusted Benzodiazepine HCI second decant supernatant)
Initially it was decided to investigate if a pH adjusted Benzodiazepine HCI second decant sample
would permeate in the test cell unit. A sample of Benzodiazepine HCI had previously been
brought up to pH 7 (from pH 0.8) using NaOH and the precipitate was allowed to settle. A sample
of supernatant was then placed in the pressure test cell and no permeation was achieved.
Trial 2 (Diluted pH Benzodiazepine HCI second decant)
A sample of the initial raw Benzodiazepine HCI feed was then diluted to 50% concentration.
Again, no permeation was obtained for this sample.
Trial 3 (Diluted oH adjusted Benzodiazepine HCI second decant supernatant)
It was then decided to dilute the supernatant to reduce the TDS. The supernatant was diluted by
50% and a sample was placed in the pressure test cell. Permeation was achieved but the rate
was too low to measure.
Trial 4 (Diluted pH adjusted Benzodiazepine HCI second decant supernatant)
To further reduce the TDS and hopefully increase the rate of permeation, the conductivity of a
supernatant sample ( at pH 7 ) was reduced by diluting by a factor of 4. Some permeation was
achieved but again the level was too low to measure.
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Trial 5 (Blended bendzodiazepine HCI sample)
It was then decided to blend a Benzodiazepine HCI sample. A sample containing 1/3 raw second
decant, 1/3 third decant and 1/3 centrifuge mother liquor was made up and fed to unit. No
permeation was achieved.
Trial 6 (Blended bendzodiazepine HCI sample with second decant oH adjusted supernatant)
A second sample containing 1/3 second decant supernatant {pH adjusted to 6), 1/3 third decant
and 1/3 centrifuge mother liquor was made up and the conduct. Both samples were tried in the
pressure test cell and in each case no permeation was achieved.
Conclusions;
The MPS44 membrane shows very little potential for treating Benzodiazepine HCI waste. Diluting,
precipitating or blending the waste in the majority of cases does not give any permeation through
the membrane. In the situations where permeation was achieved, the rate of permeation was very
low and would not be practical for any full scale plant.
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4.3 Bench scale trials on Koch CF-1 Cross Flow unit
Figure 4.10 shows a picture of the Koch recycle pressure test cell unit. The 500 ml feed cell is
mounted on top of the unit and the feed is recycled via the pump and back to the feed cell. The
membrane disc is located at the base of the feed cell.

Figure 4. iO : Diagram of Koch recycle CFl unit

4.3.1 Tailoring a protocol for CF-1 trials
This set of trials looked at the issues on Atomoxetine HCl and Benzodiazepine HCl waste that
had not been addressed in the FC3 trials. These issues were :
•
•

the exact contribution of the solvent and TDS to the inability to permeate segments of
Atomoxetine HCl waste was targeted using the MPS44 membrane.
It was also important to look at the potential of the SR3 membrane for treating
Benzodiazepine HCl waste given that no success had been achieved using the MPS44
membrane

The trials carried out are described and summarised in the following section.

99

Chapter

■/

Koch hirst Roumi Trials

4.3.2 Trials carried out
Each trial was run as a batch concentration. A summary of the trials is given in Table 4.4. Each of
the trials are summarized as follows ;
Trial 1 (MPF-44 membrane)
An air stripped Atomoxetine HCI first decant sample was fed to the CF1 unit with a high permeate
flux and volume reduction resulting
Trial 2 (MPF-44 membrane)
The flux rates achieved from trial 1 were exceptionally high. It was decided to try an unstripped
Atomoxetine HCI first decant sample also to see if there would be any permeation across the
membrane. It was expected that there would be no permeation since there was no permeation for
the first decant sample from the first round of pilot trials.
An initial flux of 12.7 Imh was achieved for this run. The run was then discontinued as the
achievable volume reduction or flux decline with time was not the main concern at this stage.
Trial 3 (MPF-44 membrane)
At this stage, there were concerns about the exceptionally high permeate fluxes obtained for the
Atomoxetine HCI first decant samples. One of the concerns was over the integrity of the MPF-44
membrane disc that was being used for the trials. It was decided to carry out a trial on a second
MPF-44 membrane disc using the same unstripped Atomoxetine HCI first decant sample. An
initial flux of 12.7 was obtained for this trial which was identical to that obtained in trial 2 using the
original MPF-44 membrane disc.
Trial 4 (MPF-44 membrane)
Since one of the membrane discs has not been compromised, it was then decided to look at the
possibility that the operating characteristics between the PP02 pilot plant and the bench scale
plant were quite different. A segment of the sample from Run 12 on the PP02 first round trials (
Tilmicosin T24 decant sample) was fed to the bench scale unit. An initial flux of 10.39 Imh was
achieved and the flux dropped off to 7.14 Imh when the volume reduction was 25%. Comparing
this to the PP02 trial, the initial permeate flux was 8.5 Imh and the flux had dropped off to 6.5 Imh
when the volume reduction was 25%. Although the fluxes are slightly higher for the CF-1 plant,
the difference is small and much of the difference could be attributed to the accuracy of
measuring the permeate flux in each trial.
Trial 5 (MPF-44 membrane)
At this stage of the trials it was becoming apparent that the high permeation rates across the
membrane for Atomoxetine HCI first decant were not due to any problem with the membranes or
the membrane plant. The next logical step was to check that the TDS levels in the feed stream
might dictate the rate of permeation, if any, achieved for an Atomoxetine HCI stream. In addition,
whether permeation occurred appeared to be dependant on whether it was a high or low
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conductivity feed. Looking at some of the results to date, the conductivity of some of the second
decant streams could be much higher than first decant samples. For this trial, a high conductivity
(42.7 mS/cm) second decant sample was fed to the pilot plant. No permeation was achieved for
this sample
Trial 6 (MPF-44 membrane)
Here, the contribution of solvent to the inability to permeate was further investigated. A sample of
high conductivity second decant was air stripped (the solvent content was 3.5% and 0% before
and after air stripping respectively). The air stripped sample was fed to the CF1 plant and again
no permeation was achieved.
Trial 7 (MPF-44 membrane)
The purpose of this trial was to assess the contribution of acid addition to the rate of permeation.
An air stripped and pH adjusted Atomoxetine HCI first decant sample, ( same sample as trial 1,
pH adjusted from 9.8 to 5.8 ) was fed to the bench scale plant. An initial permeate flux of 29.46
Imh was achieved. It was concluded that the acid contributed to the osmotic pressure given that
the initial flux is less than the 41.42 Imh achieved in trial 1.
Thai 8 (MPF-44 membrane)
For the purpose of looking at how the benzodiazepine second decant sample would perform on
the CF-1 unit, a sample was pH adjusted to pH 2 and the supernatant was fed to the CF-1 unit (
the conductivity of the supernatant was 50.5 mS/cm ). An initial rate of permeation of 3.87 Imh
was obtained. This result was slightly surprising as for the trials on the pressure test cell unit, no
permeation was obtained for the second decant supernatant sample (the conductivity in this case
was 54.8 mS/cm ). Again for the FC3 trials, permeation was achieved on a diluted sample when
the conductivity was dropped to 34 mS/cm. However, looking at the conductivity figures, the
conductivity of this trial was between the conductivities of the samples that did and did not
permeate on the pressure test cell trials which again suggests that permeation is proportional to
conductivity in the feed.
Trial 9 (SR-3 membrane)
Trial 9 was carried out on a pH unadjusted Benzodiazepine HCI second decant sample using the
SR3 membrane which was seen as a membrane that may be suitable for Benzodiazepine HCI
waste. An initial flux of 21.43 Imh was achieved for this run. The flux dropped off to 10.45 Imh at
the end of the run when a volume reduction of 42.5% had been achieved.
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Chapter 4 Koch First Round Trials

Conclusions;
(1) Ail the findings indicate that the ability or inability to permeate Atomoxetine HCI first or
second decant waste is related to the TDS levels in the waste. The rate of permeation
decreases as the TDS levels increase
(2) Acid levels in the Atomoxetine HCI waste contribute to some degree to the rate of
permeation of the waste.
(3) The scale up results going from the CF1 unit to the PP02 unit are consistent for
Tilmicosin waste
(4) The SR3 membrane shows potential in its ability to treat Benzodiazepine HCI waste

4.4 Discussion of FC3 and CF1 trials
Benzodiazepine HCI
There is little potential in using the MPS44 membrane on this waste stream. From the FC3 trials,
the only waste that would permeate was a supernatant Benzodiazepine HCI sample that was
diluted to 4x (trial 4). The conductivity of this feed was 20 mS/cm. This conductivity is much lower
than any of the conductivity of the majority of the waste produced from this process. There may
be some potential to permeate the mother liquor only but this is only one third of the waste
produced which would not be worth while.
The SR3 membrane used in the CF1 trials demonstrated the potential for treating
Benzodiazepine HCI waste. As mentioned already, this is a pH stable membrane but non solvent
stable membrane. However, Koch had suggested that the membrane should be relatively stable
with alcohols. API analysis was carried out on the permeate from SR3 membrane for run 4 and
the rejection was promising with a 99% rejection of API. There would be merit in looking at the
SR3 membrane in more detail. The long term stability of the membrane should also be
investigated in more detail.
Characterisation of the Benzodiazepine HCI waste stream showed that the API levels in the
waste may already be below the LAEG and as a result, membrane filtration may be an
unnecessary step in treating this waste stream. It is recommended that an extensive
Benzodiazepine HCI waste sampling and API analysis campaign be carried out as part of a
solution for this waste stream.
Atomoxetine HCI
The FC3 trials showed that MTBE was not a major flux inhibitor on the MPS44 membrane.
The CF1 trials showed that the main contributor to flux inhibition on the MPS44 membrane was
the TDS levels in the waste. In addition, the TDS levels can vary for both first and second decant
samples. In some cases, the TDS levels are much higher for second decant samples than first
decant samples.
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4.5 Explanation of inability to permeate some Atomoxetine HCI waste
From speaking with the Atomoxetine HCI process chemist, [50] it was confirmed that the TDS
levels in the first decant waste should be much higher than the TDS levels in the second decant
waste as most of the mandelate salt should be washed out with the first extraction. This
assumption was also made in the Atomoxetine HCI mass balance where it was assumed that
95% of the mandelate salt would be sent out in the first decant wash. Given the results from the
first round Koch trial, the pressure test cell trials and the CF1 trial, the following conclusions have
been drawn.
It is likely that one or more of the drums of Atomoxetine HCI waste collected by personnel in IE8
were mislabeled. In all likelihood, the “low conductivity first decant sample” was mislabeled and in
reality it is a second decant sample.
The conductivity of one of the first decant drums was much lov/er than the conductivity of another.
The results were:
Low conductivity first decant sample = 3.3 mS/cm
High conductivity first decant sample = 42.7 mS/cm

Table 4.5 shows the Atomoxetine HCI samples analysed during the stream characterization.
From these results, the difference in conductivity between first and second decants is clear.

Sample Description
Atomoxetine first decant
Atomoxetine first decant
Atomoxetine second decant
Atomoxetine second decant

Conductivity
(mS/cm)
Date
38.20
13-Jan-04
41.60
17-Jan-04
T3-Jan-04
1.98
17-Jan-04
1.50

TDS,
ppm
122,935
126,827
3,952
1,284

Table 4.5 : Atomoxetine final results from sampling campaign

A lot of the Atomoxetine HCI trials can be explained by this mislabeling. For example for trial 10 of
the first round Koch trials, the rate of permeation through the membrane plant was relatively good
at the beginning. The conductivity of this feed was measured as 3.3 mS/cm. When the second
drum of first decant feed was added, permeation stopped. The conductivity of this second drum
was 42.7 mS/cm. The simple answer here is that the first drum was mislabelled and was in reality
a second decant sample. The first drum permeated due to the relatively low TDS levels and
hence low osmotic pressure. The second drum did not permeate due to the relatively higher TDS
levels.
Trial 16 from the first round Koch trials, illustrates how second decant samples easily permeate
through the membrane due to relatively low TDS levels and also how first decant samples do not
permeate due to relatively high TDS levels. This trial also shows how increasing the TDS causes
the flux to drop off as 2 L of first decant waste were added to a larger sample of second decant
and the flux dropped off from 6 Imh to 1.75 Imh
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For the CF1 trials, the conductivity of the unstripped “first decant” sample was 3.3 mS/cm. It is
likely this drum was mislabelled as first decant and that it is in reality a second decant sample.
This drum of waste was collected at the same time as the other mislabelled drum used in the first
round Koch trials.
Trials 8 and 9 from the CF1 trials again demonstrate the influence of TDS on the rate of
permeation. For trial 8 and 9, a high conductivity “second decant” sample was used and no
permeation was achieved. It is likely that this is a mislabelled first decant sample.

Recommendations for the way forward for the Atomoxetine HCI process :
It is recommended that a detailed sampling campaign on Atomoxetine HCI waste be carried out
over a number of lots to show that the conductivity of first decant samples are consistently higher
than second decant samples. It would also be useful to measure the TDS levels to obtain a range
of TDS’s that would be expected for first and second decant waste.

Note the drums were labeled and then handed over to the operators in IE8 as the samples were
to be taken during the night. In hindsight, the sampling should have been overseen.
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Summary

The first section of this chapter looks at the membrane trials that were carried out at Veolia's
research centre. These trials commenced towards the end of the first round Koch trials. The
primary goals of these trials were the same as the Koch first round trials. The goals were first, to
assess the potential of volume reducing the three selected waste streams and second, to asses
the rejection of API from the membranes to determine if permeate levels would be below the
relevant LAEG’s. These objectives would be carried out on two bench scale units using the Dow
NF90 (MWCO specified as 90) and NF200 membranes (MWCO specified as 200).
Specifications for all membranes are given in Appendix I. It should be noted that besides the
Koch MPS-44 membrane, these membranes were seen as the most compatible on the market
for treating the three chosen waste streams. The main concern about these membranes was
that they were not classified as solvent stable but this stability. Again, a 75% volume reduction
was targeted as a practical economic target in relation to the potential of bringing the trials
forward to full scale.
The main findings for the Tilmicosin waste stream were that for the NF200 membrane, a volume
reduction of 55% was achieved but for the NF90 membrane a volume reduction of 70% and an
API rejection of 99.8% was achieved. The plant cleaned well and the clean water flux of the
membrane recovered to close to its original value.
The main results for Benzodiazepine Fid were that using the NF90 membrane a volume
reduction of 60% was achieved at a pressure of 60 bar (which is 20 bar above the
recommended maximum operating pressure) when the membrane failed. The API rejection was
87% which overall is more promising than the results on the Koch MPS-44 membrane
For Atomoxetine HCI, a volume reduction of 90% was obtained on the NF90 batch test at a flux
of 2 Imh, however, the API rejections were inconclusive due to the low levels of API in the
original feed.
At this stage of the trials It was decided not to take trials or exploration of Benzodiazepine HCI
or Atomoxetine HCI any further due to the success achieved on Tilmicosin waste in the Koch
first round trials.
The second section of this chapter looks at the respirometry trials that were carried out to asses
the effect of Tilmicosin permeate on the effluent feed to the waste water plant at Lilly. In
summary, additional permeate to the WWTP was found not to inhibit the performance of the
WWTP up to 15 v/v% which is more than what the addition of permeate to the WWTP would
account for with a full scale Tilmcosin plant assuming that volume reduction of 75% is achieved
(the additional increase due to Tilmicosin permeate was calculated as 8.2%).
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5.0 Tailoring a protocol for membrane trials
As with the Koch bench scale trials, all three process waste streams would be looked at. Veolia
also had good capabilities in terms of analyzing samples for various properties such as BOD5,
COD, Respirometry, Total nitrogen and Cation analysis. Veolia could also conduct standard

analysis such as pH and identifying common species in waste streams such as SO4, F, HCO3,
Ca, Fe, Sn, Ba and Si.
Veolia had a large input into the trials protocol as they had a standard template that is used for
trials. This template was refined after lengthy correspondence with Veolia. The final refined
protocol can be seen in Appendix I.
5.1 Membrane Trials
Given the success of the first round Koch trials on the Tilmicosin waste stream, it was proposed
that Veolia also look at this stream first as it was seen as the stream most likely to give a
positive result and allow membrane comparison. In addition, working with Tilmicosin would allow
the comparison of performance between the MPS-44 membrane and the NF90 and NF200
membranes. Veolia subsequently looked at Benzodiazepine HCI and finally Atomoxetine HCI
waste. The results are summarised in the following sections.
5.1.1 Materials and methods
A schematic of the pilot plant unit is shown is Figure 5.0. The process was a recycle system
with a flatsheet membrane of an area of approximately 400 cm^. The design of the system was
such that sampling of the feed, permeate and concentrate was made easy by the presence of
bleed off valves. A detailed trials protocol aswell as additional photographs of the pilot plant are
given in Appendix I.

Figure 5.0: Schematic of Veolia pilot plant
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The membranes were first subjected to standard salt rejection tests to ensure that the rejections
were within the ranges specified by the vendor. The membrane was also subjected to a dynamic
rinse which checks the permeability of the membrane. The results indicated that the membranes
were within quality tolerance.
Total Nitrogen as surrogate for API analysis
It should be noted that for these trials, total nitrogen was used to estimate the levels of API in
feed, concentrate and permeate streams for Tilmicosin, Benzodiazepine HCI and Atomoxetine
HCI trials. In addition, as the trials proceeded, process information was gathered from the
Process Flow Documents for Atomoxetine, Benzodiazpine and Tilmicosin processes respectively
[41,42,43]. For the Benzodiazepine and Atomoxetine processes, nitrogen is only present in the
base molecule for each process so it is assumed that the amount of nitrogen present in any
waste sample is proportional to the amount of API present. However for the Tilmicosin process,
nitrogen is present in the base molecule and also in one of the other reagents so the direct
relationship between API levels and nitrogen levels would not apply. Logically and in light of these
findings, the amount of nitrogen in the waste streams was only used as a rough indicator of API
levels, especially for the Tilmicosin trials.
Total nitrogen removal is calculated using : Nitrogen in feed - Nitrogen in permeate
Nitrogen in feed
5.1.3Tests on Tilmicosin
5.1.3.1 Tests carried out on the NF 200 membrane
The main results for the trials carried out on the NF 200 membrane are summarised as follows :

Run 1 : Batch test at pH 9 and a pressure of 30 bar on T24 decant sample
Figure 5.1 below shows how nitrogen removal and conductivity rejection varies with volume
reduction, at a pressure of 30 bar and a pH of 9. This run was terminated when the volume
reduction had reached approximately 35% as the permeate flux had dropped off to 2.3 Imh. In
addition the fact that the conductivity and nitrogen removals were so low indicated that the API
removal was also low in this case.
It is clear that conductivity removal decreased while nitrogen removal increased as the run
proceeded. The fall off in conductivity can be attributed to either the overall rejection of the
membrane falling off with time and possibly also to some fouling on the feed side which brings
some solute out of solution.
The increase in nitrogen rejection suggests that molecules containing nitrogen are being better
rejected as the run proceeds. This could be partially explained by the presence of 3,5 Dimethyl
piperidene (Mw = 113) in the Tilmicosin waste stream. It is possible that as the run proceeds, due
to fouling on the membrane the rejection of 3,5 Dimethyl piperidene ( and also possibly API)
increases which shows up as an increase in total nitrogen removal
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Figure 5.1

.

Graph illustrating conductivity removal, total nitrogen removal, and permeate flta at various volume

reductions for Tilmicosin run I

Run 2 : Batch test at dH7 and a pressure of 40 bar on T24 decant sample
From experience with the first round Koch trials, it was clear that dropping the pH of the feed
made a clear improvement to the permeate flux. For this test the pressure was gradually
increased in increments (15, 16.5, 17.5 and 30 bar) up to a volume reduction of around 34.9%.
Following this the pressure was maintained constant at a value of 40 bar until a low flux of 0.1 L/h
was reached. A volume reduction of 55% was achieved. The conductivity and nitrogen removals
for these trials were similar to the previous trial
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♦ conductivity removal
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Figure 5.2 : Graph illustrating conductivity removal, total nitrogen removal, and permeate Jlux at various volume
reductions for Tilmicosin run 2

As illustrated in the Koch trials, to obtain a practical rate of permeation from this membrane and
to allow the volume reduction to be pushed close to the desired value of 75%, the feed pH must
be decreased to approximately pH 7. However at this pH, the API rejection by the membrane
decreased rapidly and is nowhere near what would be required for a full scale membrane plant.
The main results are illustrated in Figure 5.2. It was concluded that this membrane was not
suitable as a potential candidate for treating Tilmicosin waste given that the achievable volume
reduction even at a reduced pH is still only 55% and also the fact that conductivity and API
removals were below 90% which would indicate that API removals may not be so good either.

5.1.3.2 Tests carried out on NF 90 membrane
Given that the NF90 membrane specifies a lower molecular weight cutoff (90 daltons) than the
NF 200 membrane, it was hoped that this membrane would provide better rejections. Given the
low permeate flux obtained for the NF200 trial carried out at pH9, it was deduced that the
permeate flux would be even lower for the NF90 membrane given that the average pore size for
this membrane is smaller. As a result, no trial was carried out at pH 9. Two successive tests were
carried out at pH 6.5. Pressure was regulated throughout the test to maintain a constant
permeate flux value. The pH was maintained at 6.5 by adding nitric acid in order to keep the
Tilmicosin soluble. The pilot test was operated in concentration mode until a maximum pressure
of 60 bar was is reached. The permeate flux was set at a low rate (2 Imh and 4 Imh) in order to
prevent clogging of the membrane. Both trials used a blended Tilmicosin feed with a blend similar
to the Koch first round trials in chapter 4. Each of the trials are summarised as follows :
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Run 3 : Test at pH 6.5 with constant flux at 2 LHM on a blended Tilmicosin sample
For this trial, the permeate flux was maintained at 2 Imh. Figure 5.3 below highlights the main
results for this trial. A conversion of approximately 67% was achieved for this trial. The
conductivity removal remained relatively constant at approximately 90% and the total nitrogen
removal was 96.3%. The volume reduction here still falls short of the targeted 75% for a single
pass on the membrane plant which does not compare favourably with the first round Koch trials.
♦ Conductivity removal
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Figure 5.3 : Graph illustrating conductivity removal and total nitrogen removal at various volume reductions for
Tilmicosin run 2

Run 4 : Test at pH 6.5 with a constant flux at 4 LHM on a blended Tilmicosin sample
The second trial was carried out at a constant flux of 4 Imh. Figure 5.4 below shows how the
conductivity and nitrogen removals varied with volume reduction. From the graph it can be seen
that both are fairly constant with an average conductivity removal of 90.8% and an average
nitrogen removal of 96.7%. A final volume reduction of 70% was achieved. Again 70% is less
satisfactory than the Koch first round volume reduction of 75%.
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♦ Conductivity removal
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Figure 5.4 : Graph illustrating comhictivity removal and total nitrogen removal at various volume reductions for
Tilmicosin run 4

Comparison and discussion
The main results for both trials are summarised in Table 5.0 below. It should also be noted that
API rejections are calculated from (API in feed - API in permeate) / API in feed.
Table 5.0 Results ofTilmicosin trials on NFVO membrane

Test
1
2

Final
Initial feed concentrate Nitrogen Volume
Operating
conductivity conductivity rejection reduction
conditions
(mS/cm)
(mS/cm)
(%)
(%)
pH 6.5, Flux 2 Lmh
28.6
67.4
96.3
64.6
pH 6.5, Flux 4 Lmh
20.3
43.4
96,7
70

API
rejection
(%)
99.8
96.8

Similar volume reductions were achieved for both trials with the volume reduction achieved for
the 4Lmh trial being slightly higher. Interestingly, the conductivity removal for the 2Lmh trial is
higher than the conductivity removal for the 4Lmh trial. However, the final feed side pressure
needed to be pushed to 60 bar to ensure the flux was maintained at 2 Imh. This makes the
suitability of the NF90 membrane questionable as this is operating above the suggested upper
pressure limit of the NF90 membrane. In summary the API rejections achievable on this
membrane were excellent but the capability to consistently achieve a 75% volume reduction was
questionable.
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Cleaning of NF90 membrane
As expected, the membrane was fouled after the run on Tilmicosin. However, given the
experience with Tilmicosin waste in the Koch trials, it was suggested that Veolia try a warm water
(50°C) low pH (pH 2) wash. The flux recovered to close to its original value after this trial.
5.1.4 Tests on Benzodiazepine HCI
5.1.4.1 Pre-treatment for precipitation
Three different drums of Benzodiazepine HCI waste were sent to Veolia namely a second decant
sample, a third decant sample and a centrifuge mother liquor sample.
An initial test on the second decant sample showed that the product could not be directly filtered
through the nanofiltration membrane. The three drums were mixed together to simulate a bulked
feed sample. NaOH was then added to this bulked feed sample in an attempt to precipitate out
the majority of the dissolved solids. The solution was then left for natural sedimentation to take
place over a weekend. The supernatant at pH4 was then collected for treatment through the
nanofiltration membrane NF 90

5.1.4.2 Tests carried out on membrane NF 90
Given that the Benzodiazepine HCI (mw = 265.8) molecule is much smaller than the Tilmicosin
molecule (Mw = 868), it was decided to work immediately with the NF90 membrane given the low
rejections that were achieved for the NF200 membrane with the Tilmicosin waste. The trial
carried out is summarised as follows
Run 1 : Batch test at oH 4 with a constant flux at 2 LHM
The trial was carried out on a supernatant blended sample where the pH was increased to 4 by
using HCI. Due to the raised chloride content, it was not possible to carry out analyses of total
nitrogen. The reject conductivity was evaluated. Figure 5.5 shows the variation of the conductivity
removal with conversion rate and from the diagram it can be seen that the conductivity removal
remained almost constant at approximately 90%. As the concentration proceeded the pressure
was gradually increased to maintain the flux at 2 Imh until a pressure of 60 bar was reached. This
run was terminated when the volume reduction was at 60% as the membrane failed with a hole
forming on the membrane surface. 60 bar is above the recommended maximum operating
pressure of 40 bar for this membrane. The average API removal for this trial was 87%.
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Figure 5.5 . Graph illustrating conductivity removal at various volume reductions for Benzodiazepine HCl run I

To summarise the Benzodiazepine HCl trial, the volume reduction achieved for the trials was 60%
and at this stage the stress on the membrane was large enough to cause a hole to form in the
membrane ( operated at 60 bar and the recommended maximum operating pressure is 35 to 40
bar). The API rejection was reasonably satisfactory at 87%. It is therefore not worthwhile looking
at this membrane any further foe Benzodiazepine HCl waste.
Cleaning of NF90 membrane
Difficulty was encountered when cleaning the NF90 membrane after this trial. Irreversible fouling
occurred and the flux did not improve after cleaning. On examination of the membrane after the
Benzodaizepine HCl trial, the membrane looked clean. However the membrane may have
become irreversibly compressed as the trials were carried out at pressure of 20bar over the
maximum allowable operation pressure. It is also possible that at this high pressure, some of the
feed side material may have become embedded in the membrane and subsequent crossflow
cleaning at lower pressure did not remove any of the embedded material.

5.1.5 Tests on Atomoxetine HCl
An Atomoxetine HCl first decant, second decant and rinse drum were sent to Veolia and Veolia
proceeded to blend the waste samples to produce a waste that was a reasonable representation
of the bulk waste produced from Atomoxetine HCl. A trial was then carried out on the waste
sample and the main result is shown in Figure 5.6
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Figure 5.6 : Graph illustrating conductivity removal at various volume reductions for Atomoxetine HCl

The API levels of both feed and concentrate for this trial were below the lower detection limit of 10
ppm and as a result, no useful information was obtained on the API rejection. The conductivity
removal from this trial was low which could mean that the majority of solute passed through the
membrane. Whether the majority of the solute present as API is passing through the membrane
remains to be seen, however it does not look promising given that total conductivity removal is
only approximately 25%.
Cleaning of the NF90 membrane
A variety of cleaning chemicals were used to clean the membrane after the Atomoxetine HCl
trials. Cleans were also carried out at various pH’s. In all cases the permeate flux was only
recovered to between 40 and 50% of its original value which indicates irreversible fouling.
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5.1.6 Main conclusions from the Veolia trials
Tilmicosin
Tilmicosin trials carried out on the NF90 membrane were reasonably satisfactory with a volume
reduction of 70% and an API rejection of 97% achieved. However, the operating pressure at the
end of the concentration was very high (60 bars), which is 20 bar beyond the maximum
recommended operating pressure for the membrane, and there was serious fouling of the
membrane. A 70% loss of permeability was observed. Cleaning with different chemical products
only allowed the recovery of 50% of initial permeability, but using water at low pH cleaned the
membrane satisfactorily.
Tests carried out on the NF200 membrane showed an insufficient retention rate for organic
molecules (< 90%). Loss of permeability during the test was high even though it was less than
that noted on the NF90 membrane.
Therefore membranes NF90 and NF200 do not appear appropriate for the treatment of effluent
that is high in concentration of Tilmicosin. Given the success of the Koch membrane in treating
Tilmicosin to date, it was felt that there was no need to carry out any further work with Veolia on
this production waste stream.
Benzodiazepine HCi
Using the NF90 membrane a volume reduction of 60% was achieved at a pressure of 60 bar
when the membrane failed. The API rejection was 87%. In summary, it appears that this
membrane gave a satisfactory rejection but the volume reduction achievable was not satisfactory
due to the high levels of TDS in the production waste stream. Moving forward with
Benzodiazepine HCI, the following avenues are worth looking at. During the Koch CF-1 trials, the
SR3 membrane showed promise in terms of API rejection and volume reduction. This membrane
could be looked at in more detail on a more extensive set of pilot trials. Also given the API levels
in the Benzodiazepine HCI samples taken to date, the levels of API in the waste may be below
the LAEG without any treatment. It is proposed that a more detailed sampling campaign be
carried out on the Benzodiazepine HCI process in the near future.
Atomoxetine HCI
For Atomoxetine HCI, although a conversion rate of 90% was obtained on the NF90 batch test at
a flux of 2 Imh, the API rejections were inconclusive due to the low levels of API in the original
feed. It is recommended that the API rejection aswell as the longterm stability of the membrane
be investigated further using this membrane.
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5.2 Effect of permeate on waste water treatment plant - respirometry trials
The objective of these trials was to determine if the Tilmicosin permeate from the membrane
plant, which would contain levels of Tilmicosin, has a toxic effect on the biomass of the water
treatment plant.
To identify the permeate toxicity, Veolia initially studied the respirometry of the effluent
introduced to the biomass at the entry of Lilly’s WWTP (current effluent). Veolia then proceeded
to look at the impact of the permeate on the biomass by injecting different percentages of
permeate into the current effluent.
Calculations were carried out and assuming a 75% volume reduction on the membrane plant
and Tilmicosin production on 2 Tilmicosin rigs, it was estimated that this permeate would
increase the volume of aqueous waste to the waste water plant by 8.2% (see Appendix J for
calculation). A sample of effluent from the Lilly WWTP was sent to Veolia and they blended the
permeate from the Tilmicosin trials with the effluent sample to simulate the 8.2% increase in
volume described above. Veolia also looked at other permeate to effluent ratios up to 15% and
the results are described in the following sections ;

5.2.1 Principle of respirometry analysis
The measurement of the rate of oxygen consumption by a biomass, called respirometry, is a
simple, efficient and rapid method for testing biomass activity and understanding its behaviour
in the presence of a determined effluent. The respirometer used was a Strathkelvin Instruments
appliance which is shown in Figure 5.7 below.

Figure 5.7 . Strathkelvin respirometer
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5.2.2 Determination of endogenous respiration and oxygen consumption
Oxygen uptake rate is the oxygen required by the bacterial mass to degrade biodegradable
organic matters and assure the vital functions of the biomass (for consuming substrate and
also endogenous maintenance). These quantities are necessarily proportional to the quantities
of COD to eliminate. The quantity of oxygen to be made available can be assessed using the
following formula;
Q O2 = a’ AL + b’ Sa
Where
Q O2; quantity of oxygen to supply per day (Kg 02/d.)
a’: correctional parameter for COD elimination expressed in Kg O2 / Kg COD
AL: mass flow of COD eliminated /day
b’; correctional parameter for auto-oxidation of sludge (endogenous respiration) expressed in
Kg 02/kg VSS.d
Sa; Total quantity of biomass in VSS present
Note ; For low concentrations of biomass and substrate, oxygen requirements for nitrification
have to be taken into account. Allylthiourea (ATU) may be added to the tests in order to inhibit
nitrification.
After having introduced the sample into the measuring cell, the concentration of dissolved
oxygen decreases in line with, and proportional to, the biomass activity.
Determining endogenous respiration (without the addition of substrate)
During endogenous respiration, microorganisms consume oxygen in order to maintain their cell
activity. The fall off in oxygen content is illustrated in Figure 5.8
Determination of coefficient b’
Coefficient b’ in kg02/(Kg VSS.d) is determined by the following formula:
b’= slope of the curve in Fig 5.8 (Kg 02/l.d) / biomass concentration(Kg VSS/L)
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Figure 5.8 : illustration offall of in oxygen concentration with time for a respirometry sample

Determination of oxygen consumption (a’)
Factor a’ can be estimated by the relation between the quantity of oxygen consumed in the
respirometric test (called rapidly biodegradable COD) and the soluble COD injected in the
effluent. The rapidly biodegradable COD corresponds to oxygen consumption linked to the
injection of a given quantity of COD.
The line of the rate of instantaneous oxygen consumption (slope) allows the determination of
T1 and T2 (T2 is the time of return to endogenous respiration) and to calculate a’.
Figure 5.9 below shows a typical graph of the instantaneous rate of oxygen consumption
versus time.

Figure 5.9 . Typical representation of instantaneous rate of oxygen uptake with time
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From this graph a’ is determined as
a’= (integration of curve in Kg

02/Kg

VSS) / (injected soluble COD Kg DCO / Kg VSS)

Figure 5.9 illustrates the generally expected n-shaped curve from a respirometry trial. The
increasing slope in shows the time where the oxygen uptake rate was increasing while the
decreasing slope on the diagram shows the time when the oxygen uptake had peaked and was
in decline. On the graph, a rapidly biodegradable section and a section that is biodegradable
with greater difficulty is observed. In effect the return to endogenous respiration is not
immediate.
Note that integration of the curve does not include endogenous respiration, only the oxygen
consumption by the substrate.
The total oxygen consumption can also be determined by recording times T1 and T2 on the
curve of oxygen consumption according to time.
Total oxygen consumption represents the total sum of consumptions linked to the addition of
substrate and endogenous respiration (see Figure 5.10 for an illustration)
A0T= a OE + A OS
So a’ = (A OT-AOE)/ADCO
With:
A OT: total oxygen consumed (mg O2/I)
A OS: oxygen for consumption of substrate (mg O2/L)
A OE: oxygen for endogenous respiration (mg O2/L)
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Figure 5.10 : illustration of total oxygen consumed by measuring T1 and T2

5.2.3 Protocol for the respirometry tests
• The activated sludge was first characterised by measuring the flocculated suspended
solids (FSS), the volatile suspended solids (VSS) and also the percentage of FSSA/SS
•

The effluent for testing was then characterised by measuring the Total Suspended Solids
(TSS), the Total Dissolved Solids (TDS), the soluble COD, total nitrogen, total
phosphorous and pH.

•

The effluent was then filtered prior to testing to remove any dirt or grit that may be
present.

•

The sludge was then prepared for endogenous respiration. The sludge was first
centrifuged, the supernatant is then eliminated. The sludge is then suspended in water
and the water is again removed by centrifugation. A COD is carried out and the sludge is
diluted to 1g/L VSS
The sludge is then left in the aeration phase.

•

The effluent is then diluted so as to give a substrate to biomass concentration of 40 mg
soluble COD per gram of VSS

As already stated, Veolia tested different proportions of permeate in the filtered effluent, up to
of 15% permeate
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The main results from the respirometry tests are summarised in Tables 5.1 to 5.4
Table 5.1 Activated Sludge Residts

Activated sludge
FSS (g/L)
VSS (g/L)
% VSS/FSS

1.82
1.56
85.80

Table 5.2 Tilmicosin Permeate Results

Tilmicosin permeate
pH
conductivity (ms/cm)
Total phosphorous (mg/I)
Chloride (mg/1)
Total nitrogen (mg/I)
COD (mg/1)

7.44
7.58
71.20
11.24
568.00
11,490.00

Table 5.3 Lilly fVaste Water Effluent Results

Lilly WWTP effluent
pH
Total phosphorous; 6.31 mg/L
Total phosphorous (filtered effluent): 4.7 mg/L
Total nitrogen (effluent) 3.48 mg/L
Total nitrogen (filtered effluent) 1.68 mg/L
COD (mg/I)
Soluble COD (mg/1)

7.70
6.31
4.70
3.48
1.68
1,872.00
1,805.00

Table 5.4 COD of Different Proportions of Permeate in the Filtered Waste Water Treatment Plant Effluent

COD of different proportions of permeate in the filtered WWTP
effluent
2% permeate in filtered effluent (mg02/l)

1859

5% permeate in filtered effluent: 2,152 (mg02/l)

2152

8.2% permeate in filtered effluent: 2,468 (mg02/l)

2468

10% permeate in filtered effluent: 2,642 (mg02/l)

2642

15% permeate in filtered effluent: 3,078 (mg02/l)

3078

5.3.4 Respirometry trials - presentation of main results
Below, oxygen consumption was profiled as a function of time. The relationship of
substrate/biomass studied is 40 mg soluble COD/g VSS. They also studied the impact of ATU
and the addition of permeate in different proportions in the filtered effluent.
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The data obtained for the first trial is plotted in Figure 5.11 below
Respirometric test

endogenous
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-m—Current

effluent
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Figure 5.11 : Plotted data from first trial on respirometer showing endogenous respiration, current effluent, airrent
effluent with ATIJ to inhibit nitrification and 8.2%permeate added to airrent effluent.

The slope of this graph represents the oxygen consumption rate for each of the four scenarios.
The data in Figure 5.11 above is exploited to produce Figure 5.12 below which plots the slope
mg02/mg VSS.h against time.
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Figure 5.12 Exploitation ofresults from first Respirometric trial

In order to guarantee the reliability of the above results, reproducibility tests were carried out
twice and the results are shown below.
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Respirometric test
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Figure 5.13 First repeat respirometry trial

Figure 5.14 Second repeat respirometry trials using multiple effluent samples containing 8.2%permeate by volume

Comparing figure Figure 5.13 with Figure 5.14, the curve profiles are very similar. Also looking
at figure 5.13, where multiple samples were trialled with Lilly effluent and 8.2% Tilmicosin
permeate, the curves are almost identical. In summary the respirometry trials are repeatable.
Referring to Figure 5.13, it can be concluded that there is very little nitrification occurring in this
trial as there is no notable difference between the slopes or curves for the filtered effluent and
the filtered effluent with ATU.
The profile of oxygen consumption of the mixture of 8.2% permeate in filtered effluent is the
same as that of the effluent alone with the same rate of oxygen consumption. However, it was
observed that the peak zone is slightly lower than that observed for the effluent only (see
Figure 5.15 below). It is concluded that the addition of 8.2% of permeate in the effluent had no
harmful effect on the biomass but that the biodegradable part was very slightly lower. It is also
important to specify that addition of permeate to the effluent leads to an increase of soluble
COD (2,468 mg O2 / L instead of 1,805 mg O2 / L).
On the graph, a rapidly biodegradable section and a section that is biodegradable with greater
difficulty was observed. In effect the return to endogenous respiration is not immediate.
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Respirometrv test
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Figure 5.15 - Respirometric trials on different proportions ofpermeate in the effluent

5.2.5 Main conclusions of the respirometry trials
The addition of Tilmicosin permeate to the current effluent from the WWTP is not inhibitory up
to 15% volume of permeate to current effluent. Tilmicosin is slightly degraded by the activated
sludge. The degradation, even if slight, is a plus to the project as the more API that is degraded
or destroyed, the lower the levels of API going into the environment. In summary, there should
be no issue with sending the permeate from any full scale Tilmicosin plant to the WWTP.
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Summary
The first round trials using the Koch PP02 on Tilmicosin had shown that the waste could be volume
reduced by 75% and that API rejections were good and indicated that the resulting API in the
permeate would be below the LAEG for Tilmicosin. However before a decision could be made on
building a fullscale tilmicosin plant, thal repeatability needed to be shown at pilot scale. Also some
further design information was required to gain confidence in scaleup design for a potential full
scale membrane plant. The resulting goals of the Tilmicosin second round trials were as follows:

•

To evaluate the variability in the composition of the bulk waste produced from the Tilmicosin
process.

•

To assess how this variability would affect the performance of the membrane plant.

•

To gain a better understanding of what physical parameters (mainly composition also more
information on pressure, temp etc) mainly affect membrane performance.

•

To consistently achieve at least a 75% volume reduction for the repeat trials

•

To show that it was possible to consistently operate significantly below the Tilmicosin LAEG

•

To carry out trials requested by Koch that were required for full scale design purposes

The first section of this chapter looks at the preparation work that was required for the trials and
also how the trials protocol was generated. The trials are then discussed as they happened and
then the main findings are summarized. The important findings relative to initial goals and what was
important to ensuring the efficient operation of a full scale plant are then discussed
The variability in waste from the Tilmicosin process is summarized in Table 6.2. This variability
appeared to have little effect on the performance of the plant as a volume reduction of at least 73%
was achieved for all the standard concentration trials carried out. However, variability in feed waste
became relevant when it was discovered that a second pass would be required to ensure that any
full scale plant would be operating sufficiently below the Tilmicosin LAEG. This was due to in some
cases higher levels of API in the feed to the membrane plant which resulted in relatively higher
levels of API in the permeate
The cleaning volumes of the plant were also optimized and taking the necessity fora two stage
plant into account, it was shown that the overall achievable volume reduction for the process would
be 60%.
The rejection of the membranes were analysed before and after the trials and It was found that the
rejection had fallen off. An autopsy was also carried out on the membranes and scratches were
found on the membrane surface. In addition, some small pieces of metal were found on the
membrane. The presence of these metal pieces were linked back to the modification work that was
carried out on the membrane plant to increase the plants capacity for this second round of trials.
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Long term stability trials were also carried out on the MPS-44 membrane. This w/as done by
carrying out a standard glucose rejection test on a MPS-44 membrane disc, submerging the disc in
Tilmicosin waste for approximately 12 months and carrying out a glucose rejection test again after
the period of submergence. The results showed no deterioration in the membrane rejection or
integrity.
In addition colour analysis was carried out on the permeate and it was shown that there is some
potential to correlate colour in the permeate with API levels which, at full scale, would be useful
when monitoring the API levels in the permeate
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6.1 Preparation for Trials
6.1.1 Collection of waste
To maximize the effectiveness of these trials, a representative bulk waste needed to be collected
from the Tilmicosin process in a 24 hour period.
The following system was designed to collect representative bulk waste. The design is very simple
but efficient and practical. This waste collection system is illustrated in Figure 6.0 below

At the time of the design, the existing waste collection process from Tilmicosin was that all
secondary waste, as it was produced, was sent to T65 which is the secondary waste day tank for
the Tilmicosin production building. This tank operates on a constant recycle which helps to keep the
contents of the tank agitated. The automation on the tank is set up so that the tank begins pumping
to E.C. (by opening the E.C. actuated control valve) when the volume in the tank reached 40% of
the total tank volume. Pumping to E.C. stops when the level in the tank reached 15%. (note . it was
possible to change both of these set points on the DCS control interface). Recycling and pumping
to E.C. is achieved by using 2 pumps P65a and P65b. The two pumps work with one pump on duty
and the second on standby.
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The sampling system design involved bleeding off a line from the exit line on T-65 that transports
waste to E.C. at some point after the recycle on that line. This bleed line was fed into a temporary
Tilmicosin waste collection tank which was a 225L stainless steel drum. The collection drum was
mounted on a pallet and located in a bunded area. The stainless steel drum was fitted with a high
level transmitter that would close an actuated valve on the bleed line once the high level was
reached, thus minimising the risk of the drum overflowing. A manual isolation valve was also
installed on the temporary line. This isolation valve was useful at weekends when the collection
drum was not in use and also when it was being changed out. Two temporary collection drums were
used for the trials, once one drum was full, it was removed and transported to the pilot plant, it was
then replaced with the second drum wtiich commenced filling and would fill roughly in a 24 hour
period again and be ready for change out for the next trial.
The control valve and level transmitter were actuated. This sampling apparatus was removed again
at the end of the trials.

6.1.2 Sizing pipe for Tiimicosin waste coiiection mechanism
The temporary bleed line for the temporary Tilmicosin sampling unit needed to be sized. The sizing
calculation was carried out as follows :
The batch cycle time for Tilmicosin is 20 hours. There are seven waste streams produced in
Tilmicosin therefore on average in a 20 hour period, seven waste streams would be produced.
The secondary waste produced in Tilmicosin was averaged for 16 lots [44] and the results are
shown in Table 6.0.
Table 6.0: Averaged Tilmicosm waste for 16 lots ofproduction

T12 decant
T24 decant
T24 1st wash
T24 2nd wash
T24 3rd wash
T6A distillate
T40 seal water*

portion of
In
kilograms Percentage 192 litre
or litres
sample (L)
of total
35
3647
67
1407
26
13
754
7
14
796
8
15
844
8
16
1288
12
24
1700
16
31

The sizing method needed to be based on one of the seven waste streams and it was decided to
base it T12 decant stream since it was the largest waste producer in the process.
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Figure 6.1 : Historian graph illustrating the weight in T12 and the level in 765 on 30'08/2004

From the historian graph shown in Figure 6.1, the green line represents the weight of T12 and the
blue line represents the level in T65. It took 24 minutes to pump out all of the T12 decant stream.
The amount dumped from the T12 decant was 3640L. For simplification it was assumed that the
T65 level was 20%. Of this 3640L, 70 L needed to be bled off in the same period. The required
flowrate would be 0.048L/sec. Assuming a 14” pipe was used, the fluid velocity would be 0.11 m/s. A
fluid velocity of 1-3 m/s is generally recommended. The purpose of the lower limit is to protect
against suspended solids dropping out and clogging the pipe. This would not be an issue for the
waste stream. In addition, valves would also be fitted to the line in the future, at least a 14" pipe was
required.
Note : the time taken to Wl T65 (and therefore for pumping out to commence) was neglected in
these calculations for simplification. The 800L volume (to fill T65) is small in comparison to the 3640
L dumped.

6.1.3 Pre-trial discussions
A general email on the forthcoming trials was sent to a Lilly Toxicology expert, a Lilly WWTP expert
and a Lilly Separations expert. The purpose of this email was to allow Lilly Global Headquarters to
make any suggestions or modifications to the proposed trials protocol in advance of the trials. The
responses to the email are summarised as follows ;
The toxicology expert had some general questions on the project e.g. the pore size of the
membranes, the solubility of the API in amyl acetate, what parameters were going to be measured
during the trials and how the plant size was going to be assessed. All questions were answered
satisfactorily.
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The waste water expert also had some general questions e.g. (1) would the plant be processing all
the secondary waste produced from the Tilmicosin process (2) would there be any other
constituents in the waste stream that may be of concern to the operation of the WWTP (3) was the
possibility of analyzing inhibition of sludge due to the API present being considered. Again, these
questions were answered satisfactorily.

In addition, a conference call was held with the separations expert prior to the trials. The highlights
of this meeting were as follows :
Up until this point, there was no attempt made to quantify the number of repeat trials that would
need to be carried out. A ballpark figure of 20 trials was proposed as this was the number of trials
that could comfortably be carried out within the allowable timeframe. Mr. Abhinava suggested
contacting a Lilly statistician in the U.S. in an attempt quantify the number of trials based on valid
results from the first round trials. In light of this meeting, two Lilly statisticians based in the U S.
were contacted and a conference call was arranged.

Based on the experience from the first round Koch trials, Mr. Abhinava also suggested looking at
the possibility of cleaning only after some runs when the flux has dropped below a set value of say
75% the original flux. In other words, the plant is only flushed after each run and if the flux is still
above 75% of its original value, the clean is discontinued. Based on the findings from the Koch first
round trials, the expectation on this proposal was that given the nature of the residue forming, the
flux would drop below 75% after each run. However, this suggestion would have more relevance if
the plant were operating in two stages where the permeate from the first stage is fed to the second
stage. In this case the level of fouling in the second stage should be much less.

6.1.4 Statistical analysis
A conference call was held with a Lilly statistician(Sethuram, S) in the U.S. The basis for any
statistical calculation was limited as there was a limited amount of relevant information available
from the first round trials (the objectives of the first round trials did not encompass collecting large
amounts of statistical data for second round trials - they were merely proof of concept trials). All the
relevant background information for the project was forwarded to Lilly’s Statistician. The useful
sample data from the first round trials is shown in Table 6.1 below.

131

Chapter 6 Second Round Trials on Tilmicosin

Table 6.1 Useful data for statistical analysis on second round Koch trials from first round Koch trials.

Run
3
8
6
9
10

Bulk
Permeate
Relative
API Bulk
API Bulk
Relative
feed
Volume
Permeate concentration LAEG (1
LAEG (2
concent ratio Reduction Concentrati that equals
process
process
on (ppm)
Description
n, ppm
production) production)
(%)
LAEG
Tk 24 decant unknown
75
22
1430
0.015
0.031
Tk 24 3'*"
14,141
80
273
1341
0.204
0.407
wash
Tk 24 decant
2,904
89
160
1205
0.133
0.266
Tk12 decant
53
2024
7,623
633
0.313
0.626
Blended
9,464
83
216
0.167
Tilmicosin
1292
0.334

The statistician explored the performance of a one sample t-test with varying sample size. Taking
into account that (API Bulk Concentration)*(Final Permeate Volume) should be less than 12.87 kg*,
he considered the scenario where he wanted the MeanO (i.e. the mean of the process) to be less
than some fraction of the LAEG, say from 0.3,0.4, 0.5, 0.6, 0.7. Note: this calculation assumed that
a 10,000 L scale applies, the calculation could be revisited for a different sized batch volume.
One way to judge the performance of a statistical test is to explore its power. In this case, the power
of the test is the ability to detect differences between the process mean and a hypothesized
alternative which will be a fraction of the LAEG. In Figure 6.2, the relationship between Power and
N (i.e the sample size) for various Meani (i.e, a fraction of the LAEG) is plotted.
*Note: After the second round Tilmicosin trials had commenced, it was discovered that a critical
environmental parameter was giving an inaccurate reading. The parameter was reading 1.26 times
higher than the actual value. As a result, all LAEG’s were officially reduced to 0.793 times their
original value. For all other sections of this project, the LAEG’s were altered to their new value.
However, for this section, the LAEG is assumed to be 12.87 kg/day (as opposed to the new value of
10. 02 kg/day). This is to illustrate the real time decision making process that was undertaken as the
project progressed in relation to statistically deciding on the number of trials to be carried out. Given
that the LAEG is still 0.793 times its original value, the affect of the falsely high LAEG should be
relatively small for this calculation given that it is planned to operate well below the LAEG at full
scale. It should be noted that the results for the second round trials were also calculated using the
new LAEG value of 10.02 kg/day.
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Figure 6.2 Illustration of relationship between power and sample size (N) with various means (meant) for lAEG
statistical analysis

In general, the higher the power, the better the test will be able to detect differences in means. It
appears that for a sample size of 15 and greater, there is no improvement in Power for any Meani.
Therefore, the statisticians recommended using 15 as the sample size.
They suggested spreading the trials out over many weeks in order to capture as much process and
assay variation as possible in order to get a good estimate of the process mean and variance i.e. no
more than three trials a week for five weeks might be a possibility.

6.1.5 Pilot plant hazop and safety checklist
A hazop and safety checklist had already been carried out for the first round pilot trials on the Koch
pilot plant. This hazop was reviewed and the safety checklist was updated for the second round
trials. For example, the electrical installation of the pilot plant was again checked (see Appendix E).

6.2 Carrying out trials
6.2.1 Introduction
The main conclusion from the first round PP02 trials on Tilmicosin was that a blended waste feed of
Tilmicosin waste could be volume reduced by 75% and that an API rejection of approximately 95%
was possible using the MPS-44 membrane.
Any full scale membrane plant would have to operate dynamically in that the Tilmicosin waste would
be collected in a 24 hour period and this batch of waste would be sent on to the membrane plant
where it would be batch processed. Also at any one time, there would be approximately 3 batches
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Tilmicosin running in the IE3 production building. In addition, the composition of the waste
produced in any 24 hour period may vary considerably. For example a case could occur where 2
streams of T12 waste and 2 streams of T24 waste would be produced and no other stream would
be produced. This would be a worst case feed to a membrane plant. Alternatively, a number of the
more dilute waste streams could be produced with one or maybe none of the T12 and T 24 decant
streams produced (see Appendix K for examples of each case).

Of

As a result, the blended stream used in round 1 trials may not have been a very accurate
representation of the waste collected in any 24 hour period. This variability needed to be assessed
aswell as the impact of this variability on the achievable volume reduction and API rejection. As a
result, it was logical to carry out repeat trials on different waste samples collected in individual
24 hour periods.
The previous set of trials on PP02 were carried out using a 301 feed tank. After discussions, it was
decided that it would be worth carrying out trials using a larger feed tank. Even though a 30L feed
tank was used for the PP02 first round trials, up to 80 L of feed were processed in a single run. This
was achieved by adding 30L of feed and more feed was added to the feed tank when the level had
dropped substantially. Given that any full scale plant is likely to operate in batch mode, it is a closer
representation of how a full scale plant would operate when the desired volume was fed to the plant
at the beginning of each run as opposed to adding segments of waste as the run proceeded. Also
to increase the possibility of obtaining funding for a full scale plant, it was felt that a pilot plant with
as large a capacity as possible would be preferred. The logic here was simply the larger the pilot
plant, the more assured the company would be that the plant would work efficiently at full scale.
Modifications were therefore made to PP02 to improve its capacity. A new feed tank was fitted with
a 225L capacity. A second membrane module was also fitted which doubled the plant’s processing
capacity. A photograph of the modified rig is shown in Figure 6.3. The newly fitted feed drum is
shown on the left hand side of the pilot plant. The two membrane modules are the horizontal
cylinders on top of the plant. The two vertical tanks at the back of the plant are the original feed and
permeate tanks (30L capacity each).
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Figure 6.3 : Modified Koch pilot plant for Koch second round trials.

6.2.2 Deciding on trials protocol
Initial trials would be carried out to gain some design information for a potential full scale plant. This
was done during the first week. The remaining trials would be set out so as to satisfy the remaining
goals above. This meant carrying out a number of repeat trials on many batches of waste. After the
first week, given the average fluxes obtained from the plant, it was decided to process 100L of
waste per trial. This was because the flux rates would only allow 100L to be processed in an 8 hour
period. From the statistical analysis, it was estimated that 15 repeat trials would be sufficicent.
However, the number of repeat trials required would also be influenced by :
•
•

•

Low feed variability from trial batches would minimize the number of required trials.
Reduced volume reduction (less than 75%) was a factor that could not be designed against.
If the target volume reduction was not achieved, an economic decision would be made
whether to go ahead with full scale or not. It was worth noting that the return from a full
scale plant should still be rapid even at say 50% volume reduction (see section 6.7 for
economic review)
Being well below the LAEG would also minimize the number of trials that would need to be
carried out. At this stage it was also suspected that the level of API in the feed influenced
the final bulk permeate API concentration.
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In addition other points of interest also needed to be investigated. There was always a concern that
a 2 stage membrane filtration may be necessary to achieve the desired low levels of API
concentrations in the effluent to the waste water plant. The necessity or otherwise for some
permeate trials would emerge as the results of final bulk permeates came back from some of the
standard concentration trials as the project proceeded.
There was also the possibility that some of the washings from the plant could contain high levels of
API that would need to be reprocessed in subsequent batches at full scale. Again the necessity or
otherwise would emerge as API concentrations in cleaning samples started coming back from the
standard concentration trials.
The effect of operating an entire batch at a higher temperature was still an unknown and it was felt
that there may be value in carrying out a standard concentration at higher temperature and to
compare these results to other standard concentrations
The initial trials protocol is summarised as follows :
Trials 1 to 4 were design trials ;
• TriaM - Temperature and pressure excursion on a volume reduced sample
• Trial 2 - Feed and Bleed simulation
• Trial 3 - Flux decay trial on a volume reduced sample
• Trial 4 - Permeate concentration trial
Trials 5 to 25 would be standard concentration trials with the possibility of permeate trials, trials with
feeds including cleaning from previous trials and the possibility of running a trial at high temperature
being included here.

6.2.3 Procedure for standard concentration trials
A procedure was laid out for the standard concentration trials. The procedure was as follows :
•

A feed sample would be collected from the exit line on T65 and brought to the pilot plant
area

•

The conductivity and pH of this sample would be recorded and measured.

•

A 100ml sample of the feed would also be taken.

•

100L of the feed sample would be added to the pilot plant feed tank, the agitator will be
turned on and the plant will be placed on full recycle. The volume of feed added to the feed
tank aswell as the level of feed in the feed tank should be noted.

The pH of the feed would be reduced to 6.5 using nitric acid. The conductivity of the feed
would again be measured. Again a sample of feed would be taken.
The concentration will be started by increasing the inlet pressure to 35 bar and rerouting the
permeate to the permeate collection tank ( From first round trials, the higher the pressure
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the greater the average flux, 35 bar is the maximum recommended typical operating
pressure for the membrane therefore the plant was logically run at 35 bar)
Intermediate samples of the concentrate and bulk permeate will be taken at set volume
reductions namely 20, 40, 50, 60, 65, 70, 75, 80 etc. The pH of the feed will be monitored
throughout the run and nitric acid will be periodically added in to maintain the pH at 6.5. The
conductivity of the concentrate and permeate at volume reductions above will also be
measured. The temperature of the feed will be allowed to rise to 20‘’C and it will then be
kept constant at this value.
The run should be terminated when the volume reduction reaches 90% orwhen the flux
drops to 2 Imh.
Samples of the final concentrate and final bulk permeate will be taken. The level in the feed
tank as well as the volume of permeate collected will be noted. The conductivity of the final
concentrate (FC) and final bulk permeate (FBP) will also be measured. Feed samples and
final bulk permeate samples will be sent for API analysis.

Cleaning the plant
•

The plant should be drained down fully and the drained material should be sent for
secondary waste disposal.

•

A minimum volume of flush water will then be added to the pilot plant and a high velocity
flush should be carried out

•

This should be repeated on a few occasions. Prior to commencing each flush, the clean
water flux (CWF) should be measured. This will give an idea of the number of repetitions of
this flush that need to be repeated. Samples of the flush being sent to drain should be taken
every 30 seconds. These samples will be sent for API analysis. The idea here is that if the
API levels are substantially low enough, these segments of wash could be sent directly to
the WWTP

•

Hot water at 50°C and low pH (not less than pH 2) will then be added into the pilot plant
and the plant will be placed on full recycle for 20 minutes. Take a sample of from the feed
tank once the 20 min has elapsed and then drain the plant again.
A final flush will again be carried out in a similar way to what has already been described.
Again samples will be taken.
Towards the end of the trials it would be expected to have API results back on the
concentrations in the different constituents of the wash. After interpretation of these results,
for the latter runs towards the end of the trial, we will reintroduce the volumes of wash (from
one run) that are high in API back into the feed tank (for the next run ) in an attempt to
practically demonstrate how the volume of wash water required for disposal can be
minimized.
137

Chapter 6 Second Round Trials on Tibnicosin

Note (1) cleaning volumes for each section of clean would be measured and recorded.
Note (2) if the CWF has recovered to 80 % of the initial CWF, the clean will be terminated. The idea
here is to minimize the volume of cleaning water being used in each run
6.2.4 Summary of trials that were carried out - including how trials protocol changed due to
results coming back
In total 25 trials were carried out. The first four trials were trials requested by Koch. Trials 5 to 17
and trial 21 were standard concentration trials. Trials 18, 22 and 25 were permeate reprocessing
trials where the permeate from previous runs was reprocessed to give an extra pure final permeate.
These trials were deemed necessary as the trials proceeded. Some of the results coming back for
API levels in the final bulk permeate were high. In some cases the API in the final bulk permeate
was twice the LAEG. It became obvious that any full scale plant would need to be a 2 pass plant
where the feed would be filtered across a membrane and the resulting permeate would be filtered
again across a second membrane. The main disadvantage of this is that the overall volume
reduction is slightly reduced ( by less than 5% ). Trials 19 and 20 used 95L of raw feed and 5L of
cleaning feed from a previous trial to simulate a likely scenario at full scale where approximately 5%
of the feed volume was made up of cleaning wash from the previous trial. Trial 23 was a standard
concentration trial carried out at high temperature. During the trials, it was suspected that the API
concentration in the feed was the dominant influence on the rate of drop off in flux and therefore the
achievable volume reduction. Run 24 was carried out to validate this theory. If the assumption was
correct, it should be difficult ( and maybe impossible ) to volume reduce by 75%. Towards the
beginning of the trials, there was some concern that the API rejection may be significantly altered at
higher temperature and it was decided to carry out one of the standard concentration trials at higher
temperature, namely trial 23.

6.2.5 Description and discussion of trials
Table 6.2 summarises the main results from the second round trials. Each type of trial are now
described and discussed.

Design thals (trials 1 to 4)
Thai 1 - Temperature and pressure excursion on a volume reduced sample
The temperature excursion trial would give information on the optimum temperature to run the full
scale plant at. The temperature of the feed entering any full scale plant is controlled by a heat
exchanger. For this trial, 187L of feed was fed to the pilot plant feed tank. The fluxrates achieved
from this feed were relatively low ( started at 4.5 Lmh ). The volume reduction achieved in a single
days operation of 8 hours was 9 percent and as a result, this trial had limited analytical data value.
A limited pressure excursion was carried out at the start of this run . As a result, all subsequent trial
feed volumes were limited to 100L.
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Trial 2 - Feed and Bleed simulation
The membrane area required, which gives the general size of the housings for the plant, are
calculated from the average flux rate required for the full scale plant. The purpose of this trial was to
provide a constant feed concentration to the plant which should give a better indication of the
average flux rate that would be required per batch run of Tilmicosin.
60L of feed was added to the pilot plant and the concentration was started once the pH had been
reduced to 6.5. The feed was volume reduced by 50% and feed was subsequently added in 5L
increments whereby the feed tank volume increased to 35L and permeation was allowed to proceed
until the permeate tank volume had dropped to 30L again. This process was repeated 8 times (i.e.
eight 5L inaements were added in total). The concentration was allowed to continue after all the
increments were added and the feed was concentrated until the feed tank volume was 20L (which
represents an overall volume reduction of 76% \Mien the holdup volume of the tank is taken into
account)
Trial 3 - Flux decay trial on a volume reduced sample
The purpose of this trial is to provide information for the pressure requirements for the full scale
plant, namely what feed pressure was required for the plant and what final pressure was required
for the plant. In essence this trial was a standard concentration trial whereby the feed was
concentrated and a flux decline versus VCF curve was drawn. The information obtained from this
trial is primarily the required starting pressure for the run and the required alteration in feedside
pressure as the run proceeds. From the results from the first round trials it was expected that the
required inlet and outlet pressures would be dose to the maximum allowable operating pressure of
40 bar (recommended operating pressure is less than max pressure i.e. doser to 35 bar is
recommended ). 100L of feed were added to the pilot plant and this feed was concentrated to a
VCF of 3. The plant was then placed on total recycle for a period of approximately an hour and a
half and the flux did not notably decrease in this period. The concentration was recommenced and
a final VCF of 4.29 was achieved.

Trial 4 - Permeate concentration trial
As a precaution for this trial, Koch wanted to reprocess the permeate from previous runs. The
results from the first round Koch trials indicated that the plant would be operating well below the
LAEG with a single membrane. However, it could not be ruled out that all samples processed in the
round one trials were lower than the average API concentration. Koch wanted to show that if needs
be that it would be possible to achieve the desired volume reduction in a 2 stage membrane plant.
All the permeate from runs 3 and 4 were mixed and fed to the membrane plant and processed. This
feed easily permeated. The initial flux was 11.25 Lmh and it dropped off to 8 Lmh the end of the
run. The feed was volume reduced by 84% and this could have been pushed further if necessary
given the high final permeate flux. As mentioned already as the trials proceeded, the permeate
results from the standard concentration trials indicated that a two stage plant would indeed be
necessary.
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Standard concentration trials (trials 5 to 17 and run 21 )
The purpose of the standard concentration trials was to show that it was possible to consistently
achieve the desired volume reduction of 75% and also that it was possible to operate consistently
and significantly below the LAEG.
For each of these trials, a volume reduction of approximately 75% was achieved. The lowest
volume reduction achieved was 73%. All other trials achieved 74% or higher.
In addition, the concentration could have been pushed further for each trial if time had permitted.
Any full scale plant will be over designed to ensure that there is enough membrane area to
process a batch of waste in the required time of 24 hours.
The relative LAEG was also calculated for each of these trials. This figure would indicate where a
full scale plant would be operating at relative to the LAEG for Tilmicosin given the API
concentration in the final bulk permeate. The initial goal at the start of the project was to operate
at 10% of the LAEG i.e. a relative LAEG of 0.1. Looking at the results from these trials, the API
concentration in the permeate was much higher than 0.1 LAEG. In some cases operation was
actually above the LAEG. For run 9, the relative LAEG was 1.99. A single pass would therefore
not give a good enough rejection given the high levels of API in the permeate. A design
incorporating a second pass would be required.
Permeate runs (trial 18. 22 and 25)
To simulate a two pass system at pilot scale, permeate was collected from two runs (to give a
large enough volume ) and this permeate was then processed through the pilot plant again as a
separate trial. This resulting “double filtered” permeate would represent the final bulk permeate
from the trial. The disadvantage of a two pass system at full scale is that the volume reduction will
be slightly reduced ( by less than 5% ). Runs 18, 22 and 25 were “permeate” trials. Each of these
trials used the permeate from the previous 2 trials as a feed.

Other points of interest from the triais
API concentration as the overriding factor controlling the achievable volume reduction (trial 23)
As the trials proceeded, it was suspected that the API was fouling the membrane and that this
was the main permeate flux controller for the process ( more so than osmotic pressure ). This
was based on the sticky residue found in the concentrate in the first round Koch trials which was
shown to be essentially API. It was decided that a large volume feed trial (run 24) would be
carried out. If the theory was correct, the permeate flux should fall off to a value similar to the end
point of the other trials i.e. 2 Lmh. This could occur possibly well before a 75% volume reduction
was achieved. Unfortunately this was one of the trials where the API concentration in the feed
was unusually high and as a result, only 62L of permeate was obtained (at this stage the flux was
so low i.e. 1.38 Lmh, that the trial had to be terminated). However, this trial did show that the
achievable volume reduction was dependant on the API concentration in the feed given the
dominant effect of the high API feed concentration. Unfortunately, time constraints on the trials
did not allow this theory to be investigated further.
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High API concentrations in some of the feeds
The concentration of API in the feed for runs 23 and 24 was a lot higher than for all the other
runs. The API concentration in the feed for run 23 was 69,649 ppm and for run 24 was 58,647
ppm. The next highest feed API concentration was 14,015 ppm for run 9. Having talked to IE3
production personnel, some Tilmicosin product that did not meet the quality specifications was
dumped into the secondary waste tank on the day that this particular waste sample was collected
for membrane trials. This was a very rare occurrence and it was the only time that it happened in
2004. In addition, IE3 production personnel decided that any future batches of Tilmicosin that
needed to be dumped would not be sent to secondary waste.

Ootimisino the cleaning of the plant

Koch suggested a cleaning method which is given in section 6.2.4. Trials commenced by using
this method. In reality, this suggested cleaning protocol is generic and may not be the best
protocol for this particular membrane feed and membrane. As the trials progressed, different
combinations of flushes and acid recycles were trialled in an attempt to find the optimal wash
sequence. The cleaning was refined and the following sequence was arrived at;
The plant should be drained and the drained material should be sent to secondary waste. A
minimum volume of water at 50°C and pH 2 should be fed to the plant. This water should be
recycled for 20 min before draining the plant. It was found that his recycle sequence may need to
be repeated more than once.
The main contributor to membrane fouling has been identified as the API itself At low pH (below
pH 5.8), the API is almost infinitely soluble in water. Therefore a minimum volume of water to
dissolve the API should be enough to bring the flux up to a reasonable value. It was suspected
that even if this had to be repeated more than once, the cleaning volume required relative to the
batch volume would be small. The required cleaning volume would be largely dictated by the hold
up volume of the full scale membrane plant. There may also be merit at the end of each clean in
flushing a minimum volume of water through the plant to displace any remaining recycle wash
that may still be held up in the plant.

Simulating a recycled clean at full scale (trials 18 and 19 )
Cleaning samples were sent for API analysis from some of the earlier runs. In light of these
results, it was apparent that the recycled acidic washes would need to be reprocessed given their
high API concentrations. It would be possible for the subsequent flushes to be sent directly to the
waste water treatment plant. Therefore for full scale operation, the recycled cleaning stream from
any batch could be incinerated or else fed to the next batch of waste to the membrane plant.
Given the high API levels in this cleaning segment and the relatively small volume, it is likely that
incineration would be the better of the two options. At full scale, the relative volume of cleaning
recycle to fresh feed should be no more than 5%. Runs 19 and 20 were carried out using 95L of
fresh feed and 5L of recycle wash from previous runs. A volume reduction of 75% was achieved

142

('hapter 6 Second Round Trials on Tilmicosin

for run 19 and a volume reduction of 80% was achieved for run 20. It is also worth noting that run
20 was carried out at lower pH ( mistakenly the pH was reduced below 6). At lower pH, the flux
rates improved greatly but the API rejections decreased.

High temperature standard concentration trial (trial 23 )
Towards the beginning of the trials, Koch were concerned that the API rejection may be
significantly altered at higher temperature and they requested a standard concentration trial be
carried out at higher temperature. The feed for run 21 was heated to 20“C and the temperature
was allowed to drift up to a final value of 29®C at the end of the run. The overall rejection for this
run was 0.955 which is close to the mean rejection of the membrane. Therefore in conclusion, the
effect of temperature on the overall rejection was limited. A comparison is shown in Figure 6.4 of
fiux decline versus VCF curves from a standard concentration run at unadjusted temperature and
for run 21 where the temperature was deliberately increased. From figure 6.4, it can be seen that
the difference between the curves is minimal.

Flux decline versus VCF curves for standard temperature and
high temperature runs

VCF
Figure 6.4 Flux decline versus VCFfor high and standard temperature runs

6.3 Summary of trial results and discussion
In summary, 25 trials were carried out and they were as follows :
•

4 scale-up trials

•

14 standard concentration trials

•

1 standard concentration trial carried out at high temperature

•

3 permeate trials
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•

1 large volume 150L concentration trial
2 trials using 5L of wash from the previous trial and 95L of fresh feed

Some of the main findings are summarised in the following sections

6.3.1 Membrane rejection
The overall rejection for the MPS 44 membranes was relatively constant ( with an average
rejection of 0.956 ) for the duration of the trials. The rejections are illustrated in Figure 6.5 below.
All but two of the rejections were higher than 0.94. The rejection of run 20 was 93.8. This run was
carried out at lower than normal pH. It is unclear what exactly happens the API at reduced pH. It
may be the simple case of the API becoming more soluble and as a result, more of the API
passes across the membrane. It may also be the case that the API breaks up into two or more
smaller molecules which pass across the membrane with greater ease. It is known that the API is
much more soluble in water as the pH is deaeased, however, there is no information on whether
the API breaks into smaller compounds or not at lower pH. The average rejection for the 24 runs
shown below is 0.956.

Overall API rejections for second round Koch trials

Run number

Figure 6.5: Illustration ofoverall API rejections for Koch second round trials
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The rejections of Tilmicosin and Desmycosin were individually evaluated and plotted in Figure 6.6
below.

Tilmicosin and Desmycosin rejections for second round trials

Tilmicosin
Desmycosin

Figure 6.6 Illustration of Tilmicosin and Desmycosin rejections for second round PPG 2 trials

From the graph it is clear that the rejections of Tilmicosin and Desmycosin are nearly identical for
every run. The rejection of Desmycosin appears to be slightly higher in every case with the
average rejections for Tilmicosin and Desmycosin being 0.954 and 0.957 respectively. This is
interesting given that the molecular weight of the Desmycosin is less than that of the Tilmicosin (
molecular weights are 868 and 756). It is noted that many research sources highlighted in the
literature review suggests that physiochemical interactions between feed solutions and
membranes influence the rejection of a particular compound by a membrane. These factors
include
•

the stereochemistry of each molecule

•

the charge interaction between each molecule and the membrane

The API rejection does not appear to have any correlation with API concentration in the feed as
illustrated in Figure 6.7. Here it can be seen that in some cases the API concentration of
Tilmicosin or Desmycosin can be higher than the other especially in runs 23 and 24 while the
rejection of the membrane remains relatively constant for these runs.
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Figure 6.7 : Feed concentrations of Tilmicosin and Desmycosin for second round PP02 trials

It appears that there is a general correlation between initial permeate flux and API concentration
in the feed as shown in figure 6.8. The possible correlation between conductivity and initial flux
was investigated and no correlation was observed. It would also have been useful to plot TDS
levels in the feed versus permeate flux rate. This would have given a better understanding as to
the change in TDS of the feed as each run proceeded and also the effect in the variation of TDS
for various runs. In reality, given that the number of samples that could be analysed was limited
with limited lab usage, the fact that the main criteria of the trials were investigated meant that
additional analysis although useful in understanding the finer points of the process, was not
practical. A correlation between TDS and permeate flowrate would also have helped in
understanding the effect of API concentration on the permeate flux. It was suspected that API
concentration in the feed and subsequent fouling of the membrane with API was the main
contributor to a decrease in permeate flux and the limits of VCF obtainable, more so than TDS for
the Tilmicosin process anyway.
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Figure 6.8 Illustration of relationship between API concentration infeed and initial permeate flux for second round
PP02 trials

6.3.2 Feed variability
The variability in feed concentration was considerable for each batch of waste produced. It
ranged from 3,186 ppm to 14,015 ppm. There was one feed sample which was outside this range
( approximately 70,000 ppm ). As mentioned already, this feed sample can be explained by a
dumping of substandard product to secondary waste when this sample was collected.
Achievable volume reduction to a large extent depends on the API concentration in the feed.
Ignoring the runs 23 & 24 with exceptionally high API levels in the feed, it was possible to achieve
close to 75% volume reduction ( based on the volume of permeate achieved relative to the
volume of feed ) for all the standard concentration trials over the range of feed API concentrations
and 65% for the simulated 2 stage process scenario.
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API feed concentrations Tilmicosin / Desmycosin (ppm)
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Figure 6.9 : Combined API concentrations in raw feed for second round trials

6.3.3 Necessity for a 2*stage process

As mentioned already, it was shown that any full scale membrane plant would need to contain 2
stages with the permeate from the first stage being fed onto the second stage due to the relatively
high levels of API in the permeate from the first stage. Figure 6.10 shows the relative LAEG’s for
all trials. It can clearly be seen that the relative LAEG is above 1 for many of the one stage trials.
Trials 18, 22 and 25 are the trials which were a two-stage membrane plant simulation. It can be
seen that the relative LAEG is well below 1 for trials 18 and 22 and the relative LAEG is just
under 1 for trial 25. It should be noted that the first stage feed for run 25 (namely the feed for runs
23 and 24) was an extreme worst case feed as discussed already in section 6.2.5. and it is likely
that a feed with this level of API would be routed to primary waste and not secondary waste but in
any case the plant is capable of delivering the required API rejection even if the overall volume
reduction was reduced (in relation to run 25 )
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Relative LAEG for second round Koch trials
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Figure 6.10: Relative LAEG for all trials for Koch second round trials

6.3.4 Overall achievable volume reduction
The volume reductions achieved for the standard concentration trials was between 73 and 75%.
For the permeate feed runs ( simulated two pass ) carried out, the volume reduction achieved
was between 86 and 90%. Assuming the lower values in both cases, the total volume reduction
for the feed would be given by :
Total volume reduction=(volume reduction in first pass)*(volume reduction in second pass) (volume required to clean the plant expressed as a percentage of total volume)
From these trials it was concluded that a single minimum volume acidic wash followed by a rinse
would be sufficient to clean the plant. From speaking to Koch engineers, the holdup volume of the
full scale plant should be of the order of a few hundred litres. Comparing this to the feed volume
per batch of 10,000L of feed, this gives a cleaning volume of approximately 3% maximum
The total volume reduction of the plant would therefore be
=(73%)*(86%)-(3%) = 60%
6.4 Determination of API levels in the plant permeate
For any full scale Tilmicosin plant, it would be important to be able to measure and monitor the
API levels in the permeate from the membrane plant. This would be important to ensure that the
API levels are at the targeted levels during normal operation and also to monitor the API levels in
the case of a breach in the membranes. It was initially expected that a membrane breach would
be seen as a change in pressure drop across the membrane bank and that a pressure transmitter
on either side of the membranes combined with some software would be sufficient to ensure that
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a breach would be detected. However the design of this system with its many membrane
modules means that a breach in the membranes may not be detected as a pressure drop aaoss
the membranes.
In normal operation, assuming that the API levels in the feed will not be higher than
approximately 15,000 ppm ( actual range from project was 3,186 to 14015ppm excluding runs 23
and 24 which were discussed already ) and that the membrane rejections remain constant, it
could be assumed that the API levels in the permeate would be well below the LAEG. However it
would still be useful to have online monitoring of the API levels. As discussed in the literature
review, conductivity cannot be said to correlate well with API levels in the permeate due to the
presence of other electrolytes in the permeate that would affect the conductivity reading.
Conductivity however could be used to indicate if a breach has occurred in the membrane as an
above average conductivity level in the permeate would possibly indicate a breach in the
membranes.
A second method that is suggested is the use of a colour detecting meter to infer the level of API.
During this project, it was shown that in general the colour in the Tilmicosin waste could be
attributed to the API levels. An experiment was carried out where samples were made up with
water and known dissolved levels of API. These samples are shown in Figure 6.11.

ItT
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50ppm

Figure 6.11 Tilmicosin in water solutions sent for colour analysis

These samples were made up varying from 50ppm to 5000 ppm of Tilmicosin which is in the
vicinity of levels that could be present in the permeate. Each sample was then sent for colour
analysis whereby the absorbance of electromagnetic radiation (which is a unitless quantity) for
each sample was measured. The maximum absorbance was obtained at a wavelength of 360nm
( which is in the ultraviolet radiation range at a slightly shorter wavelength than visible light). The
results obtained indicated a rough correlation between absorbance of light and API correlation as
shown in Figure 6.12 below.
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Plot of Spectrum Absorbance versus Tilmicosin
concentration for Tilmicosin in solution
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Figure 6.12 Illustration of the correlation between electromagnetic radiation absorbance and API concentration for
Tilmicosin in water solution

This method needs to be researched further. Many colour meters are available to buy and the
design team are looking into this as part of the membrane plant fullscale design

6.5 Membrane stability trials
6.5.1 Durability of the membranes
An autopsy was carried out on the membranes used in the second round trials on Tilmicosin. A
standard sugar rejection test was carried out on the membranes before the trials and again after
the second round trials. The sugar rejection results for the two membranes are shown in table
6.3.
Table 6.3 Sugar rejection results from second round Tilmicosin trials

Water flux

% Rejection
% Rejection glucose sucrose

Before trials
Membrane 1
Membrane 2

48lmh
481mh

98.7
98.3

98.9
99.0

After trials
Membrane 1
Membrane 2

33lmh
36lmh

90.3
80.1

91.2
81.3
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From these results, it was clear that the rejection of the membrane after trials had dropped
considerably. On inspection of the membranes, Koch found some dark spots. On microscopic
inspection of these spots, some surface scratches were found. In addition, some metal chips
were found on the membrane surface when the membrane was rolled out ( see Figure 6.13).
Feed to the membrane plant was always filtered using a 100 micron filter. As mentioned already
piping modifications were made to the pilot plant prior to the second round trials. These
modifications may also have introduced metal chips into the system. Looking at the API rejections
throughout the second round trials, the rejections were fairly constant varying from approximately
0.92 to 0.97. This would suggest that the damage to the membranes occurred either before {at
the beginning ) or after (at the end) the trials. The likely reason for the damage to the membranes
was that metal chips from the modifications to the membrane plant were circulated in the plant at
the beginning of the trials and that the damage to the membranes was caused at this stage. As a
safety precaution it would have been worthwhile to flush out the full scale plant a number of times
before any membranes were fitted to ensure that any metal c-hips e.t.c. had been flushed out of
the internal pipes.
This overall experience highlights the necessity of the prefilter on the proposed full scale
Tilmicosin plant to be running efficiently at all times and also the necessity to any full scale plant
with water without membranes in the system.
Mombrano

o

cliip.

o
Figure 6. ISA Membrane defect highlighted and Figure 6. IBB Metal chip identified
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6.5.2 Long term stability trials
As part of the first round Tilmicosin trials on the CF-1 unit, a Glucose Rejection Test was carried
out on a MPF44 membrane disc using a Glucose deionised water solution. The disc was then
submerged in a Tilmicosin T24 decant sample for 11 months ( 22 April 2004 to 23 March 2005 ).
After this time another Glucose rejection test was carried out on the same membrane disc and
the rejections were almost identical which shows that the membrane is highly stable in the
Tilmicosin waste streamV The main results of this analysis are shown in Table 6.4

Table 6.4 Results of Glucose rejection test carried out on MPF44 membrane that was stored in Tilmicosin
waste

Membrane stored from 22 April 04 to 23rd March 05
Glucose concentration
Permeate = 609 mg/I
Feed = 24,000 mg/I
Retention
23,391 mg/I
Rejection
97.46%

* note : similar trials were carried out using Atomoxetine HCI and Benzodiazepine HCl waste and
similar results were obtained

6.6 Recommendation for full scale Tilmicosin plant.
During the second round trials, it was recommended that any full scale plant should be operated
above pH 6 as at pH 5.8, Tilmicosin becomes infinitely soluble in the aqueous phase resulting in
a steep fall off in rejection. At this stage, a single stage plant was the most likely scenario for any
full scale plant. However as further results came back, it became apparent that a second stage
plant would be necessary to ensure that enough API was removed from the permeate stream.
However, what was not questioned at this stage was the need to remain operating above pH 6.
The results from trial 20 from the second round Tilmicosin trials suggests that operating at this pH
may not be entirely necessary. The main results from this trial are summarised in Table 7.0

' It should be noted that similar trials were carried out on the Ml’F-44 membrane discs using Benzodiazepine HCl and Atomoxetine
HCl samples and similar results were obtained.
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Table 7.0 Main results of low pH run (trial 20) carried out on Tilmicosin second round trials

API
concentration
that equals
API Bulk
LAEG for
feed perm Retentate Permeate Percentage Final production
cone cone. cone.
volume Flux on one rig Relative
Volume
Description
e£ml tPP>n]
reduction
Pmh]
LAEG Rejection
[L]
[pp"*]
Raw feed with
previous dean
at low pH
(approximately
4734 1097
IPH 4)

16861

80

0.80

4.50

1063

1.03

0.935

The final flux of 4.5 Imh was much higher than the standard final flux of approximately 2 Imh and
a volume reduction of 80% was easily obtained. In addition the relative LAEG was 1.03. From the
second round trial results the rejection of the membrane was found to remain relatively constant
irrespective of the feed API concentration. Therefore it could be assumed that if the permeate of
this trial were passed through a second pass, the relative LAEG could fall to approximately 0.3. In
addition, the maximum API feed concentration for these trials ( excluding trial 23 and 24 ) was
14,000 ppm. Assuming the same rejections for a feed of 14000ppm API, it is suggested that even
at this level of API feed, the relative LAEG may still be below 1. It may be worthwhile to run some
low pH trials at full scale if the volume reductions achieved at pH 6 are not entirely satisfactory.

6.7 Economic review of project
The final estimate of the overall cost of the membranes project is 3.1 million euro. This figure was
estimated from koch plant design and manufacture aswell as installation costs on site at Lilly.
The savings forecast from using the membrane plant are summarized as follows. The John Zinc
incinerator would be off line for 9 months from December 2005 to June 2006. The project
engineer estimated that from the period of March 2006 to June 2006, up to 1.85 million litres of
secondary waste would need to be disposed of off site. For simplification it was assumed that half
of this waste will be processed from March to June 2006 i.e 0.925 million litres of waste.
From looking at the production schedule forecasted for this period, the production of Tilmicosin in
IE8 and IE16 should have been approximately 233 lots. Assuming 10,000 litres of secondary
waste per lot, this gave 2.33 million litres of Tilmicosin secondary waste. Assuming that the
membrane plant only processes 3/4 of this waste, 1.75 million litres of Tilmicosin would be
processed by the membrane plant and assuming an average volume reduction in the membrane
plant of 65%, 1.14 million litres of waste would pass through the membrane plant and on to the
waste water plant. This was 1.14 million litres of waste that would not be sent for incineration. As
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a result, the 0.925 million litres of waste forecasted above for offsite disposal would not need to
be sent off site. Given that the cost of incinerating waste off site was estimated at 1 euro per litre,
this is an immediate saving of 0.925 million euro.
Looking ahead to the remainder of 2006 and all of 2007.
From July 2006 to December 2006, 115 lots of Tilmicosin were forecast for manufacture in IE8
and 37 lots are forecast for IE3. This gave a total of 152 lots of Tilmicosin. Assuming 10,000
litres of secondary waste per lot, 1.52 million litres of secondary waste would be generated within
this period. Assuming the membrane plant was fully operational within this period and an overall
volume reduction of 65%, 988,000 litres of waste would pass through the membranes and be
sent to the waste water plant. This represents 988,000 litres of waste that would not need to be
incinerated. The incineration project engineer estimated cost of incineration of secondary waste
on site was 20 cent per litre .This represented an incineration saving of 197,000 euro.
For 2007, 234 lots were forecast for production in IE3 and 230 lots are forecast for production in
IE8. This gives a total of 464 lots of Tilmicosin produced. Again assuming 10,000 litres of
secondary waste produced per lot, 4.64 million litres of secondary waste would be generated.
Again assuming a 65% volume reduction from the membrane plant, 3 million litres of waste would
pass through the membranes and sent to the waste waster treatment plant. This represented an
incineration saving of 600,000 euro.
The predictions for Tilmicosin production in 2008 and 2009 were 457 and 519 lots respectively.
Again assuming 10,000 litres of Tilmicosin secondary waste per lot and an overall volume
reduction of 65% from the membranes plant, the additional volumes of waste not being
incinerated but being sent to the waste water plant in 2008 and 2009 were 2.97 million litres and
3.37 million litres respectively and the saving on incineration was 594,000 in 2008 and 674,000 in
2009.

In summary, up to 2.97 million euro could have been saved on incineration by the end of 2009
which almost covers the original cost of the membrane plant.
Note : this calculation excludes membrane maintenance and running costs.
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7.1 Tilmicosin
7.1.1 Full scale Tilmicosin plant
It was successfully shown that a membrane plant could potentially volume reduce bulk Tilmicosin
waste by 60% including the wash volumes required for the membrane plant. In addition it was
shown that the bulk permeate produced from the membrane plant would contain levels of API that
were well below the allowable LAEG for Tilmicosin. As a direct result of the work in this project, an
order has been placed for a full scale membrane plant to source treat Tilmicosin secondary waste.
Since the production of Tilmicosin is set to double over the next few years, there is a possibility that
during some periods, Tilmicosin will be produced on two rigs at the same time. The full scale plant
is therefore being designed with the capacity to handle waste from two rigs at any one time. This
plant is to be located in IE14 and it is planned to have the plant fully operational by March 2006.

7.1.2 Recommendations for full scale Tilmicosin plant
As mentioned in section 6.7 it is recommended that some further trial work be carried out on the full
scale plant while operating at a reduced pH ( below pH 5.8 ). This trial work may lead to the
possibility of operation at a reduced pH and an increased overall volume reduction. To do this work,
a trial on a full scale batch could be processed by decreasing the feed pH to less than 5.8 ( and
above 2 ) and the API composition in the permeate could be analysed. This procedure could be
repeated for a number of batches to gain some statistical data on the API concentration in the bulk
permeate.
During these second round trials, the membrane plant was operated at a medium recirculation
flowrate. Operating the Tilmicosin membrane plant at a higher flowrate had the effect of slightly
increasing the average flux. It is recommended that the full scale membrane plant be operated at a
maximum recirculation flowrate so as to maximize the potential volume reduction. The additional
cost in the form of pumping costs should be relatively small but should be investigated.

7.2 Atomoxetine
The main problem identified in permeating Atomoxetine waste was the high levels of TDS in the
feed stream. The levels of TDS seemed to vary significantly from run to run and also for each of the
waste extractions.
Any future work on this waste stream would need to look at a method of reducing the TDS levels in
the waste prior to feeding the waste to a membrane plant. Electrodeionisation is a technology that
was identified to potentially reduce the TDS levels. Also, given the inhibitory and toxic nature of
MTBE, the solvent would need to be removed from the waste stream prior to being sent to the
WWTP. The simplest technique to do this is air stripping. Air stripping of a number of Atomoxetine
HCI waste streams was carried out throughout the trials and the efficiency was high enough to
remove MTBE to undetectable levels. The requirements for removing MTBE from larger quantities
of waste would also need to be investigated with respect to the equipment that would be required
and the residence time required in the stripping chamber.
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7.3 Benzodiazepine HCI
The MPS-44 membrane shows very little potential in treating Benzodiazepine waste. However, the
SR3 membrane showed potential in terms of achieving desirable API rejections and volume
reduction but the long term durability of the membranes is questionable.
It was noted during the trials that the API concentrations in the Benzodiazeine HCI feed were very
low to begin with. Some of these results are highlighted in Table 7.1
Table 7. / API analysis results of Benzodiazepine HCI waste

Benzodiazepine HCI samples sent to
Veolia
3rd wash sample
mother liquor sample
2nd decant sample

API (ppm)
12.6
52.2
40.9

In Appendix C, the relative LAEG for the secondary waste from this batch of Benzpdiazepine HCI
was calculated as 0.127
As a result, there may not be any need to remove the API from the waste streams going to the
WWTP. The levels of Tin in the waste are the main concern for the process as tin is inhibitory to the
biosludge even at levels of 0.4 ppm. The levels of tin in the Benzodiazepine HCI secondary waste
were estimated in section 3.1.3.2 as 0.2 kg per batch which approximates to 11 ppm per batch of
waste. Further dilution would occur in the WWTP but it is unclear whether dilution would be
sufficient. The high levels of solvent are also a concern for the WWTP, however, the MSDS for 3A
alcohol [45] suggests that 3A alcohol degrades easily and is not inhibitory or toxic to the WWTP.
Levels of chlorine in the waste are also a concern as chlorine is inhibitory to waste water plants at
10 ppm. From the Benzodiazepine HCI waste balance, the levels of chlorine in the waste streams is
relatively high and may easily exceed the lOppm level. It is unclear what form this chlorine takes in
the waste stream. Does it react with other species or does it remain free?. Ultimately a sample
would need to be sent for respirometry analysis to determine if there is any inhibition by this waste
stream. For any future work on the Benzodiazepine HCI stream, it is recommended that a detailed
sampling and API analysis campaign be carried out on the Benzodiazepine HCI waste over many
batches to asses the API levels and variability. It is also suggested that if API removal was
necessary a combination of membranes and electrodeionisation may provide a solution as an
alternative to incineration for Benzodiazepine HCI. The waste may be with an electrodeionisation
plant reduce the levels of TDS and subsequently fed to a membrane plant where the feed should
permeate much easier with lower TDS levels.
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7.4 Summary
The concept of treating watery waste by using membranes to remove the API has been discussed
for the last number of years by many leaders in the waste wayer treatment field. However, not until
now has a company been willing to carry out the necessary research to install a plant at full scale. It
is quite possible that a successful Tilmicosin plant at full scale will be a starting point for the
installation of similar technology on many Lilly production sites world wide. In addition other
pharmaceutical manufacturers have begun trials in this area. The success of this plant will also
mean that Koch may install similar technology on other manufacturing sites for the treatment of API.
With licence limits on allowable discharge limits decreasing for a variety of waste species, this
technology may prove very useful over the next number of years in meeting many of these
requirements.
Membranes have been identified as a potentially useful technology for treating aqueous waste at Eli
Lilly. To extend this technology to many different waste streams would require further investigation.
It is obvious that membranes would be a useful part of an integrated solution combining membrane
technology with other technologies as illustrated in Figure 7.0.

Watery waste
from production

Air stripping

Electro
deionisation

Precipitation

Coarse
Membrane
Filtration

<

Thermal
oxidiser

Membrane plant

WWTP
Figure 7.0 Illustration of membranes as part ofan overall solution for source treatment of aqueous waste.
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Appendix A
Waste Stream Selection Matrix

A.A1 Actual figures for stream selection matrix where applicable (applicable figures are in
red)

Product

^actopamine

THmlcosin

61831

10202

0

2,810,443

338
9

11

LAEG limit
(gday)
Waste mass
kg/year

API molecule
size
Segregation
2004
campaign
duration
weeks

Benzodiazepine
HCI

Olanz
Tech Olanz final

Ralox
Tech

Ralox
final

Atomo
final

Atomo
mandeiate

MTA
steps
4&5

MTA
steps
6&7

2400

2400

33

33

3546

3546

699,593

51,627

0

854,400

0

595,507

1,465,863

32,500 13,000

868
9

265.8
1

312,4
1

3124
1

559.54
1

509.6
1

291.82
1

407.51
4

6557 471 38
4
4

16

10

10

11

14

0

19

32

2400

4151

10

4151

6

Scoring svstem for each oarameter

LAEG limit
(kg/day)

Waste mass
(kg/year)

API Molecule
Size

Segregation

<400

More than 2 different product waste
streams flowing into the secondary waste
day tank at any one time
campaign < 2 months

100,000 < mass <
500,000

600 < size < 600

Two different product \A^ste streams
flowing onto the secondary waste day
tank at any one time

2months < campaign
< 6 months

> 500,000

>600

Only a single product feeding into the
bulk day tank at any one time

campaign > 6 months

1
(Undesirable

J

< 500

500 < limit <
4 (Neutral) 5,000

9
(Favourable) > 5000

< 100,000

Campaign Duration

A.A2 Final version of scored stream selection matrix

Weighting Product

LAEG limit
(kg/day)

Ractopamine Tilmicosin

Benzo
HCI

Olanz
Tech

Olanz
Final

Ralox
Tech

Ralox
finak

MTA MTA
Atomo Atomox steps steps
final mandelate 4/5 6/7

36

36

16

16

16

4

4

16

16

16

16

Waste mass
API
molecule
size

3

27

27

3

3

27

3

27

27

3

3

2

18

2

2

2

8

8

2

8

18

8

9

9

1

1

1

1

1

9

9

9

9

2

Segregation
2004
campaign
duration

8

18

8

8

8

8

2

18

18

8

2

1

Analytical
Method

4

4

4

4

4

4

4

4

4

4

4

Score

58

108

54

30

30

48

18

72

78

54

38

4
3

2
2

LAEG limit
(g/day)

1
(Undesirable) <500

500 < limit<
4 (Neutral) 5,000
9
(Favourable) > 5000

Waste mass
(kg/year)

API Molecule
Size

<100,000

<400

100,000 < mass <
500,000

> 500,000

Analytical
Method
Segregation
More than 2 different
product waste streams
flowing into the secondary
not
waste day tank at any one
applicable time

not
600 < size < 600 applicable

>600

not
applicable

Campaign Duration

campaign < 2 months

Two different product waste
streams flowing onto the
secondary waste daytank at 2months < campaign
any one time
< 6 months
Only a single product
feeding into the bulk day
tank at any one time

campaign > 6 months

Appendix B
Tilmicosin LAEG calculations

A Tilmicosin LAEG calculation is shown for two scenarios. The first scenario is a simpler case with a
one stage membrane plant. The second scenario is a two stage membrane plant which is the
design for the proposed full scale plant on site. Its worth noting that wash volumes have not been
taken into account. For simplification it has been assumed that the cleaning cycles would not effect
the LAEG calculation. From optimization work on washes required for a full scale plant, a relatively
small volume of water would be required to wash the plant and the segments of wash that would be
heavy in API are likely to be sent to incineration. The net effect on the LAEG calculation should be a
slight decrease in obtainable volume reduction which if anything would reduce the relative LAEG.
Both scenarios are as follows :
A.B1 Tilmicosin LAEG calculation for one stage plant
This is a sample calculation based on run 15 of the first round Koch pilot trials (see chapter 4)
Data ;.
LAEG for Tilmicosin = 10,202 g/day
Volume reduction achieved = 83%
API concentration in the final bulk permeate = 246 ppm

Calculation of bulk permeate concentration that equals the LAEG, ppm ( for Tilmicosin
production on one rig )
Cycle time for Tilmicosin (i.e. the time from the commencement of manufacturing of one batch to
the time of commencement of manufacturing of the next batch = 20 hrs
Average waste produced per batch of Tilmicosin = 10,000 L
Waste produced per day = (10,000L)(24hrs) / 20hrs = 12,000L/day
Volume of permeate produced with a volume reduction of 82% = (12,000L/day)*0.82 = 9960L/day
Bulk permeate concentration that equals the LAEG = (LAEG) / (Volume of permeate)
= (10202g/day) / (9960 L/day)
= 1.024 g/L
= 1024 mg/L
= 1024 ppm
Calculation of the relative LAEG for Tilmicosin production on one rig
Data :
Actual bulk permeate concentration of API = 216 ppm

Relative LAEG =

Actual bulk permeate concentration of API) /
{Bulk permeate concentration that equals the LAEG)

Relative LAEG = (216 ppm) / (1024 ppm) = 0.211

Note ; for Tilmicosin production on two rigs, all else being constant, the volume of permeate would
double, the bulk permeate concentration that equals the LAEG would half and the relative LAEG
would therefore double to 0.422

AB.2 Tilmicosin LAEG calculation for 2 stage plant
This is a sample calculation based on run 22 of the second round Koch pilot trials (see chapter 6)
Data :
LAEG for Tilmicosin = 10202 g/day
Volume reduction achieved for run 20 = 80%
Volume reduction achieved for run 20 = 70%
Volume reduction achieved for run 20 = 90%
API concentration in the final bulk permeate of run 22 = 220 ppm

Calculation of bulk permeate concentration that equals the LAEG, ppm ( for Tilmicosin
production on one rig )
Cycle time for Tilmicosin (i.e. the time from the commencement of manufacturing of one batch to
the time of commencement of manufacturing of the next batch = 20 hrs
Average waste produced per batch of Tilmicosin = 10,000 L
Waste produced per day = (10,000L)(24hrs) / 20hrs = 12,000L/day
Run 22 uses the permeate from njns 20 and 21 as feed. The overall volume reduction for this “two
stage process” is ; (Average volume reduction of runs 20 and 21)*(Volume reduction for run 22)
= [ 80% + 75% )/2] * 90% = 69.75%
Volume of permeate produced with a volume reduction of 69.75% = (12,000L/day)*0.6975 = 8370L/day
Bulk permeate concentration that equals the LAEG =
=
=
=

(LAEG) / (Volume of permeate)
(10202g/day) / (8370 L/day)
1.219 g/L
1219 mg/L

= 1219 ppm
Calculation of the relative LAEG for Tilmicosin production on one rig
Data :
Actual bulk permeate concentration of API = 220 ppm
Relative LAEG =

Actual bulk permeate concentration of API) /
(Bulk permeate concentration that equals the LAEG)

Relative LAEG = (220 ppm) / (1219 ppm) = 0.182

Again for Tilmicosin production on two rigs, all else being constant, the volume of permeate would
double, the bulk permeate concentration that equals the LAEG would half and the relative LAEG
would therefore double to 0.364

Appendix C
Benzodiazepine HCi LAEG Caicuiation

This calculation was carried out to determine the relative LAEG level in Benzodiazepine HCI
secondary waste. The results of the sampling campaign carried out on this waste stream for the
sample batch during this project ( see section 3.1.3.2 )are shown below ;
Second decant sample (ppm) = 40.9
Third decant sample (ppm) = 12.6
Mother liquor sample (ppm) = 52.2
Benzodiazepine HCI samples sent to
Veolia

API (ppm)

3rd wash sample

12.6

mother liquor sample

52.2

2nd decant sample

40.9

For each batch of Benzodiazepine HCI production, the waste streams and the volumes of wastes
were estimated as ( section 3.1.3.2.2 );
Second decant (L) =5826
Third decant (L) = 5826
Centrifuge mother liquor (L) = 5826
Centrifuge wash (L) =1148

Using this data, the mass of API is calculated as follows
Second decant sample = (40.9 ppm)*( 5826L) = 238 g
Third decant sample = (12.6 ppm)*(5826L) = 73g
Centrifuge mother liquor = (52.2 ppm)*(5826L) = 304g
The levels of API in the centrifuge wash are assumed as negligible, therefore the total amount of
API present in this batch is 615g
The cycle time for a batch of Benzodiazepine HCI is 48 hours, therefore the amount of API that
would be in secondary waste on a daily basis is 308 g. The LAEG for Benzodiazepine HCI is 2400g.
The relative LAEG for this batch is (304g) / (2400g) = 0.127

Appendix D
General protocol for first round trials on Koch pilot
plant

1. Waste storage
Waste would be collected from IE3 starting on Friday 20**^ Feb 2004. Waste would be transported to
a storage area outside IE11 polymer room. Waste that had been processed will also be stored in
this area before it was collected for disposal to secondary waste.
2. Commissioning procedure
A test run would be carried out on the pilot plant using water. All instrumentation and equipment
would be checked to see that it was operating correctly. Leaks if any would show up in this
commissioning period.
3. Adding waste into pilot plant
A 120L drum of waste that was being stored on a pallet in the IE11 storage area would be
transported via forklift to the pilot plant. A small sandpiper pump would be used to pump secondary
waste from the 200L drum into the 301 feed tank of the pilot plant. This would be done periodically,
the 30L feed tank will be filled and as the pilot plant processes the waste the level in the tank
wwould gradually drop to a point where the feed tank would be refilled.
When filling the tank, the 120L drum would be opened and the pump inlet hose will be inserted into
it. The outlet hose would be inserted into the 30L feed tank by slightly removing the loose lid on the
tank. Once the waste has been transferred, the 120L drum would be closed and the lid on the 30L
tank will be replaced.
4. Removing waste from the pilot plant
Waste drains off from the base of the pilot plant. At the end of each run the concentrate would be
drained into a waste collection drum which will be stored in the IE11 storage area when not in use.
5. Cleaning procedure for pilot plant
Following each run, the plant will be drained of concentrate as far as possible.
A high velocity flush to drain would be carried out using process water (hot not required) around
150 litres.
Hot process water (50‘’C) would be added to the feed tank with cleaning chemicals (nitric acid may
suffice however a Koch cleaning chemical would also be used if required). The pH and the
temperature would be checked and the water would then re-circulate though membrane for 20-30
minutes. No pressure should be applied to the membrane at this stage.
The plant would then be drained and flush with cold process water (50-100 litres). The hot and cold
water would be fed into and drained from the pilot plant in.

Appendix E
Koch pilot plant pre-startup safety checklist

Source treatment of secondary waste
Koch Pilot Plant Start Up Check-List

Item
Personnel protection and
emergency response

Comments

Page 1 of 4

Initial/Date

Is there a procedure in place to
operate the pilot plant.
Have all personnel working in the
vicinity of the plant been informed
of the safety protocol for the plantinclude IE7 operators?
Confirm that Koch representatives
have been advised on general
alarms and assembly point
Verify ail operators have been
advised on appropriate PPE
Are ear protectors in place for
personnel entering the pilot plant
area - will depend on noise level
associated with pilot plant
Advise ERT of new panel and pilot
plant, (fire)
Confirm location of nearest safety
shower, eye wash station and fire
extinguisher
Confirm location of nearest
telephone. What is the extension
number? The following numbers
should be posted beside the unit;
Security, SSL, Steve Daughney,
Barry Hennessy, Alan Edwards,
Oistin McGrath
Tour site with safety rep. and
decider if additional communication
equipment is required I.e. bleeper
or IE7 radio

— —

^

/7

Source treatment of secondary waste
Koch Pilot Plant Start Up Check-List

item
Electrical
Confirm membrane pilot plant is
adequately earthed
Confirm Electrical Power Supply
has been installed in accordance
with Lilly Procedures.

Machinery and instrumentation
Confirm Machinery Guarding is in
Place on pilot plant.
Confirm that stop button is
physically in place
Confirm stop button brings plant
rapidly to a safe state
Confirm Ex rating on motors and
instruments
Confirm details on nameplate of
dampener i.e. pressure rating
Confirm pump PRV certification is
in place and pressure set point is
47 barg
Confirm system PRV certification is
in place and pressure set point is
appropriate. Record pressure set
point
Confirm that system and pump
PR Vs relieve to safe locations
Confirm pressure dampner has
been charged to acceptable
pressure

Comments

Page 2 of 4

Initial/Date

Source treatment of secondary waste
Koch Pilot Plant Start Up Check-List

Comments

Item

Page 3 of 4

initial/Date

Installation and operation of pilot
plant
Is material associated with the pilot
plant (waste and cleaning material)
being stored in designated area
Is this material adequately labelled
and cordoned off to meet safety
standards.
Confirm pilot plant has been
acceptably sited and will not move
during testing
Confirm WFO connected
Confirm waste feed connected
Run a test on the unit using water
to check for leaks
Has Rotation check been
conducted on the pump?
Confirm high pressure switch
functionality. Ensure set pressure is
not greater than 45 barg. Record
high pressure set point
Confirm level switch functionality
Confirm that Koch are satisfied that
the pilot plant is set up in
accordance with manufacturers
recommendations and that its safe
to commence tests on the plant.
When running the unit, make sure
all flanges have some kind of
flange guard in place.

Source treatment of secondary waste
Koch Pilot Plant Start Up Check-List

Page 4 of 4

Additional Comments:
Additional Comments

Appendix F
Atomoxetine final waste titration with nitric acid

Figure F1: Graph illustrating the fall off in pH with the addition of nitric acid to a blended
Atomoxetine HCI waste sample

From Figure F1, it can be seen that with the addition of acid, the pH is relatively stable decreasing
slightly from pH 12.6 to 11.6. However, the pH suddenly crashes from 11.6 to 5.3. This rapid
decrease in pH occurred on the addition of between 4.3 and 4.9 g of acid per litre of Atomoxetine
HCI waste.

Appendix G
Graph illustrating the variation of TDS with pH for a
supernatant Benzodiazepine HCi second decant
sample

pH

Figure G. 1: Graph illustrating the pH which gives the minimum TDS levels in supernatant
Benzodiazepine HCI waste

Here a sample of Benzodiazepine HCI waste was blended so as to represent a bulked waste
stream from the process. NaOH was then added in a stepwise fashion so as to increase the pH
gradually. After each NaOH addition, the pH was measured and the precipitate that came out of
solution on addition of the caustic was allowed to settle. The conductivity of the resulting TDS was
then measured. This procedure was continued until a number of pH and conductivities had been
recorded and the data was used to generate the graph above.

Appendix H
Specifications for all membranes considered and
used

II KOCH

MEMBRANE SYSTEMS

FLUID SYSTEMS® TFC® SR®3, FOOD & DAIRY
Selective Rejection Nanofiltration Spiral Element Senes
PRODUCT
DESCRIPTION

Membrane Chemistry;
Membrane Type;

Proprietary 1=0=® pdyamce
3R«3 - seective r^ecton ranoh tiato''
Ooserved ncecular -.veiohtcut dt 2C0 3C0 caters
Sa^ tary sp ral wcurc w t net ojte'-w^ap
Cerfern-s to U3DA 3 A sta^darcs and FDA 'egu aticrs (C^R tle21)
Desaltng anc separation of p'^oteins arc cartonyorates
Diameter
3 8 O' 7.9
Length
38. 39 or 40"
Feed Spacer N1 (31 rili cr N2 (45 '"ilj

Construction:
Regulatory Status:
Application:
Options;

NOMINAL
PERFORMANCE^

OPERATING AND
DESIGN
INFORMATION*

Part Numbers
KPN
838380S
8383904
8S038O3
8882216
8383809
8383905
8503804
•’es(co!'d:c!'s

Rejection (%)
Permeate Flow
Lactose Chloride
gpd (m»/d)
TFC* 3538 SR*3 N1
99 9 30 50
1 ICO (4.2)
T"C*3539 SR«3N'
1 120 (43)
99 9 30 50
T=C*8338 SR®3M
5 4fl0 (20 3)
99 9 30 50
T=C*8522 SW N1
99 9 30 50
5 4C0 (20 3)
TFC* 3538 SR»3\2
99 9 319 50
890 (3.4)
TFC* 3539 SR*3\2
99 9 30 50
910 (3.4)
TCC*8038 5R*3 \2
99 9 30 50
4 5C0 (^7 3)
5'o acljsu 0 5S NaCI swf.cr at 200 ps ';13 8 bai ! t7T .;25't
Model

Operating Pressure Range:
Operating Temperature Range:
Cleaning Temperature Range;
pH Range • Continuous Operation;
pH Range • Clean-In-Place (CIP):
Design Pressure Drop Per Element;
Design Pressure Drop Per Vessel:

203
40
95
30

600 PS (13.8 41 4 pari
122 F (5 50 0
113'1^(35 45’C;
ICO

1.0 110

6 'C psi (0.4 0.7 bar)
30 50 psii2.1 3 4 bar)

PRODUCT
DIMENSIONS

A
inches (mm)
TC»383SSR»3\1 350 (965)
3383808
83835C4
TFC* 3839 SR»3 M 38 8 :984)
TC»8C35SR»5M 35 0 :965)
8803803
8882215
*FC»8e22SR»3M 430(^016)’
3383309
'FC»3835SR*3 \2 350 (965)
8333905
TO 3839 3R«3 N2 35 8 ;984)
3803804
TO8C35SR»3S2 350 1965)
’
'ic ’.A'j 1 lltC'cl •'-.’'Cs

Part Numbers

Mode!

B
inches (mm)
38 (96 C)
38 (56 0}
7 9 (20' 0)
7 9 (20' 0)
3 8 (96 Cl
3 8 (96 C)
7 9 (20' 0)

C
inches (mm)
0,831 (21 1)
0.831 (21.1)
1.125 (256)
1.125 (25 6)
0.83' (2' 1)
0.83' (21 1)
1.125 (256)

TFC«'SR*3. FOOD & DAIRY
Membrane Characteristics:
• '-CS 5R'«'3 elererts a'e selected vvner desa I rg arc
organ c concertraton is he cbiective
Seectve
Rejection merb'anes Drc\/ide nign 'etertor of divalent
salts c'oteirs and sjgars wme prefe^ential'y passing
ironova ent sa ts such as sociinr chlor de.

•

Chlorre toe^ance fc' TFC memcranes may be
Significanty 'educec I catayzing metals such as iron
are preserl or if tne 'eec oH and.or temperatu'e
conditions are different fnan stated

Cationic (Positively Charged) Polymers
and
Surfactants:
TFC SR5 memb'anes may be ir'eve'sid y fouled i' exposed
Operating Limits:
• Operating Pressure: I/ax mum ooe'atirg pressii''6 ter to cat one (positively cnargea) polymers or surfactants
'"C SR3 membranes is 5C€ psi (4'.4 bar) Actial Exposure to these chemicals during ope'aticn cr cleaning is
op-e'^ating c'essji'e is decercert ipor system flix 'ate not recommended and wili voiC tne ■A'a"anty
jaop'cpriate 'or 'eea scarce) as well as 'eec 'ecevery
Lubricants;
ard temoeralure conditions.
• Permeate Pressure: Permeate pressure should not For eement instahaton use only wate' O' glycenn to
exceed baseline (corcertrate) pressjre at ary tre lubricate seals ""ne use of petroleum or vegetaD e-basec
( ncludirg online oft-lme and durng transtior) Reverse oils or solvents may damage the eement and wII vo d tne
vva'ranty.
press jre wH carnage the module.
•

■

•
■

Differential Pressure: f/axii^urr dit'e'ertial cressj''e
limit is 12 dsi (0.8 oar) cer eement
Maximjm
diffe'entia c'essjre fo' ary lergtn vessel is 5C csi (4 0
bar)
Temperature: Maximjm oceratirg temperatjre is '22^
iSO'C)
Maxrrjm cearrg teirce'ature is h3‘'F
(45X)
pH: Alowable range fo' continuous oce'aticr s 3.C to
10.C.
Fo' operating outs de these cond t ons consul KMS

Water Quality for Cleaning & Diafiltration:
• pH; Recomniendec range tor clearing is' 0 to 11 .C.
• Turbidity and SDI: f/aximum 'eec turcioty is ' N^J.
Maximum ‘eec Silt Oens ty Index (SSI) s 5 0 CS-mirute
test)
• Guidelines: Pease 'e'er to the Kt/S Water Quaity
Guidelines for CP ard Ciafiltratior ’or mo'e detailed
irformaten
Chlorine and Chemical Tolerance:
• ""C SR3 memt^'anes nave a free chlorine tolerance
rat ng o' 2 000 ppm-ncurs at 77"- (25"C). pH 8
• "ne max mum continuous chlorine exposure imit is 0 2
ppm.
• Sodium metabisul'ite (w thout cata ysts s jcn as coca t) s
the p'e'e'red chemical to elnmate ''ee chlorine or
similar oxidize'S n the 'eed

Supplemental Technical Bulletins;
• RO.'NF Modj e C'eanirg Procedures
• Water Quality Guidelines 'or CIP anc Dia'i trat on
Service and Ongoing Technical Support:
Kocn Memprane Systems (KMS) has an excenenced sta'^
of professionals available to assist eno-users and CEM s 'or
optimization ol existing systems and supcort win te
development ot ne'w appi cations. Along uvln the avaiiabnity
o' supplemental technical tuiehns. KMS also offers a
complete Ine o' KCCH^RE.A'® and KOCH-uEE'**
memb'ane p'etreatment clearing and mantenance
chemicals
KMS Capability
KMS is the leade' n cross'low miembrane techrolc^y
manulacljrna reverse esmess, nanc'i t'aticn m crofiltraticr arc j t'ah t'aticn memb'anes arc memb'ane systems
The rdjst'ies we se'-ve inc'ude 'cod dairy ard ceve'age
semiccrductors. automotve. water and wastewate'
chemical ard gere'al manufacturing. KMS adds value by
providing top quality membrane p'ocucts and oy snaing ou'
experience n the design and supply o' thousands of
cross'lew' membrane svstems wondwice.
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KOCH
MEMBRANE SYSTEMS

SeIRO MPS-34 - pH Stable Membrane
Nanofiltration Spiral Module Series - 2540,4040
PRODUCT
DESCRIPTION

Mcnbranc Cnetinstry
Mcnbrane Type:
Construction
Major Applications:
Optons:

PiuL'rttii>’ Cj'i'cosilc Nd'io' lidi'icr Vcdiriaoe
iiat) c Ndali :'dli>:-i
d'o

Spifd-'<V'jjr<JcieiTai;
d'd caustic XCOVU'y r-ocjcl CU'SCr llldtCr
C''d-M'cl spdccB: S a-J 5^ '"i

PcfTcax xU.c: Stainlcas sfjcl C-M

Rejection

SPECIFICATIONS

glucose*'
sucrose

VPS-3'5 ^S'.C
vr-s-y.'t(>tc

Percent
35 1:7
35 ■ S'

57 mil Spacer

30 mil Spacer

•teCI
Percent
35
55

Membrane
Area

Permeate
Flow
gpc
5il'
2130

m^.'d
23
5’

ft^
7
53

Mcnbranc
Area

PeriTieatc
Flow

nP
15
5o

gpd
‘.K

1.500

m^'O
17
55

ft*
13
43

n*
1.2
4,0

■’eKConiiiors ROwato atUCMiaOj^ari dt'T t;X'Ci re«si>Jlcntorie)8cactilcslJi'e3^j>/Xser3%v-3Csea51tS3C

& DESIGN

'yct.d Ooefdlrg PtssLic
Vdninun Cixiat ng Tci’iixratu'O
Vd.«.inun Clean IK) 'enice'alix

INFORMATION

AJe-Adck cl‘ - vj'".i"ja'j.> opeicilcr

OPERATING

ZZ^SKigsiila-aScd';
15rT i7Q*C|i5?'f .;70‘:;r

:-‘4“
10 Ki iO ■ tari
50 wi i3 5 tarj

/•J cr.xle C'H - Cli'd''- nr <tx (C P!
VtWinun pxb:>xo oi'.': pti cicren::
Vdxmbi'i px'SijR Crag pci vUiSe ;5 i" sc' es!

no4S8 ’Cte to ffl Tmpa Jiure-Tressuc arnoocc n^er •.erMf»:ifc s tughai tun 122’' ;5C'C|
' Conc&«e doiis sliculd u 3'^oded wlun a sta^fen sled w*r«ix tube i betig ^sed

PRODUCT
DIMENSIONS

a

Model
inches
MFS 34 2543
MFS 34 4M3

383
383

b
(mm)
;955)
;S55I

inches
24
39

d

c
(mm)
i61)
'<%]

inches
0,75

0.75

(mm)
(1905)
(19 05;

TYPICAL

5^ -|C‘

157 Ace;-, d.d

3‘al.dOI-

PROCESS

377 hCI

5':} HNCs

2157 NaOH

STREAMS

■571-25514

207

'C7 "-.'DH

inches
40
40

(mm)
(1C151
(IC15)

SelRO^ MP$-34 - pH Stable Membrane
Mcnrbranc Characteristics.

Operating Envelope For Code 30 Membranes;

Coi t;'JEilu fa:'yfitrdit.i I’triHtr’u h sitsl /.•cuii';
Ail*'
(j I
lu'i'cefciluft siti'jr W

It s i vo'ortam to feltow the ciossL't - '.c-nipp-aiu'c re alci;s'i p
:j ioinos I P'dev to pro'»cnt iievo's b c cci'ipa;t.cr an:
pcriormarbo Jetenciaton Ik ‘cl OAi-'g Jiaijram sl'ee 3 k usee
as a .jjk'p if'C to opcraling Ik VPS-34 spcal rrcc jc.

Ope»^ating Limits:
• Ooerating P-'cssurc; Va* :’ifi cpcta'.r'j c'cssju b'
;e
V"S-?-1 IS f ■ C PS ;iS S'd'; Acilci cp*fa:
p'C'ss..t'j s tbxficcri upcn Syi:tn ‘’la 'ab as '.>l I tt toJ
"Lccvcay cf’d brceraiLfc ccxisilMis
• Maximum Allowca Permeate Pressure j iti i J i. Pari
• Differential Pressure Muxirum <jilltitr’>ai ctossL't I ril is
1 j PS !0.7 w; PCI oteTC'i! ya-xinun piffti'j ilial pvcssjic
•'c a"y Icr'jth vt-ssc is K ps '3 5 pa'!
• Terrperature Ma.*r jmoporali'tc b ipcia'.t.'p s IM'F
;7'J‘C) * in sia less sicci pp-reax' :jpc' a'’31'3*1 45‘C;
■* :h CF'vC pu'i'pab lupc. F-jc jactiircs pi rpLurmp-’PcJ
xmpt'dlj'c d’ ti pxss-ie pkdiC fpicr ‘.c '.np Rcc'Ji'mf'iAjp'J
.nvcxpL fer Code 3iJ me i francs i' ms ccc-nenl
• pH Aj!f*aPX 13'KiL tci pcxili'iL'xiscfx.iaici's C-11 Aif
^'P’ I’palc UDo. 'A'np'! a Sia r. css sloe permeate liiPo
is ssed conosi'xL at ds sttojkl k averje-a
• Water Quality for cleaning and Diafiltration

•

Turbidity; Vax nun feed tU'L+J ly is 1 NTU
Guidelines. Fc' nieiedclailcd nb'iiiaicr sbasc lO'U'i t
w 'l '.MS I 'O'X’SS leo'irclcjy
• Chlonnc and Chemical Exposure
• || s net 'cxonii'ipfue-p lo expose .'ip beIRCt!'. f/PS-3'l to
s'I I'i'ic Of ell • I px Jar's a^ : iriay a'Ico'II ( mcTt'aK
pedofma'ipc
• SoOL'i I elansabtc‘V.'1'Kul caialysts sutl tisocpa:: s
II c pfefct'e J cic I -cal to c in rate free e’l O' re oi sm'i a’
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• It s ixt •eeomn'p'i:e''j loexpiose ‘.np ScIR'l'*! MP;-34 to
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MKOCH
MEMBRANE SYSTEMS

SeIRO® MPS-44 - Solvent Stable Membrane
Nanofiltration Spiral Element Series 8040
-

PRODUCT
DESCRIPTION

MOTD'’anc Chemist^:
McmD'■a^c T ype:
Construction;
Majo'’ Aoplications;
Options

SPECIFICATIONS
Model

tPS-44 ai:-1u B2a
fps-w a1C40B2Z

P'u:rk;’.a’* ccriDcs :c r.ai'ofili'aiiO'i menili-are
Scivert slat t narcfil’.'Stb'i rierbrarc
bpir.i-A'Cind eterne-ii
Sc^vcri xcovi'y' p'ocu'.'l ccxKXi lra; O’’ •xni wlir sc *xn: slfoani;
FofiO C’lairio spaces
aic 57 m l

Part
Number

Rejection

Permeate Flow

(%]
glucose'
sucrose

NaCI

93 . P
93.97

K>

07'01W
J7T0214

*5

gpd

m7'd

6 250
■1 500

24 C
-TO

Membrane
Area

270
'95

Feed
Spacer

m^

mil (mm)

i5
18

3c;o7u;
57:1 45:

Tbs: Ccndiiifts aC' •ate' at 4*; pu (30 &ai(i, 86* r .;3C'*Cl
Toed jdm<r 'e<ecw
aio ghiose 13% axrjsc

OPERATING
& DESIGN
INFORMATION*

Typical Operating Pressure;
Maximum Opealmg Temperature;
Maximum Cleaning Temperature
Allowable pH - Continuous operaticwi;
Allowable pH • Clcan-ln-Olace (CIP);
Maximum Pressure Orop Per Element
Maximum Pressure >op Per Vessel (5 m series);

i2C'-5iD psi ilu-jiS id';
10''.*F (It’C)
1Cl^*F (■Ic'C)
3-‘C
2-11
10 tii iO' fcaii
50 esi li 5 btii

' - Ocrtact FY'xess T ethnology GiPx<> (tr ST'O-rift; .xf'fculifris

NOMINAL
DIMENSIONS

Model

Part
Number

M^s a 834i: e2x
'.PS U 834C' B22

3770154
3^70214

a
Indies
400
4-30

b
(mm)
(1016)

(lote;

Inches
7S
79

c
(mm)
1200
(200

inches
• 187
M87

(mm)
(33 -5)
(33 -5)

SeIRO' MPS44 - Solvent Stable Nanofiltration Membrane

Mcirb'af’e Characteristics;
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Product Information

FILMTEC^ Membranes
FILMTEC NF90-400 Nanoffltration Element

F«atur«s

The FILMTEC™ NF90-400 nanofiltration element is a high area, high productivity element
designed to renwve a high percentage of salts, nitrate, iron and organic compounds such as
pesticides, herbicides and THM precursors.
The high active area membrane combined with low net driving pressure of the membrane
allows the removal of these compounds at low operating pressure.

Product Specifications
Nominal Acdva Surface Area

Product Water Row Rate

StNiilized Sait

NaCI

7,500(28.4)

85-95

MgSOx

9,500(36.0)

>97

Product
WSMOO

GliD
149985

400(37)

1 Permeate low and saH passage based on Iw following lest conditions:
2.000 mgil NaCI. 70 psi (0.48 MPa). 77”F (2S°C} and 15%reooverY
2,000 mgll MgSO.. 70 psi (0.48 MPa). 77f (25"C) and 15%recovery
2. FlowretesIbrIrxKidualetementsmay vary'^15%
3. The above specilcalions are benchm^ values Please be sure k> operate accordng to our system design guktelinas.

Figure 1

1
J

CD

1

Brine I
Single€lemont

Dimeneione - Inchee (mm)

Product

Recovery

A

NPW^

15%

40(1,016)

B
7,9(201)

1.5(38)

1 Rater lo FUnTec Design Guideines for multiptealement applicalions and recommended element recovery rates for various feed sourcss.
2. 0emer)l to fit nominal 8.004nch (203 mm) 1.0 pressure vessel

Operating Limits

Membrane Type
Maximum Operating Temperature
Maximum Operating Pressure
Maximum Pressure Drop
pH Range, Continuous Operation®
pH Range, Short-Term Cleaning (30 min.)'’
Maximum Feed Flow
Maximum Feed Siit Density Index
Free Chlorine Tolerance^

FilmTac suppHse
couplsf part number
299171 wth each
Mement Eacbcoupiar
mciudes two 2-125
EPR o-rtngs (FrtmTec
part number 215370)

1 inch = 26.4 mm

Polyamide Thin-Film Composite
113°F (45°C)
600 psig (41 bar)
15psig(1.0 bar)
3-10
1-13
70gpm (15,9 m^/hr)
SDI5
<0.1 ppm

Maxinum tamparature tor confnuous oparaton above pH 10 is 95°F (35°C)
Rater to Ctearing Guidelines to ^ledflcalon sheet 609-23010.
Under certain comttions, Ihe presence o( lee chlohrw and other ackfeing agents will cause premature membrane biure
Since oxidation (temsge is not covered under warranty, FfimTec recommends remowng residual lee chlorine by
preteatoienl prior to membrane exposure Fheaee refer to technical buHetn 609-22010 for more toformidion
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Important
Information

Proper start-up of reverse osmosis water treatment systems is essential to prepare the
membranes for operating service and to prevent membrane damage due to overfeeding or
hydraulic shock. Following the proper start-up sequence also helps ensure that system
operating parameters conform to design specifications so that system water quality and
productivity goals can be achieved.
Before initiating system start-up procedures, membrane pretreatment, loading of the
membrane elements, instrument calibration and other system checks should be completed.
Please refer to the application information literature entitled *Start-Up Sequence” (Form No.
609-02077) for more infonnation.

Operation
Guidelines

Avoid any abrupt pressure or cross-flow variations on the spiral elements during start-up,
shutdown, cleaning or other sequences to prevent possible membrane damage. During
start-up, a gradual change from a standstill to operating state is recommended as follows;
• Feed pressure should be increased gradually over a 30-60 second time frame.
• Cross-flow velocity at set operating point should be achieved gradually over 1S-20 seconds.
• Permeate obtained from first hour of operation should be disca’ded.

General
Information

Keep elements moist at all times after initial wetting.
If operating limits and guidelines given in this bulletin are not strictly followed, the limited
warranty will be null and void.
To prevent biotogical growth during prolonged system shutdowns, it is recommended that
membrane elements ^ immersed in a preservative solution.
The customer is fully responsible for the effects of incompatible chemic^s and lubricants
on elements.
Maximum pressure drop across an entire pressure vessel (housing) is 50 psi (3.4 bar).
Avoid permeate-side backpressure at ^1 times.

RLMTEC” MetnbranM
For moft tnfonnitlon ibout FILMTEC
RMinbmM, can the Don Liquid
Saparationa bualnaaa.
North Amaricx

1-a00-447-4369

Lahn Amanca:
Eufopa:

(■«5) 11-5188-«222
1+32)3-450-2240

Padle;
Japan

+00 3 7958 3382

CNna

■•66 21 2301 9000

-•013 5460 2100

htt)7/aawi»limtec com

P89e2crf2

Nofce: Theuseof tiis product in and of itseir does not necessarily guarantee the removal o( cysts and palttogansIrcmwQtar
Effective cyst and pathogen reduction is dependent on the complete system design and on the operation and mainienance of
the system.
Notce: No freedom from any patent owned by SeHer or others is to be inferred. Because use conddions and applicable laws
may (fffer
one locaton to another and may change with time, Customer is responsUe for determining whefeer products
and the information in Iris document are appropriate Ibr Customer's use and for ensuring that Customer's workplace and
disposal practices are in compliance tteth applicable laws and other governmental enacfrnents. Seller assumes no obligafron or
liability for the informalon in this document NO WARRANTIES ARE GIVEN: ALL IMPLIED WARRANTIES Of
MERCHANTABILITY OR FITNESS FOR A PARTICIAAR PURPOSE ARE EXPRESSLY EXaUDED.

™* Trademark of The Dow Chemical Compwy (TouT) or an atfiSated company of Dow

Form No. 609-00345-0406

Product Information

FILMTEC™ Membranes
FILMTEC NF20(M00 NanofHtration Element

Features

The FILMTEC™ NF200-400 nanofiltration element is a high area, high productivity element
designed to remove a high percentage of TOC such as pesticides, herbicides and THM
precursors while having a medium to high salt passage; medium hardness passage.
The FILMTEC NF200-400 element is an ideal element for surface and ground water
applications where good organic removal is desired with partial softening in order to maintain
a minimum level of hardness for organoleptic properties and preservation of distribution
networirs.
The high active area membrane combined with low net driving pressure of the membrane
allows the removal of these compounds at low operating pressure.

Product Specifications
Nominal Active Surface Area

Product Water Flow Rato

SlablUzadSWt

CaCb

8,000 (30.3)

50-65

IIBSO4
Airarfne

6,800 (25.7)

3

Product
NF20IM00

QUID
135847

400(37)

53

1 Patmaate flow and salt passage based on tw following lest condiions
500 mgfl CaCb. 70 pa (0 48 MPa). 77°F <25°C) and 15%rBCOveiy
2,000 mgfl MgSOj, 70 pd (0.48 MPa). 77°F (25*C) and 15%faco»efy
2. Flow rales for indIvKiualelemenIs may vary-^-15%
3. Minimum rejecton is 93%.
4 The above specitcaflona are benctonatlt values. Please be siaa to operate according to ow syston dasflpi guidelines.

Figure 1

1
J

RimlFC suppittt

CD

1

oouptor part ramber
25^71 wiitiMcb

sleinant Eaoheoupiar
ndudastwo 2-125
EPR o-finQS (FMmToc
port numbar 216370)

Brine I

Stngto-Bamant

Dinwnaiona - Inctiat (mm)

fVoduct

Recovery

B

C

NFZOIMOO

15%

1.5(38)

7.9(201)

40(1,016)

1. Refer to FOnTac Design Guidelines for muMple-eleinenl applications and reoonvnendedelament recovery rales for various feed aourcas.
2. Element to ttnomnelS.OO-incb (203 mm) lb. pressure vessel.
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Operating Limits

Polyamide Thin-Film Composite

Membrane Type
Maximum Operating Temperature

113°F(45°C)

Maximum Operate Pressure

600 psig (41 bar)

Maximum Pressure Drop

15psig(1.0bar)

pH Range, Continuous Operation*

3-10

pH Range, Short-Term Cleaning (30 min.)‘'

1-12

Maximum Feed Flow

70 gpm (15.9 m^/hr)

Maximum Feed Sit Density index

SDI5

Free Chlorine Tolerance^

<0.1 ppm

Maxirum temperatjre ior oontnuous operation above pH 10 is 95°F (3S*C).
Refer to Cleei^ Quidefines in spectfioalian sheet 609-23010.
Under certain condlians, the presence of tee cMotine «id other ooddizing agents vfei cause premature marrprane Mure.
Since oxidatian (femage is not covered under vniTanty. FfenTec recommerKk removing residuai tee chlorine by
preteetnent prior to membrane eiqaosure Pleese refer to technicaibutotr) 000-22010 for nvireinfannaion.

Important
Information

Proper start-up of reverse osmosis water treatment systems is essential to prepare the
membranes lor operating service and to prevent membrane damage due to overfeeding or
hydraulic shock. Following the proper start-up sequence also helps ensure that system
operating parameters conform to design specifications so that system water quality and
productivity go^ can be achieved.
Before initiating system start-up procedures, membrane pretreatment, loading of the
membrane elements, instrument calibration and other system checks should be completed.
Please refer to the application information literature entitled *Start-Up Sequence’ (Form No.
609^2077) for more information.

Operation
Guidalines

Avoid any abrupt pressure or cross-flow variations on the spiral elements during start-up,
shutdown, deaning or other sequences to prevent possible membrane damage. During
start-up, a gradual change from a standstill to operating state is recommended as follows:
• Feed pressure should be increased gradually over a 30-60 second time frame.
• Cross-flow velocity at set operating point should be achieved gradually over 15-20 seconds.
• Permeate obtained from first hour of operation should be discarded.

General
Information

Keep elements moist at all times after initial wetting.
If operating limits and guidelines given in this bulletin are not strictly followed, the limited
warranty will be null and void.
To prevent biologica! growth during prolonged system shutdowns, it is recommended that
membrane elements be immersed in a preservative solution.
The customer is MIy responsible for the effects of incompatible chemwals and lubricants
on elements.
Maximum pressure drop across an entoe pressure vessel (housing) is 50 psi (3.4 bar).
Avoid permeate-side backpressure at all times.

FtLMTEC"* MMnbnmt
For moro IntormaUoii about FX.KTEC
mtmbraiMa, cal ttM Dov Liquid
Soptrattoaa buabwai:

Notice: Tfwuae of tVs product in and of itself does not necessarily guarantee the removal of cysb and pathogens foom water
Effacfve cyst and pathogen reduction is dependent on the complete syttan design and on the operation and maintenance of
the system.

NodhAmanca:
LalHi Amtnca:
Eurapo:
Padic

Notce; No taedam tom any patent owned by Seler or others is to be infeiTad. Because use condtions and applicable laws
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Appendix I
Protocol for Veolia bench scale trials

1. General information

Objective
The objective of these trials is to determine the API rejection rate for the three wastewaters at
different operation conditions and with different membranes
Description of the Nanofiltration laboratory rig
Two rigs will be used for the pilot trials. Diagrams of each of these rigs are shown in Figure 11 and
Figure I2 below, pilot test MG (filter surface; 464 cm^) and pilot test MP (filter surface; 232 cm^).

Figure 11: Pilot plant MG (filter surface; 464 cm'"

Figure 12 : Pilot plant MP (filter surface: 232 cm^)
The configurations of the two pilot tests are identical' They both contain a flat sheet membrane cell
including a feed and a permeate spacer (same as in the spiral wound module), operated under the
same hydraulic conditions as a spiral wound module
Each of the pilot plants is made up of the following hardware.
•

A stainless steel feed tank with stirrer, pH-meter and temperature control system,

•

Stainless steel pipe work,

•

A variable speed pump,

•

Pressure gauges.

Each rig can be operated in different modes;

1)

Continuous closed loop operation: permeate and concentrate recycled back to the feed tank.
This mode allows one to determine an eventual impact of the operation time on the API
rejection rate.

2)

Batch mode: the concentrate is recycled to the feed tank and the permeate is collected in a
permeate tank. Permeate samples are taken at to and from the permeate tank at different
recovery rates

2. Trial protocol

The tests to be carried out by Veolia were summarised under the following general
headings:
Standard tests: for each membrane, standard tests to determine permeability and salt rejection
would be conducted under standard test conditions as detailed by the membrane manufacturers,
before and after the trials.
Raw water preparation: for each raw water sample, the suspended solids would be removed by
filter bags and, if required, the pH would be adjusted to the values given above (standard polyamide
membranes only)
Membrane preparation: each new membrane is wetted by an one-hour soak in a 25% isopropyl
alcohol solution. Between two trials, the membranes are rinsed thoroughly with demineralised
water. If a significant permeability loss is observed after the rinse (> 15%), the membrane will be
replaced by a new one.
Membrane solvent stability tests: both membranes would be soaked in the three waste waters
(after filtration), for 4 weeks, as soon as Veolia receive them from Lilly. A standard test would be
conducted after the soak on each membrane sample.
Standard API removal trials: (2 membranes with the 3 waste waters

->

6 trials); batch mode as

described above at 20 L/h/m^ and 25°C. Initial and intermediate permeate samples taken at to, 50%,
75% and 90% recovery as far as attainable and at 50 bar at a flux rate of 20 L/h/m^. Final permeate
& concentrate samples taken at 50 bar at a flux rate of 5 L/h/m^ (or when the pump starts to draw
air)

Impact of operation time: (NF200 with the Atomoxetine HCI waste water and the Benzodiazapene
HCI taken at to and after 8, 24 & 36 hours of operation.
Impact of flux rate: (both membranes with the Atomoxetine HCI waste water and the
Benzodiazepine HCI waste water

4 trials): continuous operation as described above at 25'’C.

Permeate samples taken at 10, 20 and 30 L/h/m^, each after 15 minutes of operation.
Impact of temperature: (both membranes with the Atomoxetine HCI waste water and the
Benzodiazepine HCI waste water

->

4 trials): continuous operation as described above at 20 L/h/m^.

Permeate samples taken at 15, 25 and 35’’C, each after 15 minutes of operation.
It must be stressed that a lot of the trials proposed above were dependant on the ability of each
membrane to permeate each of the three waste streams.

3. Sampling analysis carried out by Veolia
3 raw waste waters:
•

BOD5, COD, TDS, pH, and conductivity

•

APIs and solvents (200 mL)

3 conditioned feeds:
•

BOD5, COD, TKN, ICP, pH. SO4, F, HCO3, Ca, Fe, Sn, Ba and Si

•

API and solvents (200 mL)

Intermediate permeates of standard API trials, permeate of all other trials and final feed or
operation time trials :
•

pH, conductivity

•

APIs (100 mL)

Final permeate of standard API trials (6 samples!:
•

BOD5, COD, refractory COD, TDS (3 samples only), respirometry (3 samples only), TKN, pH,

conductivity, SO4, F, HCO3 and Si
•

APIs and solvents (200 mL)

Final concentrate of standard API trials f6 samples)
•

TKN, ICP, pH, conductivity, SO4, F, HCO3 and Si

•

API’s and solvents (200 mL)

Appendix J
Calculation of the potential increase in volume of
effluent feed to the WWTP due to permeate from a
full scale membrane plant

At this stage of the project, it was still planned that a single stage full scale plant would be sufficient.
In light of this information, it was assumed that the overall volume reduction would be 70% i.e. a
75% volume reduction of the waste being reduced to 70% when the cleaning volumes required for
the plant are taken into account
It was also assumed that Tilmicosin production would be on 2 rigs and the volume of waste
produced per batch of Tilmicosin would be 10,000L.
It was also assumed that the cycle time for Tilmicosin production will be 24 hours
The additional volume of waste being sent to the waste water plant is given by ;
(Volume of waste produced per batch)*(Number of rigs producing Tilmicosin at one time)*(Overall
volume reduction)
= (10,000 L/batch )*( 2 rigs ) * ( 70% volume reduction )
= 14,000 L/day of Tilmicosin permeate
In 2004, the average volume of waste being sent to the WWTP was 170 m^/day.
Therefore the additional volume being sent to the WWTP would be (14,000L/day) / (170,000L/day)
=

8.2%

Appendix K
Examples of high and low volume of Tiimicosin
waste from production in a 24 hour period

Example of high flow

A80109;ANS3rr24: VVN24A PNT - Sampte

A0O109/AiNS3VySTLN65B PNT-Sample

Figure K1: Trend graph of Tilmicosin secondary waste day tank (T65) on 1^ December 2004

15837 litres
The graph above shows the mass of process material in Tank 12 in the Tilmicosin process ( green
line ) and also T24 (maroon line). These tanks are the sources of five of the seven waste streams
from the Tilmicosin process. The other two sources are T6a (distillate) and T40 (vacuum pump seal
water).
The blue line is the level in T65 which is the secondary waste day tank from the Tilmicosin process.
The y-axis of the graph gives the level in T65 and the x axis plots the changes in each parameter
with time.
The volume of waste was roughly calculated as follows ;
Any peak in the T65 level represents a waste stream being dumped from the process with T65
subsequently filling and emptying to environmental control. Where at all possible, blue peaks are
linked to streams being dumped from T12 and T24. Note flat elevated segments of the blue line
represent that T65 has been filled due to the addition of a waste stream, but the amount added was
not enough to cause the tank to empty on a high level switch (the high and level switches are set
up so that the T65 will empty when more than 800L are added.
Looking at the plot above, there are two T12 decants, a T24 decant and 2 sets of 3 T23 washes.
The mass of waste produced in each case was estimated by looking at the masses of T12 and T24
before and after each waste stream is dumped.
Besides these peaks, there is one other peak which cannot be liked to T12 or T24 waste streams,
which is highlighted above. This peak probably represents a T40 or a T6a waste stream. From the
mass balance in chapter 3, the average volume of waste from a T40 and a T6a segment are 1,700L
and 1400L respectively. Given that it is unclear whether the peak represents a T40 orT6a stream.

an average waste volume of 1650L was assumed. The summation of the identified waste streams is
summarised below in sequence as they were produced :
T12 decant = 3743 L
T24 decant = 1420 L
T24 first wash = 643 L
Unidentified waste stream = 1650 L
T24 second wash = 571 L
T24 third wash = 659 L
T24 decant = 1378 L
T24 first wash = 690 L
T12 decant = 3780 L
T24 second wash = 753 L
T24 third wash = 550 L
Total volume of waste = 15,837 L

Example of low flow

A80109/AWS3T24:WN24A PNT-Sampte

A80109/A)NS3WST:LNe5B .PNT-Sttnple

Figure K2: Trend graph of Tilmicosin secondary waste day tank (T65) on 29 November 2004

Here it can be seen that there are far less waste streams produced in this 24 hour period. There is
only one unidentified waste stream which is the second peak on the graph (with the arrow pointing
to it. The waste streams produced were quantified as before as follows ;

T24 third wash = 706 L
Unidentified = 1650 L
T12 decant = 3795 L
T24 decant = 1403 L
T24 first wash = 516 L
T24 second wash = 747 L
T24 third wash = 734 L
Total volume of waste -9,551 L
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